<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">87392</article-id><article-id pub-id-type="doi">10.7554/eLife.87392</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>The chemorepellent, SLIT2, bolsters innate immunity against <italic>Staphylococcus aureus</italic></article-title></title-group><contrib-group><contrib contrib-type="author" id="author-50910"><name><surname>Bhosle</surname><given-names>Vikrant K</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2103-6454</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-309411"><name><surname>Sun</surname><given-names>Chunxiang</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-309412"><name><surname>Patel</surname><given-names>Sajedabanu</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-324965"><name><surname>Ho</surname><given-names>Tse Wing Winnie</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4465-7859</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund10"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-309413"><name><surname>Westman</surname><given-names>Johannes</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-309414"><name><surname>Ammendolia</surname><given-names>Dustin A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-324966"><name><surname>Langari</surname><given-names>Fatemeh Mirshafiei</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="fund12"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-309415"><name><surname>Fine</surname><given-names>Noah</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-324967"><name><surname>Toepfner</surname><given-names>Nicole</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-309416"><name><surname>Li</surname><given-names>Zhubing</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-309417"><name><surname>Sharma</surname><given-names>Manraj</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-309418"><name><surname>Glogauer</surname><given-names>Judah</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-309419"><name><surname>Capurro</surname><given-names>Mariana I</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-309420"><name><surname>Jones</surname><given-names>Nicola L</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-64125"><name><surname>Maynes</surname><given-names>Jason T</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2050-3620</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="aff" rid="aff13">13</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund11"/><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-324968"><name><surname>Lee</surname><given-names>Warren L</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="aff" rid="aff14">14</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund9"/><xref ref-type="fn" rid="con16"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-309421"><name><surname>Glogauer</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff15">15</xref><xref ref-type="aff" rid="aff16">16</xref><xref ref-type="fn" rid="con17"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-80261"><name><surname>Grinstein</surname><given-names>Sergio</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0795-4160</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con18"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-309422"><name><surname>Robinson</surname><given-names>Lisa A</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1714-1929</contrib-id><email>lisa.robinson@sickkids.ca</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="aff" rid="aff17">17</xref><xref ref-type="aff" rid="aff18">18</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con19"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/057q4rt57</institution-id><institution>Cell Biology Program, The Hospital for Sick Children Research Institute</institution></institution-wrap><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03dbr7087</institution-id><institution>Faculty of Dentistry, University of Toronto</institution></institution-wrap><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff><aff id="aff3"><label>3</label><institution>The Keenan Research Centre for Biomedical Science, Unity Health Toronto</institution><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03dbr7087</institution-id><institution>Department of Laboratory Medicine &amp; Pathobiology, Medical Sciences Building, University of Toronto</institution></institution-wrap><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03dbr7087</institution-id><institution>Department of Molecular Genetics, Medical Sciences Building, University of Toronto</institution></institution-wrap><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/057q4rt57</institution-id><institution>Program in Molecular Medicine, The Hospital for Sick Children Research Institute</institution></institution-wrap><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03dbr7087</institution-id><institution>Department of Biochemistry, Medical Sciences Building, University of Toronto</institution></institution-wrap><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff><aff id="aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/042aqky30</institution-id><institution>Department of Pediatrics, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden</institution></institution-wrap><addr-line><named-content content-type="city">Dresden</named-content></addr-line><country>Germany</country></aff><aff id="aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/057q4rt57</institution-id><institution>Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children</institution></institution-wrap><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff><aff id="aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03dbr7087</institution-id><institution>Department of Physiology, Medical Sciences Building, University of Toronto</institution></institution-wrap><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff><aff id="aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03dbr7087</institution-id><institution>Department of Paediatrics, Temerty Faculty of Medicine, University of Toronto</institution></institution-wrap><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff><aff id="aff12"><label>12</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/057q4rt57</institution-id><institution>Department of Anesthesia and Pain Medicine, The Hospital for Sick Children</institution></institution-wrap><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff><aff id="aff13"><label>13</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03dbr7087</institution-id><institution>Department of Anesthesiology &amp; Pain Medicine, Temerty Faculty of Medicine, University of Toronto</institution></institution-wrap><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff><aff id="aff14"><label>14</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03dbr7087</institution-id><institution>Department of Medicine and Interdepartmental Division of Critical Care Medicine, Temerty Faculty of Medicine, University of Toronto</institution></institution-wrap><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff><aff id="aff15"><label>15</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03zayce58</institution-id><institution>Department of Dental Oncology and Maxillofacial Prosthetics, University Health Network, Princess Margaret Cancer Centre</institution></institution-wrap><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff><aff id="aff16"><label>16</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05deks119</institution-id><institution>Centre for Advanced Dental Research and Care, Mount Sinai Hospital</institution></institution-wrap><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff><aff id="aff17"><label>17</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03dbr7087</institution-id><institution>Institute of Medical Science, University of Toronto, Medical Sciences Building, University of Toronto</institution></institution-wrap><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff><aff id="aff18"><label>18</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/057q4rt57</institution-id><institution>Division of Nephrology, The Hospital for Sick Children</institution></institution-wrap><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Rothlin</surname><given-names>Carla V</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03v76x132</institution-id><institution>Yale University</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Rothlin</surname><given-names>Carla V</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03v76x132</institution-id><institution>Yale University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>29</day><month>09</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e87392</elocation-id><history><date date-type="received" iso-8601-date="2023-03-03"><day>03</day><month>03</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2023-09-10"><day>10</day><month>09</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2022-11-12"><day>12</day><month>11</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.11.11.515814"/></event></pub-history><permissions><copyright-statement>© 2023, Bhosle et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Bhosle et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-87392-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-87392-figures-v1.pdf"/><abstract><p>Neutrophils are essential for host defense against <italic>Staphylococcus aureus</italic> (<italic>S. aureus</italic>). The neuro-repellent, SLIT2, potently inhibits neutrophil chemotaxis, and might, therefore, be expected to impair antibacterial responses. We report here that, unexpectedly, neutrophils exposed to the N-terminal SLIT2 (N-SLIT2) fragment kill extracellular <italic>S. aureus</italic> more efficiently. N-SLIT2 amplifies reactive oxygen species production in response to the bacteria by activating p38 mitogen-activated protein kinase that in turn phosphorylates NCF1, an essential subunit of the NADPH oxidase complex. N-SLIT2 also enhances the exocytosis of neutrophil secondary granules. In a murine model of <italic>S. aureus</italic> skin and soft tissue infection (SSTI), local SLIT2 levels fall initially but increase subsequently, peaking at 3 days after infection. Of note, the neutralization of endogenous SLIT2 worsens SSTI. Temporal fluctuations in local SLIT2 levels may promote neutrophil recruitment and retention at the infection site and hasten bacterial clearance by augmenting neutrophil oxidative burst and degranulation. Collectively, these actions of SLIT2 coordinate innate immune responses to limit susceptibility to <italic>S. aureus</italic>.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>SLIT2</kwd><kwd>ROBO1</kwd><kwd>staphylococcus</kwd><kwd>neutrophils</kwd><kwd>p38 MAPK</kwd><kwd>LL-37</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000024</institution-id><institution>Canadian Institutes of Health Research</institution></institution-wrap></funding-source><award-id>PJT-169167</award-id><principal-award-recipient><name><surname>Robinson</surname><given-names>Lisa A</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000024</institution-id><institution>Canadian Institutes of Health Research</institution></institution-wrap></funding-source><award-id>OV2 170656</award-id><principal-award-recipient><name><surname>Lee</surname><given-names>Warren L</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000196</institution-id><institution>Canada Foundation for Innovation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Maynes</surname><given-names>Jason T</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002957</institution-id><institution>Technische Universität Dresden</institution></institution-wrap></funding-source><award-id>Department of Pediatrics, University Hospital Carl Gustav Carus</award-id><principal-award-recipient><name><surname>Toepfner</surname><given-names>Nicole</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001804</institution-id><institution>Canada Research Chairs</institution></institution-wrap></funding-source><award-id>Vascular Inflammation and Kidney Injury</award-id><principal-award-recipient><name><surname>Robinson</surname><given-names>Lisa A</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution>Foundation Blanceflor Boncompagni Ludovisi, née Bildt</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Westman</surname><given-names>Johannes</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000165</institution-id><institution>Hospital for Sick Children Research Training Centre</institution></institution-wrap></funding-source><award-id>RESTRACOMP</award-id><principal-award-recipient><name><surname>Westman</surname><given-names>Johannes</given-names></name><name><surname>Ammendolia</surname><given-names>Dustin A</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100007687</institution-id><institution>Swedish Society of Medicine</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Westman</surname><given-names>Johannes</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001804</institution-id><institution>Canada Research Chairs</institution></institution-wrap></funding-source><award-id>Mechanisms of Endothelial Permeability</award-id><principal-award-recipient><name><surname>Lee</surname><given-names>Warren L</given-names></name></principal-award-recipient></award-group><award-group id="fund10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100013873</institution-id><institution>Government of Ontario</institution></institution-wrap></funding-source><award-id>Ontario Graduate Scholarship</award-id><principal-award-recipient><name><surname>Ho</surname><given-names>Tse Wing Winnie</given-names></name></principal-award-recipient></award-group><award-group id="fund11"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001805</institution-id><institution>Canada Foundation for Innovation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Maynes</surname><given-names>Jason T</given-names></name></principal-award-recipient></award-group><award-group id="fund12"><funding-source><institution-wrap><institution>Mitochondrial Innovation Initiative</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Langari</surname><given-names>Fatemeh Mirshafiei</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>SLIT2, a prototypic neuro-repellent, spatiotemporally coordinates host defense against <italic>Staphylococcus aureus</italic> infection by priming neutrophils and stimulating release of reactive oxygen species and secondary and tertiary granules, potently enhancing bactericidal actions of neutrophils.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p><italic>Staphylococcus aureus</italic> (<italic>S. aureus</italic>) is a commensal bacterium as well as a skillful, facultative pathogen causing diverse human diseases ranging from localized SSTI to life-threatening disseminated sepsis (<xref ref-type="bibr" rid="bib39">Krismer et al., 2017</xref>; <xref ref-type="bibr" rid="bib44">Lowy, 1998</xref>). Neutrophils, the most abundant subset of leukocytes in circulation, form a formidable first-line of defense against <italic>S. aureus</italic> invasion and spread (<xref ref-type="bibr" rid="bib30">Guerra et al., 2017</xref>). Accordingly, patients with neutropenia and defective neutrophil functions are highly susceptible to recurrent and more severe <italic>S. aureus</italic> infections (<xref ref-type="bibr" rid="bib6">Buvelot et al., 2017</xref>; <xref ref-type="bibr" rid="bib16">Donadieu et al., 2011</xref>; <xref ref-type="bibr" rid="bib52">Neehus et al., 2021</xref>). Infections caused by antibiotic-resistant strains of <italic>S. aureus</italic> have been steadily increasing worldwide, suggesting that strategies to enhance the effective recruitment of neutrophils and their inherent bactericidal properties are needed to combat the morbidity and mortality associated with <italic>S. aureus</italic> infections (<xref ref-type="bibr" rid="bib9">Chambers and Deleo, 2009</xref>; <xref ref-type="bibr" rid="bib34">Jernigan et al., 2020</xref>).</p><p>A recent transcriptomic study noted that mRNA encoding Slit guidance ligand 2 (SLIT2), a canonical neuro-repellent, is locally upregulated during <italic>S. aureus</italic>-induced mastitis (<xref ref-type="bibr" rid="bib31">Günther et al., 2017</xref>). Among the three mammalian SLIT family members, SLIT1 is exclusively expressed in the nervous system (<xref ref-type="bibr" rid="bib85">Wu et al., 2001</xref>), while SLIT2 and SLIT3 are also detected outside the nervous system (<xref ref-type="bibr" rid="bib3">Bhosle et al., 2020</xref>; <xref ref-type="bibr" rid="bib36">Kim et al., 2018</xref>). We and others have previously reported that SLIT2 inhibits directed neutrophil migration in vitro as well as in vivo (<xref ref-type="bibr" rid="bib10">Chaturvedi et al., 2013</xref>; <xref ref-type="bibr" rid="bib78">Tole et al., 2009</xref>; <xref ref-type="bibr" rid="bib85">Wu et al., 2001</xref>; <xref ref-type="bibr" rid="bib86">Ye et al., 2010</xref>; <xref ref-type="bibr" rid="bib88">Zhou et al., 2022</xref>). We also showed that the cleaved N-terminal fragment of SLIT2, N-SLIT2, acts via its receptor, Roundabout guidance receptor 1 (ROBO1), to attenuate inflammasome activation in macrophages by inhibiting macropinocytosis (<xref ref-type="bibr" rid="bib3">Bhosle et al., 2020</xref>). Additionally, we and others previously reported that primary human and murine neutrophils express ROBO1 (<xref ref-type="bibr" rid="bib64">Rincón et al., 2018</xref>; <xref ref-type="bibr" rid="bib78">Tole et al., 2009</xref>; <xref ref-type="bibr" rid="bib86">Ye et al., 2010</xref>), but not ROBO2 (<xref ref-type="bibr" rid="bib64">Rincón et al., 2018</xref>). Despite the inhibitory actions of N-SLIT2 on chemotaxis and macropinocytosis in innate immune cells, administration of N-SLIT2 in vivo does not confer increased susceptibility to bacterial infections (<xref ref-type="bibr" rid="bib10">Chaturvedi et al., 2013</xref>; <xref ref-type="bibr" rid="bib43">London et al., 2010</xref>). It remains unknown if and how N-SLIT2 affects neutrophil responses during <italic>S. aureus</italic> infection.</p><p>Herein, we show that N-SLIT2 does not inhibit, but rather enhances, the killing of extracellular <italic>S. aureus</italic> by neutrophils. In the presence of N-SLIT2, human and murine neutrophils respond more robustly to <italic>S. aureus</italic> by activating p38 mitogen-activated protein kinase (MAPK) signaling, enhancing the production of extracellular reactive oxygen species (ROS) and release of secondary and tertiary granule contents by neutrophils. In a murine model of <italic>S. aureus</italic>-induced SSTI (<xref ref-type="bibr" rid="bib63">Prabhakara et al., 2013</xref>), we found that endogenous levels of SLIT2 protein declined significantly early on but rose to peak levels approximately 3 days after infection, and that blocking endogenous SLIT2-ROBO1 signaling at the site of infection enhanced bacterial survival and worsened the infection. Our results suggest that changes in the levels of SLIT2 at local sites of infection may coordinate neutrophil recruitment, retention, and bactericidal responses to effectively and synergistically target <italic>S. aureus</italic>. Our work identifies SLIT2 as an endogenous regulator of neutrophil number and activity that coordinates immune responses vital to combat disseminated infection of bacterial pathogens.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>N-SLIT2 augments extracellular ROS production in response to <italic>S. aureus</italic></title><p>We first investigated how SLIT2 affects neutrophil-mediated killing of <italic>S. aureus</italic>. Incubation of primary human neutrophils with bioactive N-SLIT2, but not inactive N-SLIT2ΔD2 which lacks the ROBO1/2-binding D2 LRR domain (<xref ref-type="bibr" rid="bib57">Patel et al., 2012</xref>), significantly reduced extracellular <italic>S. aureus</italic> as early as 30 min (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Decreased extracellular bacteria could result from increased internalization via phagocytosis, and/or increased extracellular bacterial killing. Intriguingly, N-SLIT2 did not affect the ability of human neutrophils (<xref ref-type="fig" rid="fig1">Figure 1B–D</xref>) or RAW264.7 murine macrophages to phagocytose <italic>S. aureus</italic> (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A–C</xref>). To determine whether N-SLIT2 decreased bacterial survival by stimulating phagocyte ROS production, a process dependent on NADPH oxidase complex (NOX) activity, we incubated neutrophils with the pan-NOX-inhibitor, diphenyleneiodonium chloride (DPI). DPI partially restored extracellular bacterial survival in the presence of N-SLIT2 (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>). Next, we directly examined the effects of N-SLIT2 on extracellular ROS production by human neutrophils exposed to <italic>S. aureus</italic>. Neutrophils incubated with vehicle control or with N-SLIT2 alone had very low basal levels of ROS. As expected, <italic>S. aureus</italic> induced significant ROS production that was indistinguishable from that seen in cells incubated with <italic>S. aureus</italic> and bio-inactive N-SLIT2ΔD2 (<xref ref-type="fig" rid="fig1">Figure 1E–F</xref>). Surprisingly, human neutrophils co-incubated with bio-active N-SLIT2 and <italic>S. aureus</italic> produced significantly more extracellular ROS than <italic>S.aureus</italic>-exposed neutrophils incubated with vehicle or N-SLIT2ΔD2 (<xref ref-type="fig" rid="fig1">Figure 1E–F</xref>). We found that neutrophils exposed to another secondary ROS-inducing stimulus, namely phorbol-12-myristate-13-acetate (PMA), also produced more extracellular ROS in the presence of N-SLIT2 compared to N-SLIT2ΔD2 (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E</xref>). Similar observations were also noted for mouse bone marrow-derived neutrophils (BMDN) indicating that the effect of N-SLIT2 to further enhance extracellular ROS production by <italic>S. aureus</italic>-exposed neutrophils is not species-specific (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1F</xref>). To determine whether the observed effects of N-SLIT2 occurred through the canonical ROBO1 receptor, we pre-incubated N-SLIT2 with the soluble N-terminal fragment of the ROBO1 receptor (N-ROBO1). N-ROBO1 fully blocked the ability of N-SLIT2 to boost extracellular ROS production in neutrophils exposed to <italic>S. aureus</italic> (<xref ref-type="fig" rid="fig1">Figure 1G–H</xref>). Since activation of Rac GTPases is essential for optimal NOX function in neutrophils (<xref ref-type="bibr" rid="bib15">Diebold and Bokoch, 2001</xref>; <xref ref-type="bibr" rid="bib33">Hordijk, 2006</xref>), we next tested the effects of N-SLIT2 on Rac. N-SLIT2 alone failed to activate Rac but instead required a second stimulus, namely <italic>S. aureus</italic> (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1G</xref>). Together, these results demonstrate that N-SLIT2 enhances neutrophil-mediated killing of <italic>S. aureus</italic>, partly by amplifying extracellular ROS production in a ROBO1-dependent manner.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>N-SLIT2 augments extracellular reactive oxygen species (ROS) production in response to <italic>S</italic>. <italic>aureus.</italic></title><p>(<bold>A</bold>) Neutrophils, isolated from healthy human donors, were incubated with vehicle (HBSS), N-SLIT2 (30 nM) or N-SLIT2ΔD2 (30 nM) for 15 min, followed by exposure to <italic>S. aureus</italic> (MOI 10) for the indicated times. Extracellular <italic>S. aureus</italic> counts were determined by serial dilution. n=3. The statistical comparisons between N-SLIT2 and N-SLIT2ΔD2 groups are shown. p=0.0072 (0.5 hr), p=0.0105 (1 hr), p=0.0478 (1.5 hr), and p=0.0852 (2 hr). (<bold>B</bold>) Human neutrophils were treated with vehicle, N-SLIT2 or N-SLIT2ΔD2 for 15 min and then incubated with unoposonized <italic>S. aureus</italic> expressing GFP (MOI 10) for an additional 45 min. Extracellular bacteria were labeled using donkey anti-human IgG-Cy3. Neutrophil plasma membranes were labeled using Concanavalin A-AF647. At least 100 neutrophils per treatment were imaged. n=3. The phagocytic efficiency (<bold>C</bold>) and index (<bold>D</bold>) were calculated. (<bold>E</bold>) The experiments were performed as in ‘A’ and extracellular ROS production was measured every 5 min using isoluminol relative luminescent units (RLU). n=4. The averages of four experiments are shown. The timepoint with maximum extracellular ROS (35 min) is marked with a dotted rectangle. (<bold>F</bold>) Extracellular ROS production corresponding to maximum isoluminol RLU was compared among experimental groups. p=0.0031 (vehicle vs <italic>S. aureus</italic>), p=0.0099 (<italic>S. aureus</italic> vs N-SLIT2 + <italic>S. aureus</italic>), and p=0.0055 (N-SLIT2 + <italic>S. aureus</italic> vs N-SLIT2ΔD2 + <italic>S. aureus</italic>). (<bold>G</bold>) Experiments were performed as described In (<bold>E</bold>) in parallel incubating N-SLIT2 (30 nM) with N-ROBO1 (NR; 90 nM) for 1 hr at room temperature before adding to the cells. n=4. Averages of all experiments are shown. The timepoint with maximum extracellular ROS (40 min) is marked with a dotted rectangle. (<bold>H</bold>) The timepoint with maximum isoluminol relative luminescent units (RLU) was compared across experimental groups. p=0.0057 (vehicle vs <italic>S. aureus</italic>), p=0.0018 (<italic>S. aureus</italic> vs N-SLIT2 + <italic>S. aureus</italic>), and p=0.0028 (N-SLIT2 + <italic>S. aureus</italic> vs N-ROBO1 +N-SLIT2 + <italic>S. aureus</italic>). Mean values ± SEM. *p&lt;0.05, and **p&lt;0.01. The source data are available as <xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>The file contains source data for <xref ref-type="fig" rid="fig1">Figure 1A, C, D, F, H</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-87392-fig1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87392-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Anti-staphylococcal actions of N-SLIT2 are partially dependent on increases in extracellular ROS production.</title><p>(<bold>A</bold>) RAW264.7 macrophages were incubated with vehicle, N-SLIT2 (30 nM) or N-SLIT2ΔD2 (30 nM) for 15 min and then with unoposonized <italic>S</italic>. <italic>aureus</italic> expressing GFP (MOI 10) for an additional 45 min. Extracellular bacteria were labeled using donkey anti-human IgG-Cy3. Macrophage plasma membranes were stained using Acti-stain-AF670. At least 100 macrophages per experimental condition were imaged. n=3. The phagocytic efficiency (<bold>B</bold>) and index (<bold>C</bold>) were calculated. (<bold>D</bold>) Experiments were performed as in Figure (1 A). In some experiments, cells were pre-incubated with DPI (10 μM) for 5 min and then incubated with N-SLIT2 (30 nM) in the presence of diphenyleneiodonium chloride (DPI) for an additional 15 min. n=3. Statistical comparisons between N-SLIT2 and DPI + N-SLIT2 groups are p=0.0082 (0.5 hr), p=0.0259 (1 hr), p=0.1592 (1.5 hr), and p=0.4285 (2 hr). (<bold>E</bold>) Experiments were performed as in Figure (1E) using PMA (200 nM) as a secondary stimulus instead of <italic>S. aureus</italic>. Maximum isoluminol relative luminescent units (RLU) was compared. n=4. p=0.0006 (vehicle vs PMA), p=0.0065 (PMA vs N-SLIT2 + PMA), and p=0.0092 (N-SLIT2 + PMA vs N-SLIT2ΔD2 + PMA). (<bold>F</bold>) Murine bone marrow-derived neutrophils were treated as described in Figure (1E). n=5. p=0.0005 (vehicle vs <italic>S. aureus</italic>), p=0.0064 (<italic>S. aureus</italic> vs N-SLIT2 + <italic>S. aureus</italic>), and p=0.0082 (N-SLIT2 + <italic>S. aureus</italic> vs N-SLIT2ΔD2 + <italic>S. aureus</italic>). (<bold>G</bold>) Human neutrophils were treated as described in (<bold>F</bold>) and active levels of Rac were measured using a Rac1/2/3 calorimetric G-LISA. n=4. p=0.0024 (vehicle vs <italic>S. aureus</italic>), p=0.0088 (<italic>S. aureus</italic> vs N-SLIT2 + <italic>S. aureus</italic>), and p=0.0038 (N-SLIT2 + <italic>S. aureus</italic> vs N-SLIT2ΔD2 + <italic>S. aureus</italic>). Mean values ± SEM. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001. The source data are available as <xref ref-type="supplementary-material" rid="fig1s1sdata1">Figure 1—figure supplement 1—source data 1</xref>.</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>The file contains source data for <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B–G</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-87392-fig1-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87392-fig1-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-2"><title>N-SLIT2 primes NOX by p38-mediated phosphorylation of NCF1</title><p>We next studied how N-SLIT2 increases extracellular ROS production in neutrophils. We wondered whether N-SLIT2 induces NOX priming and extracellular ROS production by prompting phosphorylation and translocation of Neutrophil Cytosolic Factor 1 (NCF1; p47phox), a key component of the NOX complex, to the plasma membrane (<xref ref-type="bibr" rid="bib20">El-Benna et al., 2009</xref>; <xref ref-type="bibr" rid="bib40">Li et al., 2010</xref>). We found that N-SLIT2 increased phosphorylation of the conserved Ser<sup>345</sup> residue of NCF1 in neutrophils (<xref ref-type="fig" rid="fig2">Figure 2A–B</xref>), as well as in RAW264.7 macrophages (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A–B</xref>). As SLIT2-ROBO2 signaling was recently reported to activate NOX function in neurons by activating protein kinase C (PKC) (<xref ref-type="bibr" rid="bib75">Terzi et al., 2021</xref>), we examined the effects of N-SLIT2 on PKC activation in neutrophils. PKC activity in cells is tightly regulated by its phosphorylation (<xref ref-type="bibr" rid="bib27">Freeley et al., 2011</xref>). N-SLIT2 did not induce phosphorylation of PKC in neutrophils (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C–F</xref>). SLIT2 orthologues have been reported to activate p38 MAPK signaling in <italic>Xenopus</italic> and <italic>C. elegans</italic> neurons (<xref ref-type="bibr" rid="bib7">Campbell and Okamoto, 2013</xref>; <xref ref-type="bibr" rid="bib60">Piper et al., 2006</xref>). The p38 MAP kinases are also known to phosphorylate NCF1 at the Ser<sup>345</sup> residue to mediate NOX priming (<xref ref-type="bibr" rid="bib14">Dang et al., 2006</xref>). We, therefore, investigated the effects of N-SLIT2 on p38 MAPK signaling in mammalian phagocytes. N-SLIT2 potently induced p38 MAPK activation in both neutrophils (<xref ref-type="fig" rid="fig2">Figure 2C–D</xref>) and macrophages (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1G–H</xref>). Congruent with these results, incubation with two distinct pharmacologic inhibitors of p38 MAPKs blocked the observed N-SLIT2-induced increase in extracellular ROS in neutrophils exposed to <italic>S. aureus</italic> (<xref ref-type="fig" rid="fig2">Figure 2E–F</xref>). We and others previously showed that SLIT2-ROBO1 signaling robustly activates RhoA, which in turn can activate Rho-associated protein kinases (ROCK), in several cell types, including macrophages and cancer cells (<xref ref-type="bibr" rid="bib3">Bhosle et al., 2020</xref>; <xref ref-type="bibr" rid="bib38">Kong et al., 2015</xref>). We found that in the presence of the selective ROCK inhibitor, Y-27632, N-SLIT2 failed to activate p38 MAPK in neutrophils (<xref ref-type="fig" rid="fig2">Figure 2G–H</xref>). These findings indicate that N-SLIT2 does not activate, but rather primes, the NOX complex in a p38 MAPK-dependent manner in phagocytes to upregulate ROS production in response to injurious biologic and pharmacological secondary stimuli, including <italic>S. aureus</italic> and PMA, respectively. Additionally, N-SLIT2-induced activation of the RhoA/ROCK pathway is essential for its effect on p38 MAPK signaling in neutrophils.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>N-SLIT2 primes NADPH oxidase complex (NOX) by p38-mediated phosphorylation of Neutrophil Cytosolic Factor 1 (NCF1).</title><p>(<bold>A</bold>) Human neutrophils were exposed to vehicle, N-SLIT2 or N-SLIT2ΔD2 for 15 min and the protein lysates were immunoblotted for phospho-NCF1 (Ser345) and total NCF1 (Ser345). n=4. A representative blot is shown. (<bold>B</bold>) Experiments were performed as in (<bold>A</bold>), densitometry was performed, and the ratio of phospho-NCF1 /NCF1 was obtained. n=4. p=0.0002 (vehicle vs N-SLIT2) and p=0.0004 (N-SLIT2 vs N-SLIT2ΔD2). (<bold>C</bold>) Experiments were performed as in (<bold>A</bold>) and immunoblotting performed for phospho-p38 (Thr180/Tyr182) and total p38. n=4. A representative blot is shown. (<bold>D</bold>) Experiments were performed as in (<bold>C</bold>), densitometry was performed, and the ratio of phospho-p38 /p38 was obtained. p=0.0006 (vehicle vs N-SLIT2) and p=0.0004 (N-SLIT2 vs N-SLIT2ΔD2). (<bold>E</bold>) Human neutrophils were incubated with vehicle, <italic>S. aureus</italic>, N-SLIT2 + <italic>S. aureus</italic>, N-SLIT2 + <italic>S. aureu</italic>s + SB203580 (SB, 10 μM), or N-SLIT2 + <italic>S. aureus</italic> + p38 MAPK Inhibitor IV (i4, 10 μM), and extracellular reactive oxygen species (ROS) were measured as described in Figure (1E). n=4. The averages of four experiments are shown. The timepoint with maximum extracellular ROS (40 min) is marked with a dotted rectangle. (<bold>F</bold>) Experiments were performed as in (<bold>E</bold>) and extracellular ROS production at 40 min compared among groups. n=4. p=0.0036 (<italic>S. aureus</italic> vs N-SLIT2 + <italic>S. aureus</italic>), p&lt;0.0001 (N-SLIT2 + <italic>S. aureus</italic> vs N-SLIT2 + <italic>S. aureus</italic> +SB203580), and p&lt;0.0001 (N-SLIT2 + <italic>S. aureus</italic> vs N-SLIT2 + <italic>S. aureus</italic> + p38 MAPK Inhibitor IV). (<bold>G</bold>) Human neutrophils were exposed to vehicle, N-SLIT2 or N-SLIT2 and Y-27632 together for 15 min and immunoblotting was performed for phospho-p38 (Thr180/Tyr182) and total p38. n=4. A representative blot is shown. (<bold>H</bold>) Experiments were performed as in (<bold>G</bold>), densitometry was performed, and the ratio of phospho-p38 /p38 was obtained. p=0.0004 (vehicle vs N-SLIT2) and p=0.0007 (N-SLIT2 vs N-SLIT2 + Y-27632). Mean values ± SEM. **p&lt;0.01, ***p&lt;0.001, and ****p&lt;0.0001. The source data are available as <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref> and <xref ref-type="supplementary-material" rid="fig2sdata2">Figure 2—source data 2</xref>.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>The file contains source data for <xref ref-type="fig" rid="fig2">Figure 2B, D, F, H</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-87392-fig2-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>The file contains source data for <xref ref-type="fig" rid="fig2">Figure 2A, C, G</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-87392-fig2-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87392-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>N-SLIT2 does not activate PKC signaling in neutrophils.</title><p>(<bold>A</bold>) RAW264.7 cells were incubated with vehicle, N-SLIT2 or N-SLIT2ΔD2 for 15 min, and the protein lysates were immunoblotted for phospho-NCF1 (Ser345), and total Neutrophil Cytosolic Factor 1 (NCF1) (Ser345).n=4. (<bold>A</bold>) representative blot is shown. (<bold>B</bold>) Experiments were performed as in (<bold>A</bold>), densitometry was performed, and the ratio of phospho-NCF1/NCF1 was obtained. p=0.0007 (vehicle vs N-SLIT2) and p=0.0008 (N-SLIT2 vs N-SLIT2ΔD2). (<bold>C</bold>) Representative immunoblot showing lysates from human neutrophils treated with vehicle, N-SLIT2, N-SLIT2ΔD2, or PMA (200 nM) for 15 min and probed with phospho-PKC (Thr497) and β-actin. n=4. (<bold>D</bold>) Densitometry analysis of phospho-PKC/β-actin ratios for experiments in (<bold>C</bold>).<italic>p</italic>&lt;0.0001 (vehicle vs PMA). (<bold>E</bold>) Representative immunoblot showing lysates from human neutrophils treated with vehicle, N-SLIT2, N-SLIT2ΔD2, or PMA (200 nM) for 15 min and probed with phospho-PKCδ (Tyr311) and total PKCδ. n=4. (<bold>F</bold>) Densitometry analysis of phospho-PKCδ/PKCδ ratios for experiments in (<bold>E</bold>).<italic>p</italic>&lt;0.0001 (vehicle vs PMA). (<bold>G</bold>) RAW264.7 cells were treated as described in (<bold>A</bold>) and the protein lysates were immunoblotted for phospho-p38 (Thr180/Tyr182) and total p38. n=4. A representative blot is shown. (<bold>H</bold>) Densitometry analysis of phospho-p38/p38 ratios for experiments in (<bold>E</bold>).<italic>p</italic>&lt;0.0001 (vehicle vs N-SLIT2) and p&lt;0.0001 (N-SLIT2 vs N-SLIT2ΔD2). Mean values ± SEM. ***p&lt;0.001 and ****p&lt;0.0001. The source data are available as <xref ref-type="supplementary-material" rid="fig2s1sdata1">Figure 2—figure supplement 1—source data 1</xref> and <xref ref-type="supplementary-material" rid="fig2s1sdata2">Figure 2—figure supplement 1—source data 2</xref>.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>The file contains source data for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B, D, F, H</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-87392-fig2-figsupp1-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2s1sdata2"><label>Figure 2—figure supplement 1—source data 2.</label><caption><title>The file contains source data for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A, C, E, G</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-87392-fig2-figsupp1-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87392-fig2-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-3"><title>N-SLIT2 enhances p38 MAPK-mediated exocytosis of secondary and tertiary granules</title><p>Sequential cytoskeletal changes in neutrophils have been shown to play an important role in their priming (<xref ref-type="bibr" rid="bib2">Bashant et al., 2019</xref>; <xref ref-type="bibr" rid="bib77">Toepfner et al., 2018</xref>). We performed Real-time deformability cytometry (RT-DC) and found that exposure of blood to N-SLIT2 reduced neutrophil cell area and deformability although the effect did not reach statistical significance (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A–B</xref>; <xref ref-type="bibr" rid="bib2">Bashant et al., 2019</xref>; <xref ref-type="bibr" rid="bib77">Toepfner et al., 2018</xref>). Next, since exposure to the NOX inhibitor, DPI, only partially reversed the effects of N-SLIT2 on extracellular <italic>S. aureus</italic> survival, we pondered whether other anti-microbial functions of neutrophils are also modified by N-SLIT2. In addition to the oxidative burst, degranulation has been shown to play an important role in the bactericidal responses of neutrophils against <italic>S. aureus</italic> (<xref ref-type="bibr" rid="bib22">Ferrante et al., 1989</xref>; <xref ref-type="bibr" rid="bib79">Van Ziffle and Lowell, 2009</xref>). Neutrophils contain four types of granules, each containing different classes of anti-microbial peptides, of which secondary and tertiary granules are most important for eliminating <italic>S. aureus</italic> (<xref ref-type="bibr" rid="bib5">Borregaard and Cowland, 1997</xref>; <xref ref-type="bibr" rid="bib50">Mollinedo, 2019</xref>; <xref ref-type="bibr" rid="bib79">Van Ziffle and Lowell, 2009</xref>). To investigate the effects of N-SLIT2 on degranulation, we utilized a recently optimized flow cytometry protocol using specific cluster of differentiation (CD) markers of granule exocytosis (<xref ref-type="bibr" rid="bib24">Fine et al., 2019</xref>). Another advantage of using a flow cytometry-based approach is that it circumvents the in vitro neutrophil isolation step which is known to affect cellular activation (neutrophil gating strategy; <xref ref-type="fig" rid="fig3">Figure 3A</xref>). Neither <italic>S. aureus</italic> alone nor <italic>S. aureus</italic> together with N-SLIT2 induced primary granule (CD63) secretion (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>). Congruent with published literature (<xref ref-type="bibr" rid="bib45">Lu et al., 2014</xref>; <xref ref-type="bibr" rid="bib70">Schmidt et al., 2012</xref>), the bacteria alone stimulated secondary granule (CD66b) exocytosis from neutrophils (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D</xref>). This effect was strikingly enhanced by exposure to N-SLIT2 (<xref ref-type="fig" rid="fig3">Figure 3B</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D</xref>). Additionally, the actions of N-SLIT2 were completely obliterated by pharmacological inhibition of p38 MAPK signaling using SB 203580 or p38 MAPK Inhibitor IV, but not MEK1/2 signaling using PD 184161 (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). It is noteworthy that N-SLIT2 also augmented surface expression of <italic>S. aureus</italic>-induced CD18, which is stored in both secondary and tertiary granules, in a p38 MAPK dependent manner (<xref ref-type="fig" rid="fig3">Figure 3C</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E</xref>; <xref ref-type="bibr" rid="bib5">Borregaard and Cowland, 1997</xref>; <xref ref-type="bibr" rid="bib50">Mollinedo, 2019</xref>). On the other hand, we found no differences in the surface expression of CD16, which is stored in secretory vesicles, in any of the tested conditions, a finding in agreement with the priming-associated CD marker signature described for neutrophils in circulation and tissues (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1F</xref>; <xref ref-type="bibr" rid="bib24">Fine et al., 2019</xref>). We next used the surface expression of CD66b and CD11b to calculate the percentage of primed neutrophils (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D and G</xref>; <xref ref-type="bibr" rid="bib24">Fine et al., 2019</xref>). Exposure of blood to N-SLIT2 and <italic>S. aureus</italic> together significantly increased the fraction of primed neutrophils as compared to <italic>S. aureus</italic> alone (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). Next, we measured the secretion of LL-37, a highly potent cationic anti-staphylococcal peptide that is selectively stored in neutrophil secondary granules in its pro-peptide form (<xref ref-type="bibr" rid="bib53">Noore et al., 2013</xref>; <xref ref-type="bibr" rid="bib73">Sørensen et al., 1997</xref>). Incubation of human neutrophils with <italic>S. aureus</italic> resulted in the release of LL-37, which was further amplified in the presence of N-SLIT2 and blocked by the p38 inhibitors (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). Production of neutrophil extracellular traps (NETosis) is known to be modulated by intra- and extra-cellular ROS and can also regulate anti-bacterial responses by neutrophils in vitro and in vivo (<xref ref-type="bibr" rid="bib61">Poli and Zanoni, 2023</xref>). We investigated the effects of N-SLIT2 on NETosis and found that exposure to N-SLIT2 alone failed to induce NETosis. Treatment of neutrophils with N-SLIT2 and <italic>S. aureus</italic> together resulted in more NETosis than that with the bacteria alone but this effect was not statistically significant (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1H–J</xref>). Collectively, our results indicate that SLIT2-induced activation of p38 MAPK augments the production of extracellular ROS, exocytosis of secondary granules, and secretion of the anti-bacterial LL-37 peptide from neutrophils in response to exposure to <italic>S. aureus</italic>.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>N-SLIT2 enhances p38 MAPK-mediated exocytosis of secondary and tertiary granules.</title><p>(<bold>A–D</bold>) 100 μl whole blood from human subjects was exposed to different treatments for 15 min at 37 °C, as indicated. The samples were immediately fixed on ice with 1.6% paraformaldehyde (PFA) and surface CD markers labeled. n=5. (<bold>A</bold>) Gating strategy for human blood neutrophils: Red blood cells and dead cell debris were excluded based on FSC-A × SSC-A. Doublets were excluded based on SSC-A × SSC-W. Neutrophils were gated in whole blood leukocytes using CD16<sup>high</sup> × SSC-A<sup>high</sup>. (<bold>B</bold>) Human neutrophils were exposed to vehicle, N-SLIT2, or N-SLIT2ΔD2 with or without the p38 MAPK inhibitors, SB 203580 (SB; 10 μM) or p38 MAPK Inhibitor IV (i4; 10 μM), or the MEK1/2 inhibitor PD 184161 (PD; 10 μM) for 15 min, followed by exposure to <italic>S. aureus</italic> (<italic>Sa</italic>) for another 15 min at 37 °C, as indicated. Geometric mean fluorescence intensity (gMFI) for CD66b (secondary granules) is shown. p=0.0122 (vehicle vs <italic>Sa</italic>), p&lt;0.0001 (vehicle vs N-SLIT2 + <italic>Sa</italic>) p=0.0003 (<italic>Sa</italic> vs N-SLIT2 + <italic>Sa</italic>), p=0.0006 (N-SLIT2 + <italic>Sa</italic> vs N-SLIT2ΔD2 + <italic>Sa</italic>), p&lt;0.0001 (N-SLIT2 + <italic>Sa</italic> vs N-SLIT2 + <italic>Sa</italic> + SB), and p&lt;0.0001 (N-SLIT2 + <italic>Sa</italic> vs N-SLIT2 + <italic>Sa</italic> + i4). (<bold>C</bold>) Neutrophils were treated as in (<bold>B</bold>) and gMFI for CD18 (secondary and tertiary granules) is noted. p=0.0022 (vehicle vs <italic>Sa</italic>), p&lt;0.0001 (vehicle vs N-SLIT2 + <italic>Sa</italic>) p&lt;0.0001 (<italic>Sa</italic> vs N-SLIT2 + <italic>Sa</italic>), p&lt;0.0001 (N-SLIT2 + <italic>Sa</italic> vs N-SLIT2ΔD2 + <italic>Sa</italic>), p&lt;0.0001 (N-SLIT2 + <italic>Sa</italic> vs N-SLIT2 + <italic>Sa</italic> + SB), and p&lt;0.0001 (N-SLIT2 + <italic>Sa</italic> vs N-SLIT2 + <italic>Sa</italic> + i4). (<bold>D</bold>) Human neutrophils were exposed to vehicle, N-SLIT2, or N-SLIT2ΔD2 with or without the p38 MAPK inhibitors, SB 203580 (SB; 10 μM) or p38 MAPK Inhibitor IV (i4; 10 μM), or the MEK1/2 inhibitor PD 184161 (PD; 10 μM) for 15 min, followed by exposure to <italic>S. aureus</italic> (<italic>Sa</italic>) for another 15 min at 37 °C, as indicated. Primed neutrophils were identified by cell surface labeling CD66b<sup>high</sup> × CD11b<sup>high</sup> and fold changes in % primed neutrophils relative to vehicle treatment are shown. p=0.0246 (vehicle vs <italic>Sa</italic>), p&lt;0.0001 (vehicle vs N-SLIT2 + <italic>Sa</italic>) p=0.0002 (<italic>Sa</italic> vs N-SLIT2 +<italic>Sa</italic>), p=0.0008 (N-SLIT2 + <italic>Sa</italic> vs N-SLIT2ΔD2+ <italic>Sa</italic>), p&lt;0.0001 (N-SLIT2 + <italic>Sa</italic> vs N-SLIT2 + <italic>Sa</italic> + SB), and p&lt;0.0001 (N-SLIT2 + <italic>Sa</italic> vs N-SLIT2 + <italic>Sa</italic> + i4). (<bold>E</bold>) Human neutrophils were exposed to vehicle or N-SLIT2 with or without p38 MAPK inhibitors, SB or i4, or the MEK1/2 inhibitor PD for 15 min, then exposed to <italic>S. aureus</italic> (<italic>Sa</italic>) for another 15 min at 37 °C, as indicated. Supernatants were collected and secreted LL-37 levels were measured using an ELISA. n=4. p=0.0092 (vehicle vs <italic>Sa</italic>), p&lt;0.0001 (vehicle vs N-SLIT2 + <italic>Sa</italic>) p=0.0005 (<italic>Sa</italic> vs N-SLIT2 + <italic>Sa</italic>), p&lt;0.0001 (N-SLIT2 + <italic>Sa</italic> vs N-SLIT2 + <italic>Sa</italic> + SB), and p&lt;0.0001 (N-SLIT2 + <italic>Sa</italic> vs N-SLIT2 + <italic>Sa</italic> + i4). Mean values ± SEM. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001 and ****p&lt;0.0001. The source data are available as <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>The file contains source data for <xref ref-type="fig" rid="fig3">Figure 3B–E</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-87392-fig3-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87392-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>N-SLIT2 does not significantly affect NETosis.</title><p>(<bold>A–B</bold>) Blood isolated from healthy human donors was exposed to vehicle (0.9% NaCl), or N-SLIT2 or N-SLIT2ΔD2 (total volume: 50 μl) for 45 min. Samples were diluted with Real-time deformability cytometry (RT-DC) buffer (950 μl), RT-DC was performed, and neutrophil deformation (<bold>A</bold>) and neutrophil area (<bold>B</bold>) were calculated. n=4 biological replicates. For neutrophil deformation (<bold>A</bold>), <italic>p</italic>=0.0955 (vehicle vs N-SLIT2) and p=0.0581 (N-SLIT2 vs N-SLIT2ΔD2) and for the neutrophil area (<bold>B</bold>), <italic>p</italic>=0.0676 (vehicle vs N-SLIT2) and p=0.0631 (N-SLIT2 vs N-SLIT2ΔD2). (<bold>C–G</bold>) Representative histograms are shown for human neutrophils with different treatments as described in <xref ref-type="fig" rid="fig3">Figure 3</xref> to detect cell-surface expression of the following CD markers: (<bold>C</bold>) CD63, (<bold>D</bold>) CD66b, (<bold>E</bold>) CD18, (<bold>F</bold>) CD16, and (<bold>G</bold>) CD11b. (<bold>H–J</bold>) Neutrophils isolated from healthy human donors were incubated with vehicle, <italic>S. aureus</italic> (MOI 10), N-SLIT2, N-SLIT2ΔD2, alone or in combination as indicated in a 96-well plate and Sytox Green (5 μM) was added to each well. Fluorescence was measured at 15 min intervals for 3 hr and NETotic indices were calculated. n=4 biological replicates. (<bold>H</bold>) Average of all readings is shown. Shaded regions represent Mean values ± SEM. NETotic indices at 2 hr (<bold>I</bold>), and 3 hr (<bold>J</bold>) are also shown. (<bold>I</bold>) <italic>p</italic>=0.0004 (vehicle vs <italic>S. aureus</italic>), p&lt;0.0001 (vehicle vs N-SLIT2 + <italic>S. aureus</italic>), p=0.0003 (vehicle vs N-SLIT2ΔD2+ <italic>S. aureus</italic>), p=0.0883 (<italic>S. aureus</italic> vs N-SLIT2 + <italic>S. aureus</italic>), and p=0.1096 (N-SLIT2 + <italic>S. aureus</italic> vs N-SLIT2ΔD2+ <italic>S. aureus</italic>). (<bold>J</bold>) <italic>p</italic>&lt;0.0001 (vehicle vs <italic>S. aureus</italic>), p&lt;0.0001 (vehicle vs N-SLIT2 + <italic>S. aureus</italic>), p&lt;0.0001 (vehicle vs N-SLIT2ΔD2+ <italic>S. aureus</italic>), p=0.0949 (<italic>S. aureus</italic> vs N-SLIT2 + <italic>S. aureus</italic>), and p=0.0732 (N-SLIT2 + <italic>S. aureus</italic> vs N-SLIT2ΔD2+ <italic>S. aureus</italic>). *p&lt;0.05, ***p&lt;0.001, and ****p&lt;0.0001. The source data are available as <xref ref-type="supplementary-material" rid="fig3s1sdata1">Figure 3—figure supplement 1—source data 1</xref>.</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>The file contains source data for <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A, B, I, J</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-87392-fig3-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87392-fig3-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-4"><title>Blocking endogenous SLIT2 exacerbates tissue injury in <italic>S. aureus</italic> SSTI</title><p>A recent transcriptomic screen has reported that SLIT2 mRNA is upregulated during <italic>S. aureus</italic>-induced mastitis (<xref ref-type="bibr" rid="bib31">Günther et al., 2017</xref>). To determine whether this increase is conserved at a protein level during SSTI, we used an established murine model of <italic>S. aureus</italic> SSTI, which mimics community-acquired human infections (<xref ref-type="bibr" rid="bib63">Prabhakara et al., 2013</xref>). Surprisingly, we found that local SLIT2 levels were reduced as early as 12 hr after the infection (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Following the initial decrease, the levels of SLIT2 gradually increased to reach a peak at 3 days (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Unlike SLIT2, SLIT3 levels in the infected tissue remained significantly lower than in control mock-infected tissue for the first 2 days (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). To ascertain the target of SLIT2 in <italic>S. aureus</italic> SSTI, we used a soluble N-ROBO1 to block endogenous SLIT2 (<xref ref-type="bibr" rid="bib3">Bhosle et al., 2020</xref>; <xref ref-type="bibr" rid="bib29">Geraldo et al., 2021</xref>). Based on the observed peak in endogenous SLIT2 levels at Day 3 after <italic>S. aureus</italic> infection, N-ROBO1 or control IgG was administered on Days 2 and 3 after infection (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>). Strikingly, the bacterial counts were more than twofold higher in N-ROBO1-treated mice as compared to the IgG-treated counterparts (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>). We and others have shown that SLIT2-ROBO1 signaling inhibits chemotactic neutrophil migration in vivo but this has not been examined in the context of an infection so far (<xref ref-type="bibr" rid="bib10">Chaturvedi et al., 2013</xref>; <xref ref-type="bibr" rid="bib78">Tole et al., 2009</xref>; <xref ref-type="bibr" rid="bib88">Zhou et al., 2022</xref>). <italic>S. aureus</italic> infection in mice who received control IgG treatment or no other treatment resulted in microabscess formation with immune cell infiltration (<xref ref-type="fig" rid="fig4">Figure 4B–D</xref>). In N-ROBO1-treated mice, <italic>S. aureus</italic> infection caused much more extensive tissue injury characterized by diffuse, rather than localized, inflammation (<xref ref-type="fig" rid="fig4">Figure 4B–D</xref>). Interestingly, in the absence of bacterial infection, neutralization of endogenous SLIT2 augmented immune cell infiltration in the skin but did not result in local tissue damage in the form of acanthosis (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). Next, we directly examined tissue neutrophil infiltration in SSTI using immunohistochemical (IHC) staining (Ly6G<sup>+</sup>F4/80<sup>-</sup> cells) (<xref ref-type="bibr" rid="bib8">Chadwick et al., 2021</xref>). In the absence of SSTI, N-ROBO1 treatment alone was sufficient to increase neutrophil infiltration (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D–E</xref>). In line with our earlier findings using H&amp;E, animals administered <italic>S. aureus</italic> and N-ROBO1 exhibited significantly more local neutrophil infiltration in infected tissue as compared to those administered <italic>S. aureus</italic> alone or <italic>S. aureus</italic> with control IgG (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D–E</xref>). Finally, we used IHC to measure 8-hydroxy-2'-deoxyguanosine (8-OHdG) levels as a marker of free radical-induced oxidative tissue injury (<xref ref-type="bibr" rid="bib71">Sima et al., 2016</xref>). N-ROBO1-treated mice had an almost 50% reduction in the 8-OHdG-positive lesion area as compared to animals which received either <italic>S. aureus</italic> alone or <italic>S. aureus</italic> and control IgG (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1F–G</xref>). Together, our findings suggest that immediately after infection the rapid decrease in local levels of SLIT2 promotes infiltration of neutrophils into the site of infection. The later increase in SLIT2 levels may serve dual functions: local retention of neutrophils due to SLIT2’s chemorepellent actions, and direct effects on neutrophils to enhance ROS production and anti-staphylococcal killing responses.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Blocking endogenous SLIT2 exacerbates tissue injury in <italic>S</italic>. <italic>aureus</italic> skin and soft tissue infection (SSTI).</title><p>(<bold>A</bold>) Ear skin samples were collected from mock-infected (0) and <italic>S. aureus</italic>-infected mice at indicated time points, homogenized, and tissue SLIT2 levels were measured using an ELISA. n=6 mice per group. p=0.0290 (Mock infection vs <italic>S. aureus</italic> 0.5 day), p&lt;0.0001 (Mock infection vs <italic>S. aureus</italic> 3 days). (<bold>B</bold>) Representative images of gross pathology of ear tissue from animals treated as described in (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>). (<bold>C–D</bold>) Samples were collected as described in (<bold>B</bold>), fixed in formalin, and stained with hematoxylin and eosin. Scale bar = 100 μm (<bold>D</bold>) Experiments were performed as in (<bold>C</bold>). The lesions were blindly scored on an ascending scale of severity (0–5). n=6. p=0.0002 (Mock infection vs <italic>S. aureus</italic>), p&lt;0.0001 (Mock infection vs <italic>S. aureus</italic> + N-ROBO1), p=0.0060 (<italic>S. aureus</italic> vs <italic>S. aureus</italic> + N-ROBO1), p=0.0016 (<italic>S. aureus</italic> + Ctr IgG vs <italic>S. aureus</italic> + N-ROBO1). Mean values ± SEM. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, and ****p&lt;0.0001. The source data are available as <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>The file contains source data for <xref ref-type="fig" rid="fig4">Figure 4A, D</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-87392-fig4-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87392-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Inhibition of endogenous SLIT2 signaling increases tissue neutrophil infiltration, and attenuates tissue-associated ROS.</title><p>(<bold>A</bold>) Ear skin samples were collected as described in (<xref ref-type="fig" rid="fig4">Figure 4A</xref>) and tissue SLIT3 levels were measured using an ELISA. n=5. p=0.0002 (Mock infection vs <italic>S. aureus</italic> 0.5 day), p=0.0003 (Mock infection vs <italic>S. aureus</italic> 1 day), and p=0.0067 (Mock infection vs <italic>S. aureus</italic> 2 days). (<bold>B</bold>) In vivo protocol to block endogenous SLIT2 during <italic>S. aureus</italic> skin and soft tissue infection (SSTI). Ear pinnae were infected with 5 × 10<sup>6</sup> colony forming units (CFU) of <italic>S. aureus</italic> or mock-infected (saline injection) as indicated on day 0. On 2<sup>nd</sup> and 3<sup>rd</sup> day, local injections of either 7 μg of control (Ctr) IgG or N-Roundabout guidance receptor 1 (ROBO1) were given at the site of infection. Skin samples were collected on the 4<sup>th</sup> day after infection. (<bold>C</bold>) Samples were collected as described in (<bold>B</bold>) and were homogenized and <italic>S. aureus</italic> CFU were counted by serial dilution. p&lt;0.0001 (<italic>S. aureus</italic> vs <italic>S. aureus</italic> + N-ROBO1) and p&lt;0.0001 (<italic>S. aureus</italic> + Ctr IgG vs <italic>S. aureu</italic>s + N-ROBO1). N=8. (<bold>D–E</bold>) Animals were treated as described in (<bold>B</bold>), skin samples fixed in formalin, stained with Ly6G (red) and F4/80 (green) antibodies, and DAPI (blue). Scale bar = 200 μm. (<bold>E</bold>) Percent neutrophils (Ly6G<sup>+</sup> F4/80<sup>–</sup>) per unit tissue area were calculated using HALO software. N=4. p=0.0475 (Mock infection vs N-ROBO1), p=0.0008 (Mock infection vs <italic>S. aureus</italic>), p&lt;0.0001 (Mock infection vs <italic>S. aureus</italic> + N-ROBO1), p=0.0397 (<italic>S. aureus</italic> vs <italic>S. aureus</italic> + N-ROBO1), and p=0.0127 (<italic>S. aureus</italic> + Ctr IgG vs <italic>S. aureus</italic> + N-ROBO1). (<bold>F–G</bold>) Animals were treated as described in (<bold>B</bold>), and skin samples were collected, fixed in formalin, stained with an anti-8-OHdG antibody, and developed with 3,3'-Diaminobenzidine (DAB) staining. (<bold>F</bold>) Red arrowheads indicate DAB positive regions, Scale bar = 100 μm. (<bold>G</bold>) Fold changes (compared to mock infection) in % DAB +ve nuclei were calculated using HALO software. N=4. p&lt;0.0001 (Mock infection vs <italic>S. aureus</italic>), p=0.0332 (Mock infection vs <italic>S. aureus</italic> + N-ROBO1), and p=0.0001 (<italic>S. aureus</italic> vs <italic>S. aureus</italic> + N-ROBO1). Mean values ± SEM. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001 and ****p&lt;0.0001. The source data are available as <xref ref-type="supplementary-material" rid="fig4s1sdata1">Figure 4—figure supplement 1—source data 1</xref>.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>The file contains source data for <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A, C, E, G</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-87392-fig4-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87392-fig4-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-5"><title>Dermal microvascular endothelial cells are a source of SLIT2 during <italic>S. aureus</italic> infection</title><p>We next investigated the potential cellular source of SLIT2 during SSTI. Under specific non-infectious conditions, dermal microvascular endothelial cells (DMEC) and fibroblasts have been previously reported to secrete SLIT2 (<xref ref-type="bibr" rid="bib58">Pilling et al., 2014</xref>; <xref ref-type="bibr" rid="bib66">Romano et al., 2018</xref>). To test this possibility, we used a human dermal microvascular endothelial cell line, HMEC-1 (<xref ref-type="bibr" rid="bib1">Ades et al., 1992</xref>). Infection of HMEC-1 with <italic>S. aureu</italic>s was sufficient to reduce SLIT2 production at 12 hr at the level of mRNA as well as protein (<xref ref-type="fig" rid="fig5">Figure 5A–B</xref>). However, the effect was reversed at 48 hr, at which time infected cells produced more SLIT2 than their non-infected counterparts (<xref ref-type="fig" rid="fig5">Figure 5A–B</xref>). We next examined how other factors which could be found in a Staphylococcal abscess, namely hypoxia and low pH (acidosis), (<xref ref-type="bibr" rid="bib11">Costa and Horswill, 2022</xref>; <xref ref-type="bibr" rid="bib87">Zhang et al., 2022</xref>), modulate SLIT2 production by vascular endothelial cells. Lowering the pH of the medium to 6.6 did not change <italic>SLIT2</italic> mRNA in HMEC-1 cells (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>). In contrast, growing the cells in a hypoxic (1% O<sub>2</sub>) environment replicated the effects of <italic>S. aureus</italic> infection on SLIT2 production (<xref ref-type="fig" rid="fig5">Figure 5C–D</xref>). Finally, we tested the ability of conditioned media from HMEC-1 cells to regulate LL-37 secretion by neutrophils. Conditioned media from HMEC-1 cells taken 48 hr after bacterial infection boosted LL-37 secretion and this effect was blocked by SLIT2 neutralization using N-ROBO1 (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>). The same effect was also observed with conditioned media from hypoxic cells (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>). Our findings suggest that <italic>S. aureus</italic> infection and local tissue oxygen levels could collectively regulate SLIT2 production by DMEC in SSTI.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Dermal microvascular endothelial cells are a source of SLIT2 during <italic>S</italic>. <italic>aureus</italic> infection.</title><p>(<bold>A–B</bold>) HMEC-1 cells were infected with <italic>S. aureus</italic> (MOI 1), where indicated and cultured for 6, 12, 24, and 48 hr. Total cellular RNA and culture media were collected at each time point. n=4 biological replicates. (<bold>A</bold>) <italic>SLIT2</italic> and <italic>GAPDH</italic> (housekeeping gene) mRNA expression levels were measured using Quantitative PCR (qPCR). p=0.0191 (vehicle vs <italic>S. aureus</italic> at 12 hr), and p=0.0100 (vehicle vs <italic>S. aureus</italic> at 48 hr). (<bold>B</bold>) SLIT2 levels were measured in the culture supernatant using ELISA and normalized to the total protein concentration in the supernatant. p=0.0222 (vehicle vs <italic>S. aureus</italic> at 12 hr), and p=0.0001 (vehicle vs <italic>S. aureus</italic> at 48 hr). (<bold>C–D</bold>) HMEC-1 cells were cultured in normoxic (20% O<sub>2</sub>) or hypoxic (1% O<sub>2</sub>) conditions for 6, 12, 24, and 48 hr, as indicated. Total cellular RNA and culture media were collected at each time point. n=4 biological replicates. (<bold>C</bold>) <italic>SLIT2</italic> and <italic>GAPDH</italic> (housekeeping gene) mRNA expression levels were measured using qPCR. p=0.0253 (normoxia vs hypoxia at 12 hr), and p=0.0019 (normoxia vs hypoxia at 48 hr). (<bold>D</bold>) SLIT2 levels were measured in culture supernatant using ELISA and normalized to total protein concentration in the supernatants. p=0.0204 (normoxia vs hypoxia at 12 hr), and p=0.0011 (normoxia vs hypoxia at 48 hr). Mean values ± SEM. *p&lt;0.05, **p&lt;0.01, and ***p&lt;0.001. The source data are available as <xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>The file contains source data for <xref ref-type="fig" rid="fig5">Figure 5A–D</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-87392-fig5-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87392-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Dermal microvascular endothelial cells are a source of SLIT2 during <italic>S. aureus</italic> infection.</title><p>(<bold>A</bold>) HMEC-1 cells were cultured in a medium with pH 7.4, 7.0, and 6.6, as indicated, for 6, 12, 24 hr. Total cellular RNA and culture supernatant were collected at each time point. n=4 biological replicates. (<bold>A</bold>) <italic>SLIT2</italic> and <italic>GAPDH</italic> (housekeeping gene) mRNA expression levels were measured using Quantitative PCR (qPCR). All p values were &gt;0.05. (<bold>B</bold>) Experiments were conducted as described in Figures (5A-B) for <italic>S. aureus</italic> infection and Figures (5C-D) for hypoxia treatment. Culture supernatants were collected at 48 hr. n=4 biological replicates. Before adding culture supernatant to the cells, it was incubated with Ctr IgG (90 nM) or N-ROBO1 (90 nM) for 1 hr, as indicated. Freshly isolated human neutrophils were resuspended in HMEC-1 culture supernatant, and <italic>S. aureus</italic> (SA; MOI 10) was added as a second stimulus for LL-37 secretion. LL-37 levels in the media were measured using an ELISA. n=4 biological replicates. p=0.0005 (vehicle medium vs SA medium), p=0.0362 (SA medium vs SA medium + N-ROBO1), p=0.0473 (SA medium + Ctr IgG vs SA medium + N-ROBO1). H, hypoxia; N, normoxia. p=0.0002 (N medium vs H medium), p=0.0190 (H medium vs H medium + N-ROBO1), and p=0.0088 (H medium + Ctr IgG vs H medium + N-ROBO1). Mean values ± SEM. *p&lt;0.05, ***p&lt;0.001, and ****p&lt;0.0001. The source data are available as <xref ref-type="supplementary-material" rid="fig5s1sdata1">Figure 5—figure supplement 1—source data 1</xref>.</p><p><supplementary-material id="fig5s1sdata1"><label>Figure 5—figure supplement 1—source data 1.</label><caption><title>The file contains source data for <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A, B</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-87392-fig5-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87392-fig5-figsupp1-v1.tif"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>We demonstrate here that N-SLIT2 augments extracellular ROS production by primary human and murine neutrophils in response to secondary stimulation with <italic>S. aureus</italic> and PMA. This effect is neutralized by incubating N-SLIT2 with N-ROBO1 and is, therefore, mediated via the canonical SLIT2-ROBO1 signaling pathway. These findings are in keeping with those of Wu et al., who reported that SLIT2 potentiates fMLP-induced oxidative burst in neutrophil-like HL-60 cells, without activating it on its own (<xref ref-type="bibr" rid="bib85">Wu et al., 2001</xref>). Our work suggests that the inability of N-SLIT2 alone to induce ROS production by neutrophils could be explained by the lack of Rac activation (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1G</xref>), as the latter is essential for activation of the NOX complex (<xref ref-type="bibr" rid="bib15">Diebold and Bokoch, 2001</xref>). We recently reported that SLIT2-ROBO1 signaling inhibits macropinocytosis in macrophages in vitro as well as in vivo (<xref ref-type="bibr" rid="bib3">Bhosle et al., 2020</xref>). We show here that N-SLIT2 has no effect on phagocytosis of <italic>S. aureus</italic> by neutrophils and macrophages, in keeping with our previous observation that N-SLIT2 does not affect FcγR-mediated phagocytosis of opsonized particles by neutrophils (<xref ref-type="bibr" rid="bib10">Chaturvedi et al., 2013</xref>), and an independent recent report showing that SLIT2 does not affect phagocytosis of <italic>M. tuberculosis</italic> by innate immune cells (<xref ref-type="bibr" rid="bib4">Borbora et al., 2023</xref>). Together, these results suggest that N-SLIT2 can selectively promote some phagocyte functions while attenuating or not affecting others.</p><p>The phagocyte oxidative burst is a powerful tool for host defense against versatile pathogens such as <italic>S. aureus</italic> (<xref ref-type="bibr" rid="bib6">Buvelot et al., 2017</xref>; <xref ref-type="bibr" rid="bib52">Neehus et al., 2021</xref>). The oxidative burst can be further enhanced by priming agents, including tumor necrosis factor-α, which increase ROS production in response to secondary activating stimuli but have no effect on their own (<xref ref-type="bibr" rid="bib14">Dang et al., 2006</xref>). In the resting state, three out of the five core components of the NOX complex, namely NCF1, NCF2, and NCF4, reside in the cytosol while the other two, CYBA and CYBB, are transmembrane proteins (<xref ref-type="bibr" rid="bib19">El-Benna et al., 2008</xref>). We selectively investigated NCF1 (also known as p47phox) because of its well-characterized role in promoting NOX activation at the plasma membrane, and therefore, extracellular ROS production (<xref ref-type="bibr" rid="bib40">Li et al., 2010</xref>; <xref ref-type="bibr" rid="bib82">Warnatsch et al., 2017</xref>). The primed state of the NOX complex is characterized by phosphorylation of its cytosolic components, including NCF1, followed by their membrane translocation (<xref ref-type="bibr" rid="bib19">El-Benna et al., 2008</xref>). We found that, upon exposure to N-SLIT2, NCF1 is phosphorylated at the conserved Serine<sup>345</sup> residue, which in turn results in NOX priming (<xref ref-type="bibr" rid="bib14">Dang et al., 2006</xref>) in phagocytes. To date, more than a dozen cellular protein kinases, including PKC and p38 MAPKs, have been implicated in NCF1 phosphorylation (<xref ref-type="bibr" rid="bib20">El-Benna et al., 2009</xref>). Terzi et al., postulated that neuronal SLIT2-ROBO2 signaling could activate PKC (<xref ref-type="bibr" rid="bib75">Terzi et al., 2021</xref>). We observed that in neutrophils, N-SLIT2 did not activate PKC. These findings could be explained by the observation that in a cell-free system, the PKC-interacting protein AKAP79 binds to the C-termini of ROBO2/3, but fails to bind to the C-terminus of ROBO1 (<xref ref-type="bibr" rid="bib68">Samelson et al., 2015</xref>). Our studies revealed that N-SLIT2 induced p38 activation in human neutrophils and that inhibition of p38 signaling potently attenuated the observed N-SLIT2-mediated increase in oxidative burst. These results are in accordance with the observation that SLIT2 and its orthologues can stimulate p38 MAPK signaling in non-mammalian neurons (<xref ref-type="bibr" rid="bib7">Campbell and Okamoto, 2013</xref>; <xref ref-type="bibr" rid="bib60">Piper et al., 2006</xref>). Our results are also in agreement with a recent study reporting hyperactivation of p38 MAPK in mice genetically overexpressing SLIT2 (<xref ref-type="bibr" rid="bib80">Wang et al., 2020</xref>). Interestingly, during the oxidative burst, PKC and p38 MAPK target distinct serine residues in the NCF1 C-terminus for phosphorylation (<xref ref-type="bibr" rid="bib14">Dang et al., 2006</xref>; <xref ref-type="bibr" rid="bib26">Fontayne et al., 2002</xref>; <xref ref-type="bibr" rid="bib49">Meijles et al., 2014</xref>). This might explain how N-SLIT2 (which activates p38) and PMA (which activates PKC) act synergistically during ROS production by human neutrophils. Together, these findings show that N-SLIT2-ROBO1 signaling primes the phagocyte NOX complex via p38 MAPK-mediated phosphorylation of NCF1. Intriguingly, SLIT2-induced p38 MAPK activation is not limited to innate immune cells. Li et al. recently demonstrated that N-SLIT2-ROBO1 signaling similarly activates p38 in pancreatic ductal adenocarcinoma cells as well as metastatic tumors but the underlying mechanism was not elucidated (<xref ref-type="bibr" rid="bib42">Li et al., 2023b</xref>). Using a specific pharmacological inhibitor to disrupt cellular ROCK signaling (Y-27632), we show here that SLIT2-induced modulation of Rho/ROCK signaling is vital for its effect on p38 MAPK activity. Finally, we investigated SLIT2-induced cytoskeletal changes in neutrophils in whole blood using an established biophysical approach, RT-DC (<xref ref-type="bibr" rid="bib2">Bashant et al., 2019</xref>; <xref ref-type="bibr" rid="bib77">Toepfner et al., 2018</xref>). There was a trend for neutrophils from N-SLIT2-treated blood samples to be smaller and less deformed as compared to counterparts treated with N-SLIT2ΔD2, but this did not reach statistical significance (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A–B</xref>). This could be due to the dilution of the sample with RT-DC buffer thereby reducing the magnitude of NSLIT-2-induced effects. N-SLIT2 can also interact with other proteins present in whole blood, thereby modulating the activity of the protein.</p><p>An ever-growing body of evidence reveals phenotypic and functional heterogeneity of neutrophils in the circulation as well as in tissues (<xref ref-type="bibr" rid="bib12">Crainiciuc et al., 2022</xref>; <xref ref-type="bibr" rid="bib24">Fine et al., 2019</xref>; <xref ref-type="bibr" rid="bib67">Sagiv et al., 2015</xref>). As some of the neutrophil subtypes are sensitive to in vitro isolation methods, a more representative snapshot of their inherent properties is enabled by optimized flow cytometry protocols that use whole blood preparations (<xref ref-type="bibr" rid="bib24">Fine et al., 2019</xref>; <xref ref-type="bibr" rid="bib23">Fine et al., 2016</xref>). We found that in addition to priming neutrophils, N-SLIT2 also enhanced exocytosis of secondary granules after exposure to <italic>S. aureus</italic>, stimulating the release of LL-37, an antimicrobial cathelicidin peptide which is highly effective in killing <italic>S. aureus</italic> extracellularly at nanomolar concentrations (<xref ref-type="bibr" rid="bib53">Noore et al., 2013</xref>). Our results are congruent with previous reports that exposure to <italic>S. aureus</italic> increases CD66b surface levels in neutrophils (<xref ref-type="bibr" rid="bib48">Mattsson et al., 2003</xref>), but we noted that this effect was further augmented by concurrent exposure to both N-SLIT2 and <italic>S. aureus</italic>. This can be explained by our observation that N-SLIT2 activates p38 MAPK and primes the NOX complex. In neutrophils, priming of the NOX complex by p38 MAPK results in the exocytosis of secondary granules, and LL-37 is stored in its pro-peptide form in secondary granules (<xref ref-type="bibr" rid="bib62">Potera et al., 2016</xref>; <xref ref-type="bibr" rid="bib73">Sørensen et al., 1997</xref>; <xref ref-type="bibr" rid="bib81">Ward et al., 2000</xref>). Indeed, we observed that inhibition of NOX partially blocked the effects of N-SLIT2, while inhibition of p38 MAPK abolished both extracellular ROS production as well as secondary granule release.</p><p>Although N-SLIT2 enhanced <italic>S. aureus</italic>-induced exocytosis of secondary granules in neutrophils, it did not alter cell-surface levels of the phagocytic receptor, CD16. Similarly, exposure to N-SLIT2 did not change cell-surface levels of CD63, a protein stored in primary (azurophilic) granules of neutrophils (<xref ref-type="bibr" rid="bib5">Borregaard and Cowland, 1997</xref>). Our results are in line with studies showing that neither <italic>S. aureus</italic> nor p38 activation induces primary granule release from neutrophils (<xref ref-type="bibr" rid="bib45">Lu et al., 2014</xref>; <xref ref-type="bibr" rid="bib62">Potera et al., 2016</xref>). Together, these findings show that N-SLIT2-induced activation p38 MAPK is responsible for the secretion of secondary granules which contain the anti-staphylococcal peptide, LL-37 (<xref ref-type="fig" rid="fig6">Figure 6</xref>). There was a trend towards increased NETosis in neutrophils exposed to N-SLIT2 and <italic>S. aureus</italic> together as compared to those exposed to either <italic>S. aureus</italic> alone or <italic>S. aureus</italic> and N-SLIT2ΔD2 together, but the effect was not statistically significant. <italic>S. aureus</italic> is known to induce NETosis in both a NOX-dependent and –independent manner (<xref ref-type="bibr" rid="bib17">Douda et al., 2015</xref>; <xref ref-type="bibr" rid="bib56">Parker et al., 2012</xref>; <xref ref-type="bibr" rid="bib59">Pilsczek et al., 2010</xref>). Additionally, <italic>S. aureus</italic> actively degrades NETs (<xref ref-type="bibr" rid="bib76">Thammavongsa et al., 2013</xref>). More studies are needed to investigate the role of SLIT2-ROBO1 signaling in the modulation of NETosis.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Proposed mechanism of N-SLIT2’s anti-bacterial action.</title><p>The binding of the Leucine-rich repeat D2 domain of N-SLIT2 to cell-surface ROBO1 results in the activation of p38 MAPK signaling in neutrophils. Active p38 MAPK phosphorylates cytosolic Neutrophil Cytosolic Factor 1 (NCF1) (p47phox), which is in its resting state, inducing translocation to the plasma membrane, thereby converting NCF1 to its primed state, forming a multi-protein NOX complex. In the presence of secondary stimuli such as <italic>S. aureus</italic> (and PMA), N-SLIT2-induced phosphorylation of NCF1 results in increased extracellular oxidative burst by neutrophils. The activation of p38 MAPK also augments exocytosis of secondary and tertiary granules. Secondary granules contain hCAP-18 which is cleaved extracellularly into its active form, the anti-microbial peptide, LL-37. Together, the N-SLIT2-mediated upsurge in both reactive oxygen species (ROS) production and LL-37 secretion promotes enhanced extracellular killing of <italic>S. aureus</italic>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87392-fig6-v1.tif"/></fig><p>Using a murine model of community-associated <italic>S. aureus</italic>-induced SSTI, we found that endogenous levels of SLIT2 protein at the site of infection were significantly reduced at 12 hr after infection, and subsequently increased to reach a peak at 3 days post-infection. Local levels of SLIT3 were also reduced at 12 hr but did not increase more than those in uninfected controls. Congruent with our findings, a local reduction in <italic>SLIT3</italic> mRNA levels was recently reported in patients after <italic>S. aureus</italic>-induced SSTI (<xref ref-type="bibr" rid="bib28">Fyhrquist et al., 2019</xref>). Importantly, we found that locally blocking endogenous SLIT2 at time points when it is most abundantly expressed resulted in enhanced <italic>S. aureus</italic>-induced SSTI. These results are consistent with our previous observation that the neutralization of endogenous SLIT2 enhances macrophage macropinocytosis and inflammatory cytokine production in vivo in a peritonitis model (<xref ref-type="bibr" rid="bib3">Bhosle et al., 2020</xref>). We also observed a significant reduction in oxidative tissue injury, measured using 8-OHdG, in SSTI in mice treated with N-ROBO1 to neutralize endogenous SLIT2. Intriguingly, these animals also showed augmented neutrophil infiltration in SSTI which is in line with the well-established function of SLIT2 as a neutrophil chemorepellent (<xref ref-type="bibr" rid="bib10">Chaturvedi et al., 2013</xref>; <xref ref-type="bibr" rid="bib78">Tole et al., 2009</xref>; <xref ref-type="bibr" rid="bib88">Zhou et al., 2022</xref>). Our results are also in accord with a recent report showing that <italic>M. tuberculosis</italic> infection upregulates SLIT2 expression in macrophages in vivo and this is associated with increased ROS signaling (<xref ref-type="bibr" rid="bib4">Borbora et al., 2023</xref>). In recent years, vascular endothelial cells have emerged as an important source of endogenous SLIT2 in vivo (<xref ref-type="bibr" rid="bib66">Romano et al., 2018</xref>; <xref ref-type="bibr" rid="bib74">Tavora et al., 2020</xref>). It was recently reported that miR-218 is differentially secreted in milk in a bovine model of <italic>S. aureus</italic> mammary infection (<xref ref-type="bibr" rid="bib46">Ma et al., 2019</xref>). Since SLIT2 is a well-known host gene for miR-218 in vascular endothelial cells (<xref ref-type="bibr" rid="bib72">Small et al., 2010</xref>), we asked whether DMEC, an endothelial cell type involved in SSTI, can secrete SLIT2 in response to <italic>S. aureus</italic> infection. In accord with results from our in vivo experiments, SLIT2 expression was reduced at 12 hr and then increased at 48 hr following <italic>S. aureus</italic> infection of cultured DMEC cells in vitro. Exposure of HMEC-1 to hypoxia, typically found in advanced <italic>S. aureus</italic> SSTI-associated abscesses, also phenocopied the SLIT2 expression pattern in vitro. S. aureus infection is also known to upregulate cellular hypoxia-inducible factor 1-alpha (HIF-1α) signaling in vitro as well as in vivo (<xref ref-type="bibr" rid="bib83">Werth et al., 2010</xref>; <xref ref-type="bibr" rid="bib87">Zhang et al., 2022</xref>). Additionally, Li et al., very recently reported that HIF-1α negatively regulates SLIT2 expression in vascular smooth muscle cells (<xref ref-type="bibr" rid="bib41">Li et al., 2023a</xref>). These findings have important implications for <italic>S. aureus</italic>-induced SSTI. First, <italic>S. aureus-</italic> and/or hypoxia-induced early upregulation of HIF-1α in DMEC could directly suppress SLIT2 production. It also opens up the possibility of multiple cell types being involved in the regulation of local levels of SLIT2 in SSTI and this will be the subject of future investigation.</p><p>Taken together, these results indicate that host-derived SLIT2 plays an important role in the spatiotemporal modulation of innate immune responses during bacterial infection. The rapid initial decrease in SLIT2 (and SLIT3) at the site of infection may serve to augment the immediate recruitment of neutrophils to combat the infection, while the rise in SLIT2 several days later may promote localized retention of recruited neutrophils and enhancement of their bactericidal properties. In this manner, spatiotemporal regulation of SLIT2/ROBO1 activity may potently direct bacterial killing and confer effective host protection against pathogenic infection. Further studies are needed to explore the precise mechanisms by which levels of SLIT2 are modulated in the face of bacterial infection and to explore the potential of SLIT2 as a novel anti-microbial therapeutic. Recent studies by independent research groups suggest that SLIT2 could not only serve as a therapeutic to combat <italic>S. aureus</italic>, but could have broader anti-microbial activity against a number of pathogens including <italic>Mycobacterium tuberculosis</italic>, intestinal pathogens, H5N1 influenza, and SARS-CoV-2 (<xref ref-type="bibr" rid="bib4">Borbora et al., 2023</xref>; <xref ref-type="bibr" rid="bib32">Gustafson et al., 2022</xref>; <xref ref-type="bibr" rid="bib43">London et al., 2010</xref>). Given mounting concerns about the growing resistance of bacterial pathogens to conventional pharmacologic antibiotic treatment, SLIT2 may represent an attractive alternative or synergistic therapeutic strategy.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><p>All antibodies, chemicals, reagents, and assay kits are listed in the Key Resources Table.</p><sec id="s4-1"><title>Cell culture</title><p>RAW264.7 (TIB-71; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:CVCL_0493">CVCL_0493</ext-link>) cells were purchased from the American Type Culture Collection (ATCC; Manassas, VA, USA). Cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM; Wisent, St-Bruno, QC, Canada) supplemented with 10% heat-inactivated fetal bovine serum (FBS; Wisent) with 1% antibiotic/antimycotic (Wisent) at 37 °C and 5% CO<sub>2</sub>. FreeStyle 293-F (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:CVCL_D603">CVCL_D603</ext-link>) cells were purchased from Thermo Fisher Scientific (Mississauga, ON, Canada) and were grown in FreeStyle 293 Expression Medium (GIBCO, Thermo Fisher Scientific). HMEC-1 (CRL-3243; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:CVCL_0307">CVCL_0307</ext-link>) cells were bought from ATCC and were maintained in EBM-2 Basal Medium (CC-3156) and EGM-2 MV Microvascular Endothelial Cell Growth Medium SingleQuots supplements (CC-4147) from Lonza (Kingston, ON, Canada) in an incubator at 37 °C and 5% CO<sub>2</sub>. All cell lines were used for experiments at a passage of less than 10. All cell lines tested negative for mycoplasma using the Mycoplasma Plus PCR kit (#302008, Agilent Technologies, Santa Clara, CA, USA).</p></sec><sec id="s4-2"><title>Production of recombinant SLIT2 proteins</title><p>Large-scale production of bio-inactive human N-SLIT2ΔD2 was performed by transfecting FreeStyle 293-F cells with human N-SLIT2ΔD2 cDNA (1 ug/mL) using PEI reagent (Polyethyleneimine, linear, M.W. 25,000, Thermo Fisher Scientific) (<xref ref-type="bibr" rid="bib57">Patel et al., 2012</xref>). After 5 days, the culture medium was loaded onto HisPur Ni-NTA resin (Thermo Fisher Scientific), washed with imidazole (35 mM), eluted with imidazole (250 mM), and desalted using a Pierce Zeba desalting column (7 K MWCO; Thermo Fisher Scientific). Protein molecular weight was determined by immunoblotting using anti-6XHIS-HRP conjugated antibody. Protein activity was assayed by using a spreading assay in RAW264.7 cells, as described previously (<xref ref-type="bibr" rid="bib3">Bhosle et al., 2020</xref>). Recombinant human N-SLIT2 was purchased from PeproTech (Cranbury, NJ, USA). Endotoxin levels in all preparations were measured using ToxinSensor Chromogenic LAL Endotoxin Assay Kit (GenScript, Piscataway, NJ, USA) and were less than 0.05 EU/ml.</p></sec><sec id="s4-3"><title>Study approvals</title><p>The protocol (#1000070040) for human blood collection from healthy adult donors was reviewed and approved by The Hospital for Sick Children (SickKids, Toronto, ON, Canada) Research Ethics Board. Written, informed consent was obtained from all participants prior to their participation. The animal studies were reviewed and approved by SickKids Animal Care Committee (ACC) (protocol #1000049735 – <italic>S. aureus</italic> infection) and The Centre for Phenogenomics (Toronto, ON, Canada) ACC (protocol #21–0326 – murine neutrophil isolation). The protocols for RT-DC experiments (# EK89032013, EK458102015) with human blood were approved by the ethics committee of the Technische Universität Dresden.</p></sec><sec id="s4-4"><title>Human neutrophil isolation</title><p>All reagents were filtered through Detoxi-Gel Endotoxin Removing Gel Columns (Thermo Fisher Scientific) prior to neutrophil isolation. Human neutrophils were isolated using a density-gradient separation method (<xref ref-type="bibr" rid="bib54">Ostrowski et al., 2020</xref>). Briefly, 30 ml of blood was collected in sterile BD Vacutainer EDTA (BD Biosciences, Mississauga, ON, Canada) tubes and layered on the top of PolymorphPrep (Progen, Wayne, PA, USA) in a 1:1 ratio. The layered mixture was spun at 500 g (acceleration 1 and deceleration 0) for 30 min to separate polymorphonuclear neutrophils (PMN) from mononuclear cells. PMN were washed with Hank’s balanced salt solution with calcium and magnesium (HBSS+/+; Wisent) and then subjected to red blood cell lysis using 0.2% NaCl followed by 1.6% NaCl for 30 s each. Neutrophils were resuspended in HBSS+/+ and used within 1 hr for all experiments.</p></sec><sec id="s4-5"><title>Murine BMDN isolation</title><p>C57BL/6 mice aged 8–12 weeks were purchased from Charles River Laboratories (St-Constant, QC, Canada). Mice were euthanized by CO<sub>2</sub> inhalation, and their tibias and femurs were resected and cut at both ends. Bone marrow cells were extracted and added to Percoll (Sigma-Aldrich, Oakville, ON, Canada) gradient solutions of 82%/65%/55% as previously described (<xref ref-type="bibr" rid="bib78">Tole et al., 2009</xref>). The solution was centrifuged, and murine neutrophils were collected from an 82%/65% interface. Red blood cell lysis was performed as described above.</p></sec><sec id="s4-6"><title><italic>S. aureus</italic> killing assays</title><p><italic>Staphylococcus aureus subsp. Aureus Rosenbach (S. aureus</italic>) (ATCC 25923) was purchased from ATCC. The extracellular bactericidal activity of neutrophils was assayed as described previously (<xref ref-type="bibr" rid="bib47">Magon et al., 2020</xref>), with some modifications. Freshly isolated neutrophils (1 × 10<sup>5</sup>) were incubated with vehicle (HBSS+/+), N-SLIT2, or N-SLIT2ΔD2 for 15 min at 37 °C and then incubated with unoposonized <italic>S. aureus</italic> (MOI 10) for an additional 15 min at 37 °C. End-over rotation (6 rpm) was used to prevent neutrophil clumping. Tubes were centrifuged at 100 g for 5 min and neutrophil pellets were discarded. Supernatant samples containing the extracellular bacteria were collected. Bacterial colony forming units (CFU) were determined using serial dilution followed by overnight culture in Tryptic Soy Agar (TSA) with 5% sheep blood (Remel, Lenexa, KS, USA) (<xref ref-type="bibr" rid="bib47">Magon et al., 2020</xref>).</p></sec><sec id="s4-7"><title><italic>S. aureu</italic>s phagocytosis assays</title><p>The GFP-expressing strain <italic>of S. aureus</italic> USA300 LAC was grown at 37 °C overnight with shaking in Todd-Hewitt broth (BD Biosciences) with erythromycin (3 µg/ml) for selection (<xref ref-type="bibr" rid="bib25">Flannagan and Heinrichs, 2018</xref>). Just before the phagocytosis assay, RAW264.7 macrophages or freshly-isolated human neutrophils were incubated with vehicle, N-SLIT2 or N-SLIT2ΔD2 for 15 min at 37 °C.</p><p>Overnight <italic>S. aureus</italic> USA300 LAC were diluted to OD<sub>600nm</sub> 0.05 in Todd-Hewitt broth containing erythromycin and cultivated until logarithmic growth (OD<sub>600nm</sub> 0.5) at 37 °C. Bacterial aggregates were dispersed using a 27-gauge needle (BD Biosciences) prior to infection. Unopsonized <italic>S. aureus</italic> was centrifuged onto RAW264.7 macrophages (MOI 10) or human neutrophils (MOI 10), and phagocytosis was allowed to proceed for 45 min at 37 °C under 5% CO<sub>2</sub>. Samples were washed three times in sterile PBS and fixed in 3% paraformaldehyde (PFA) (Electron Microscopy Sciences, Hatfield, PA, USA) for 15 min at room temperature. Samples were blocked with block buffer, consisting of PBS containing 2% FBS and 2% bovine serum albumin (BSA) for 30 min at room temperature. To label bound but non-internalized bacteria, samples were incubated with human total IgG for 30 min at room temperature. Non-internalized bacteria were visualized using donkey anti-human IgG-Cy3 for 30 min at room temperature. To label the cell nuclei, samples were permeabilized with Triton-X100 (0.2%) for 10 min and incubated with DAPI for 10 min. The surface of RAW264.7 cells was labeled with Acti-stain-AF670 for 10 min at room temperature. The surface of neutrophils was labeled with Concanavalin A-AF647 for 30 min.</p><p>Confocal images were acquired using a spinning disk system (WaveFX; Quorum Technologies Inc, Puslinch, ON, Canada). The instrument consists of a microscope (Axiovert 200 M; Zeiss, Toronto, ON, Canada), scanning unit (CSU10; Yokogawa Electric Corp, Calgary, AB, Canada), electron-multiplied charge-coupled device (C9100-13; Hamamatsu Photonics), five-line (405-, 443-, 491-, 561-, and 655 nm) laser module (Spectral Applied Research, Richmond Hill, ON, Canada), and filter wheel (MAC5000; Ludl) and is operated by Volocity software version 6.3 (PerkinElmer, Waltham, MA, USA). Confocal images were acquired using a 63 x/1.4 N.A. oil objective (Zeiss) coupled with an additional 1.53 magnifying lens and the appropriate emission filter. Phagocytic Index and Phagocytic Efficiency were quantified as described below (<xref ref-type="bibr" rid="bib84">Westman et al., 2020</xref>).<disp-formula id="equ1"><mml:math id="m1"><mml:mrow><mml:mi>P</mml:mi><mml:mi>h</mml:mi><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>o</mml:mi><mml:mi>c</mml:mi><mml:mi>y</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>c</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>I</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:mi>e</mml:mi><mml:mi>x</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>N</mml:mi><mml:mi>u</mml:mi><mml:mi>m</mml:mi><mml:mi>b</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>n</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>z</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>S</mml:mi><mml:mo>.</mml:mo><mml:mspace width="thinmathspace"/><mml:mi>a</mml:mi><mml:mi>u</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>N</mml:mi><mml:mi>u</mml:mi><mml:mi>m</mml:mi><mml:mi>b</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>p</mml:mi><mml:mi>h</mml:mi><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>o</mml:mi><mml:mi>c</mml:mi><mml:mi>y</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math></disp-formula><disp-formula id="equ2"><mml:math id="m2"><mml:mrow><mml:mi>P</mml:mi><mml:mi>h</mml:mi><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>o</mml:mi><mml:mi>c</mml:mi><mml:mi>y</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>c</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>E</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi><mml:mi>i</mml:mi><mml:mi>c</mml:mi><mml:mi>i</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>c</mml:mi><mml:mi>y</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>N</mml:mi><mml:mi>u</mml:mi><mml:mi>m</mml:mi><mml:mi>b</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>n</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>z</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi><mml:mspace width="mediummathspace"/><mml:mi>S</mml:mi><mml:mo>.</mml:mo><mml:mspace width="thinmathspace"/><mml:mi>a</mml:mi><mml:mi>u</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>N</mml:mi><mml:mi>u</mml:mi><mml:mi>m</mml:mi><mml:mi>b</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>n</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>z</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>S</mml:mi><mml:mo>.</mml:mo><mml:mspace width="thinmathspace"/><mml:mi>a</mml:mi><mml:mi>u</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi><mml:mspace width="thinmathspace"/><mml:mo>+</mml:mo><mml:mspace width="thinmathspace"/><mml:mi>N</mml:mi><mml:mi>u</mml:mi><mml:mi>m</mml:mi><mml:mi>b</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>b</mml:mi><mml:mi>o</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>S</mml:mi><mml:mo>.</mml:mo><mml:mspace width="thinmathspace"/><mml:mi>a</mml:mi><mml:mi>u</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mfrac></mml:mrow></mml:math></disp-formula></p></sec><sec id="s4-8"><title>Extracellular ROS production</title><p>Extracellular ROS levels were measured using an isoluminol-based chemiluminescence assay (<xref ref-type="bibr" rid="bib13">Dahlgren et al., 2007</xref>). Human or murine neutrophils (5 × 10<sup>5</sup>) were incubated with isoluminol (3 mmol/L) and horseradish peroxidase (6 U) in a 96-well plate and exposed to N-SLIT2 or N-SLIT2ΔD2 for 15 min immediately followed by a secondary stimulus consisting of <italic>S. aureus</italic> (MOI 10) or PMA (100 nM) at 37 °C. Chemiluminescence was measured every 5 min (for a total of 45 min) using a Varioskan LUX Plate Reader (Thermo Fisher Scientific).</p></sec><sec id="s4-9"><title>Rac G-LISA</title><p>Activation of Rac1/2/3 was measured by G-LISA as previously described (<xref ref-type="bibr" rid="bib3">Bhosle et al., 2020</xref>). Following the experimental treatment, neutrophils were lysed using boiling (95 °C) lysis buffer with protease inhibitors (provided in the kit), and assays were performed according to the manufacturer’s instructions (<xref ref-type="bibr" rid="bib3">Bhosle et al., 2020</xref>). Readings were obtained at 490  nm using a Varioskan LUX Plate Reader.</p></sec><sec id="s4-10"><title>NETosis assay</title><p>NETosis assays were performed as previously described (<xref ref-type="bibr" rid="bib17">Douda et al., 2015</xref>). Briefly, neutrophils were seeded at a density of 5 × 10<sup>4</sup> and exposed to N-SLIT2 or N-SLIT2ΔD2 in HBSS+/+ medium for 15 min immediately followed by a secondary stimulus of <italic>S. aureus</italic> (MOI 10) at 37 °C, where indicated. In parallel wells, cells were lysed using 0.5% (vol/vol) Triton X-100. The cell-impermeable nucleic acid stain, Sytox Green (5 μM) was added to all wells and the fluorescence was measured at 523 nm at 15 min intervals for 3 hr using a SpectraMax Gemini EM Fluorescence plate reader (Molecular Devices, San Jose, CA). To calculate the NETotic index, the readout from Triton X-100-treated wells was considered as 100% cell lysis (and DNA release), and the index was calculated as a percent of DNA release at each time point.</p></sec><sec id="s4-11"><title>Inhibitor treatments</title><p>Before adding N-SLIT2 to the cells, neutralization was performed by pre-incubating N-SLIT2 with N-ROBO1 at a 1:3 molar ratio for 1 hr at room temperature. In experiments using conditioned media, the media were exposed to either control IgG or N-ROBO1 at a final concentration of 1 μg/ml for 1 hr at room temperature, immediately before adding to the neutrophils. For ROCK inhibition, neutrophils were exposed to Y-27632 (10 μM) and N-SLIT2 (30 nM) simultaneously for 15 min. p38 MAPK (SB 203580 and p38 MAPK Inhibitor IV) and MEK 1/2 inhibitors (PD 184161) were used at a final concentration of 10 μM each for 15 min.</p></sec><sec id="s4-12"><title>Immunoblotting</title><p>Neutrophils were lysed in boiling RIPA lysis buffer (60 mM Tris, pH 7.5, 10% Glycerol, 1% TX-100, 150 mM NaCl, 0.5% Na-deoxycholate, 0.1% SDS, 1 mM EDTA) and 1 X protease and phosphatase inhibitor (#MSSAFE, Sigma-Aldrich). Protein lysate (30 μg) with 2 X Laemmli buffer (in 1:1 ratio) was loaded onto a 4–20% gradient gel (Bio-Rad, Mississauga, ON, Canada). The gel was transferred onto a PVDF membrane using the Trans-Blot Turbo Transfer System (Bio-Rad). Membranes were blocked for 1 hr at room temperature in a blocking buffer (5% BSA in PBS-T), with a solution containing primary antibodies. After washing and the addition of the secondary antibody, membranes were developed using SuperSignal West Dura and photographed using the Bio-Rad GelDoc system with Image Lab software. The denistometric quantifications were performed using ImageJ software, version 1.51 v (<xref ref-type="bibr" rid="bib69">Schindelin et al., 2012</xref>).</p></sec><sec id="s4-13"><title>Flow cytometry</title><p>All treatments were performed with whole blood for 15 min at 37 °C. Immediately following the treatment, the samples were fixed with PFA (1.6%) for 15 min on ice. RBCs were lysed three times with Pharm Lyse (BD Biosciences) for 10 min on ice. Cells were resuspended in flow-assisted cell sorting (FACS) buffer (HBSS-/-, 1% BSA, 2 mM EDTA), labeled with an antibody cocktail for 30 min on ice in the dark, and washed three times with FACS buffer. Sample acquisition was performed using a Sony Spectral Cell Analyzer SA3800 in a standardization mode. At least 1 × 10<sup>5</sup> gated events were acquired per sample (<xref ref-type="bibr" rid="bib24">Fine et al., 2019</xref>; <xref ref-type="bibr" rid="bib23">Fine et al., 2016</xref>). Data were analyzed using FlowJo software (BD Biosciences, version 10). Human multicolor flow cytometry panel and gating were done as previously described (<xref ref-type="bibr" rid="bib24">Fine et al., 2019</xref>).</p></sec><sec id="s4-14"><title><italic>S. aureus</italic> infection of HMEC-1 cells</title><p>One day before infection, HMEC-1 cells were plated at a density of 0.3 × 10<sup>6</sup> cells per well in a six-well plate and the infection protocol was carried out as previously described (<xref ref-type="bibr" rid="bib65">Rollin et al., 2017</xref>). Briefly, overnight cultures of <italic>S. aureus</italic> were diluted to OD<sub>600nm</sub> 0.05, cultivated until OD<sub>600nm</sub> 0.5 (logarithmic growth) at 37 °C, and resuspended in serum-free basal medium. Bacteria were added to HMEC-1 cells at MOI of 1 and incubated for 1 hr at 37 °C and 5% CO<sub>2</sub>. Cells were washed three times with PBS containing 300 μg/ml gentamicin to kill extracellular bacteria and then cultured for indicated times in full medium (2 ml per well) containing 50 μg/ml gentamicin. At the end of the infection period, the conditioned medium was snap-frozen using liquid nitrogen, stored at –80 °C, and cellular RNA was isolated as described below.</p></sec><sec id="s4-15"><title>Hypoxia treatment of HMEC-1 cells</title><p>One day before specific treatments, HMEC-1 cells were plated at a density of 0.3 × 10<sup>6</sup> cells per well in two six-well plates. One plate was incubated at 37 °C in a hypoxia chamber (BioSpherix, Parish, NY) supplemented with 1% O<sub>2</sub> and 5% CO<sub>2</sub> and the other plate was concurrently incubated in a normoxic (20% O<sub>2</sub>) tissue-culture incubator (37 °C and 5% CO<sub>2</sub>). At the end of each culture period, conditioned media supernatants were snap-frozen using liquid nitrogen, and cellular RNA was isolated as described below.</p><p>In some experiments freshly isolated human neutrophils (10<sup>6</sup> cells per condition) were resuspended in 500 μl conditioned medium collected from HMEC-1 cells. In some cases, the conditioned medium was pre-treated with control IgG or N-ROBO1 (1 μg/ml) for 1 hr at room temperature just before resuspending the neutrophils. Neutrophils were then stimulated with <italic>S. aureus</italic> (MOI 10) for 15 min and the supernatant was collected by centrifuging the cells at 500 g for 5 min. The LL-37 levels in the supernatants were measured using an ELISA as described below.</p></sec><sec id="s4-16"><title>Culture of HMEC-1 cells at different extracellular pH conditions</title><p>The extracellular pH of the media was adjusted using a modified version of the protocol using different concentrations of sodium bicarbonate (NaHCO<sub>3</sub>) (<xref ref-type="bibr" rid="bib37">Kondo and Osawa, 2017</xref>). Endothelial Basal Medium MCDB 131 was prepared as follows: 2.9 g of MCDB 131 powder (without supplements) (#E3000-01B, United States Biological, Salem, MA) was dissolved in 250 ml of ddH<sub>2</sub>O and the pH of the medium was adjusted using a stock solution of 0.33 M NaHCO<sub>3</sub> as described in <xref ref-type="table" rid="table1">Table 1</xref>.</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Amount of NaHCO<sub>3</sub> added to MCDB 131 medium.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Final pH</th><th align="left" valign="bottom">NaHCO<sub>3</sub> stock (µl) added to 1 ml of medium</th><th align="left" valign="bottom">Final molarity (NaHCO<sub>3</sub>) mM</th></tr></thead><tbody><tr><td align="char" char="." valign="bottom">7.4</td><td align="left" valign="bottom">42.5</td><td align="left" valign="bottom">14</td></tr><tr><td align="char" char="." valign="bottom">7</td><td align="left" valign="bottom">30</td><td align="left" valign="bottom">10</td></tr><tr><td align="char" char="." valign="bottom">6.6</td><td align="left" valign="bottom">9</td><td align="left" valign="bottom">3</td></tr></tbody></table></table-wrap><p>The complete MCDB 131 medium was supplemented with 0.7% FBS, 10 ng/ml EGF, and 1 μg/ml hydrocortisone (all from Lonza, Kingston, ON, Canada), and filter-sterilized using a 0.22 μm membrane filter, as recommended by the manufacturer. The final pH of the complete medium was checked after incubation at 37 °C and 5% CO<sub>2</sub> for 24 hr. HMEC-1 cells were cultured in a complete MCDB 131 medium (pH 7.4) for 2 weeks before experiments. One day before the experiments, HMEC-1 cells were seeded in a six-well plate at a density of 0.3 × 10<sup>6</sup> cells per well. On the day of the experiment, the culture medium (pH 7.4) was replaced with a medium with the indicated pH (6.6, 7.0, and 7.4) for 6, 12, and 24 hr at 37 °C and 5% CO<sub>2</sub>. The cells did not survive pH 6.6 beyond 24 hr. At the end of each treatment, media supernatants were snap-frozen using liquid nitrogen and RNA was isolated as described below.</p></sec><sec id="s4-17"><title>Quantitative reverse transcription-polymerase chain reaction</title><p>Total cellular RNA was isolated using the RNeasy Plus Mini Kit (#74136, Qiagen, Toronto, ON, Canada). The cDNA was synthesized from 1 μg total RNA by reverse transcription-polymerase chain reaction using the Superscript VILO MasterMix (#11755, Thermo Fisher Scientific). Finally, quantitative real-time PCR (qPCR) was performed using Power SYBR Green PCR Master Mix (#4367659, Thermo Fisher Scientific) with the following cycling parameters: 95 °C for 10 min, then 40 cycles of 95 °C for 15 s, 60 °C for 60 s. The forward and reverse primers (sequences in Key Resources Table) were used in a final concentration of 100 nM each (total reaction volume: 25 μl).</p></sec><sec id="s4-18"><title>ELISA</title><p>Following treatment of neutrophils supernatants were collected and snap-frozen in liquid nitrogen. The ELISA to measure LL-37 (#HK321, Hycult Biotech, Uden, Netherlands) was performed as per the manufacturer’s protocol. In some experiments, murine ear pinnae were homogenized and the levels of murine SLIT2 and SLIT3 were measured by ELISA (SLIT2 kit, #CSB-E11039m, CUSABIO, Wuhan, China) (SLIT3 kit, #LS-F7173, LSBio, Seattle, WA, USA) as per the manufacturers’ protocols (<xref ref-type="bibr" rid="bib3">Bhosle et al., 2020</xref>). Human SLIT2 ELISA (for HMEC-1 conditioned media) (#CSB-E11038h, CUSABIO, Wuhan, China) was performed according to the manufacturer’s instructions using a validated kit (<xref ref-type="bibr" rid="bib35">Jiang et al., 2022</xref>). The optical density readings were measured on a microplate reader at 450 nm (VersaMax 190, Molecular Devices).</p></sec><sec id="s4-19"><title>Real-time deformability cytometry (RT-DC)</title><p>Citrate-anticoagulated whole blood (46 μl) was exposed to 4 μl of Vehicle (0.9% NaCl), or N-SLIT2 (30 nM) or N-SLIT2ΔD2 (30 nM) and incubated at room temperature on a shaker at 300 rpm for 45 min. Immediately after, each sample was diluted with 950 μl of RT-DC buffer (Cell Carrier, Zellmechanik Dresden, Dresden, Germany) composed of 1 x PBS and 0.5% methylcellulose (final volume: 1 ml), and the sample viscosities were adjusted to 25 mPa s at 24 °C. RT-DC measurements were performed as described previously using an AcCellerator instrument (Zellmechanik Dresden, Dresden, Germany) (<xref ref-type="bibr" rid="bib2">Bashant et al., 2019</xref>; <xref ref-type="bibr" rid="bib55">Otto et al., 2015</xref>; <xref ref-type="bibr" rid="bib77">Toepfner et al., 2018</xref>). RT-DC measurements were collected at a cellular flow rate of 0.12 µL/s (0.03 µL/s sample flow and 0.09 µL/s sheath flow). To exclude red blood cells (singlets and doublets), a gate for cell-size 5–16 µm parallel to and 5–20 µm perpendicular to the flow direction was applied. For acquiring measurements, an inverted microscope equipped with a high-speed EMOS camera was used and the images were captured at a frame rate of 2000 frames/s as cells reached the end of the constriction channel (<xref ref-type="bibr" rid="bib2">Bashant et al., 2019</xref>; <xref ref-type="bibr" rid="bib18">Ekpenyong et al., 2017</xref>). The leukocyte populations were identified based on cell size and mean brightness (<xref ref-type="bibr" rid="bib77">Toepfner et al., 2018</xref>). Image analysis was carried out using ShapeOut2 software and Python 3.7 as previously described (<xref ref-type="bibr" rid="bib2">Bashant et al., 2019</xref>). ShapeOut2 is available as an open-source application on <ext-link ext-link-type="uri" xlink:href="https://github.com/ZELLMECHANIK-DRESDEN/ShapeOut2">GitHub</ext-link> (<xref ref-type="bibr" rid="bib51">Müller et al., 2019</xref>). Cell deformation, a measure of how much cell shape deviates from circularity, was calculated as follows:<disp-formula id="equ3"><mml:math id="m3"><mml:mi>d</mml:mi><mml:mi>e</mml:mi><mml:mi>f</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:mn>2</mml:mn><mml:msqrt><mml:mi>π</mml:mi><mml:mi>A</mml:mi></mml:msqrt></mml:mrow><mml:mrow><mml:mi>l</mml:mi></mml:mrow></mml:mfrac></mml:math></disp-formula></p><p>where A is the convex hull area and l is the length of the convex hull perimeter.</p></sec><sec id="s4-20"><title>Epicutaneous <italic>S. aureus</italic> infection model</title><p>Sample sizes (<italic>n</italic>) for all in vivo experiments were calculated using G*Power software version 3.1.9.2 (Universität Düsseldorf, Germany) (<xref ref-type="bibr" rid="bib21">Faul et al., 2007</xref>). An experimental unit (n) was defined as a single animal. All collected data points were included in the analysis (no exclusions). The epicutaneous model of murine <italic>S. aureus</italic> infection has been described previously (<xref ref-type="bibr" rid="bib63">Prabhakara et al., 2013</xref>). C57BL/6 mice aged 8–12 weeks, of either sex, were anesthetized using an intraperitoneal injection of ketamine (50 mg/kg) and xylazine (5 mg/kg). The left ear was cleaned with 70% ethanol and pricked 10 times with an <italic>S. aureus</italic>-coated or sterile uncoated (mock infection) 25 G BD SafetyGlide needle (#305901, BD Biosciences). The mean inoculation dose of <italic>S. aureus</italic> was determined to be 5 × 10<sup>6</sup> CFU/lesion, as determined by plating serial dilutions of homogenates from ear pinnae 4 hr after the infection. Mice were monitored twice daily. In some experiments, under anesthesia, mice received subcutaneous ear injections of N-ROBO1 or control IgG (7  µg) on days 2 and 3 after inoculation with <italic>S. aureus</italic>. Animals were euthanized using CO<sub>2</sub> inhalation on day 4 after infection; ear pinnae were cleaned, resected in 500 μl of sterile PBS, and homogenized using a Fisherbrand 150 Handheld Homogenizer (#15-340-167, Thermo Fisher Scientific). Bacterial CFUs were determined by serial dilution.</p></sec><sec id="s4-21"><title>Histopathology</title><p>Coronal sections (5 μm thick; three sections per sample) were embedded in Paraffin. Two sections per sample were counterstained with hematoxylin and eosin (H&amp;E) at The Centre for Phenogenomics (TCP, Toronto, ON, Canada) and were scanned using 3DHistech Slide Scanner (The Hospital for Sick Children Imaging Facility, Toronto, ON, Canada) at 40 x magnification and examined under blinded conditions on a scale of 1–5 at TCP Pathology Core as defined previously (<xref ref-type="bibr" rid="bib63">Prabhakara et al., 2013</xref>). The scoring system is indicated by:</p><list list-type="simple"><list-item><p>0, no evidence of inflammation</p></list-item><list-item><p>1, minimal to mild focal dermal inflammatory infiltrates with or without dermal acanthosis;</p></list-item><list-item><p>2, mild multifocal dermal infiltrates with or without intraepidermal microabscesses;</p></list-item><list-item><p>3, multifocal to diffuse moderate dermal inflammatory infiltrates extending to the skeletal muscles with or without intraepidermal microabscesses;</p></list-item><list-item><p>4, marked dermal inflammatory infiltrates extending to the skeletal muscle and cartilage with or without intraepidermal microabscesses;</p></list-item><list-item><p>5, full thickness auricular necrosis or massive inflammation with myositis and chondritis.</p></list-item></list><p>Immunohistochemical (IHC) labeling and analyses were performed at TCP Pathology Core in a blinded manner. To examine oxidative damage and neutrophil infiltration in tissue, 8-OHdG staining and Ly6G-F4/80 labeling, respectively, were performed as previously described (<xref ref-type="bibr" rid="bib71">Sima et al., 2016</xref>). Briefly, tissue samples were fixed using 10% formalin for 24 hr, and then transferred to PBS. Two 5 μm-thick paraffin-embedded coronal sections per sample were used- one for 8-OHdG labeling and one for Ly6G-F4/80 labeling. For 8-OHdG labeling, samples were immunostained in a Leica BOND-Max instrument (Leica Biosystems, Concord, ON, Canada) using the BOND Epitope Retrieval Solution 1 (#AR9961, Leica Biosystems), and incubated with a primary rabbit anti–8-OHdG antibody (#bs-1278R, Bioss, Atlanta, GA) for 1 hr (dilution 1:500 i.e. 2 µg/ml), followed by detection with a Bond Polymer Refine Detection kit (#DS9800, Leica Biosystems), containing a peroxide block, a polymer reagent, DAB (3,3'-Diaminobenzidine) chromogen, and a hematoxylin counterstain, as per the manufacturer’s guidelines. Slides were scanned at 20 x using an Olympus VS-120 scanner (Evident, Tokyo, Japan). Image analysis was performed using HALO Image Analysis Platform V3.6.4134 (Indica Labs, Albuquerque, NM). For quantification, the Area Quantification Module V2.4.2 (Indica Labs) was used. The fold changes in % DAB +ve nuclei (compared to samples from mock-infected tissue) were calculated.</p><p>To label neutrophils (Ly6G<sup>+</sup>F4/80<sup>–</sup>) in tissues (<xref ref-type="bibr" rid="bib8">Chadwick et al., 2021</xref>), formalin-fixed 5 μm coronal sections were submitted to heat-induced epitope retrieval with citrate buffer, pH 6.0 for 10 min in a pressure cooker, followed by washing with 1 x TBS containing 0.1% Tween 20 (TBS-T; EMD Millipore) and permeabilization with 0.5% Triton X-100 (BioShop, Burlington, ON, Canada) for 5 min at room temperature. The tissue sections were washed with TBS-T and then blocked in DAKO Protein Block, Serum-Free (#X0909, Agilent Technologies, Mississauga, ON, Canada) for 10 min at room temperature. The slides were incubated overnight with the following primary antibodies: Rabbit monoclonal [EPR22909-135] directed to Ly6G (1:500 i.e. 1.4 µg/ml, #ab238132, Abcam, Toronto, ON, Canada) and Rat monoclonal [CI: A3-1] directed to F4/80 (1:100 i.e. 10 µg/ml, #ab6640, Abcam). The following day, slides were washed 3 x with TBS-T, and then incubated with respective secondary antibodies: anti-rabbit IgG tagged with AF-555 (Red, #A-21428, Thermo Fisher Scientific) and anti-rat IgG tagged with AF-488 (Green, #A-11006, Thermo Fisher Scientific), for 1 hr at room temperature (both dilutions - 1:200 i.e. 10 µg/ml). The slides were washed three times with TBS-T and incubated with DAPI (Thermo Fisher Scientific) for 5 min. Finally, after washing three times with TBS-T, slides were mounted with Vectashield Vibrance Antifade mounting medium (#H-1700, Vector Labs, Newark, CA) and scanned 20 x using an Olympus VS-120 slide scanner (Evident, Tokyo, Japan). Image analysis was performed using the HALO Image Analysis Platform V3.6.4134 (Indica Labs). For the quantification of Ly6G<sup>+</sup>F4/80<sup>–</sup> cells, the Highplex FL V4.2.14 module (Indica Labs) was used. The percent neutrophils (Ly6G<sup>+</sup>F4/80<sup>–</sup> cells) per unit tissue area was calculated.</p></sec><sec id="s4-22"><title>Statistics</title><p>GraphPad Prism 9 was used for all statistical analyses (San Diego, CA, USA). All experiments were performed using at least 3 biological replicates; exact numbers of replicates are noted in the figure legends. For experiments using cell lines (RAW264.7, HMEC-1), a biological replicate was defined as cells from different frozen stocks and different passage numbers. For primary cells (human and murine neutrophils), each replicate was performed using cells from a different donor. For in vivo experiments, each animal was considered as a single replicate. All data are presented as mean +/- standard error of mean (SEM). Shapiro-Wilk test was first used to confirm a normal (Gaussian) distribution. For normal distribution, one-way ANOVA followed by Tukey’s post hoc analysis was used. Data with non-Gaussian distribution were analyzed using a Mann-Whitney test. Statistical tests are described in the figure legends. A <italic>p</italic>-value of less than 0.05 was considered statistically significant. The <italic>p</italic>-values are reported up to four decimal places.</p></sec><sec id="s4-23"><title>Data availibility</title><p>All data supporting the findings of this study are available within the paper, its supplementary information files, and source data are provided as a Source Data file linked to this article. This study did not generate any new code.</p></sec><sec id="s4-24"><title>Biological materials</title><p>Unique biological materials used in this study will be made available upon reasonable request to the corresponding author (LAR).</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Investigation, Visualization, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Investigation</p></fn><fn fn-type="con" id="con3"><p>Investigation</p></fn><fn fn-type="con" id="con4"><p>Investigation</p></fn><fn fn-type="con" id="con5"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con6"><p>Visualization</p></fn><fn fn-type="con" id="con7"><p>Investigation</p></fn><fn fn-type="con" id="con8"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con9"><p>Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con10"><p>Investigation</p></fn><fn fn-type="con" id="con11"><p>Investigation</p></fn><fn fn-type="con" id="con12"><p>Investigation</p></fn><fn fn-type="con" id="con13"><p>Resources, Methodology</p></fn><fn fn-type="con" id="con14"><p>Resources</p></fn><fn fn-type="con" id="con15"><p>Conceptualization, Resources, Methodology</p></fn><fn fn-type="con" id="con16"><p>Conceptualization, Resources, Methodology</p></fn><fn fn-type="con" id="con17"><p>Resources</p></fn><fn fn-type="con" id="con18"><p>Conceptualization, Resources, Writing – review and editing</p></fn><fn fn-type="con" id="con19"><p>Conceptualization, Supervision, Funding acquisition, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>The protocol (#1000070040) for human blood collection from healthy adult donors was reviewed and approved by The Hospital for Sick Children (SickKids, Toronto, ON, Canada) Research Ethics Board. Written, informed consent was obtained from all participants prior to their participation.</p></fn><fn fn-type="other"><p>The animal studies were reviewed and approved by SickKids Animal Care Committee (ACC) (protocol #1000049735 - <italic>S. aureus</italic> infection) and The Centre for Phenogenomics (Toronto, ON, Canada) ACC (protocol #21-0326 - murine neutrophil isolation).</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-87392-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting file.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Dr. Ronald S Flannagan (University of Western Ontario, London, ON, Canada) for a gift of <italic>S. aureus</italic> (USA300 LAC) strain expressing GFP (<xref ref-type="bibr" rid="bib25">Flannagan and Heinrichs, 2018</xref>). We thank SickKids Imaging Facility for the use of slide scanners and plate readers. We thank Milan Ganguly, Vivian Bradaschia, and Kyle Roberton in the Pathology Core at The Centre for Phenogenomics (Toronto, ON, Canada) for the IHC and image analysis services. We thank Uta Falke for technical assistance with the RT-DC experiments. We thank Dr. Spencer A Freeman (The Hospital for Sick Children, Toronto, ON, Canada) for helpful discussions. This work was supported by a grant from The Canadian Institutes of Health Research (CIHR) grant to LAR (PJT-169167). LAR also holds a Canada Research Chair in Vascular Inflammation and Kidney Injury. The work in the MG lab was funded by charitable donations to his lab. JW was supported by the Swedish Society of Medicine, the Foundation Blanceflor Boncompagni Ludovisi, née Bildt, and Restracomp. DAA was supported by Restracomp at The Hospital for Sick Children and an NSERC CGS-D scholarship. Work in the WLL laboratory was supported by an operating grant from the CIHR (OV2 170656); WLL also holds a Canada Research Chair in Mechanisms of Endothelial Permeability; TWWH was supported by an Ontario Graduate Scholarship award. JTM would like to thank the Canada Foundation for Innovation for infrastructure funding. FML is a holder of the Mitochondrial Innovation Initiative (Mito2i) as a scholarship. NT was supported by the Department of Pediatrics, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ades</surname><given-names>EW</given-names></name><name><surname>Candal</surname><given-names>FJ</given-names></name><name><surname>Swerlick</surname><given-names>RA</given-names></name><name><surname>George</surname><given-names>VG</given-names></name><name><surname>Summers</surname><given-names>S</given-names></name><name><surname>Bosse</surname><given-names>DC</given-names></name><name><surname>Lawley</surname><given-names>TJ</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>HMEC-1: establishment of an immortalized human microvascular endothelial cell line</article-title><source>The Journal of Investigative Dermatology</source><volume>99</volume><fpage>683</fpage><lpage>690</lpage><pub-id pub-id-type="doi">10.1111/1523-1747.ep12613748</pub-id><pub-id pub-id-type="pmid">1361507</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bashant</surname><given-names>KR</given-names></name><name><surname>Vassallo</surname><given-names>A</given-names></name><name><surname>Herold</surname><given-names>C</given-names></name><name><surname>Berner</surname><given-names>R</given-names></name><name><surname>Menschner</surname><given-names>L</given-names></name><name><surname>Subburayalu</surname><given-names>J</given-names></name><name><surname>Kaplan</surname><given-names>MJ</given-names></name><name><surname>Summers</surname><given-names>C</given-names></name><name><surname>Guck</surname><given-names>J</given-names></name><name><surname>Chilvers</surname><given-names>ER</given-names></name><name><surname>Toepfner</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Real-time deformability cytometry reveals sequential contraction and expansion during neutrophil priming</article-title><source>Journal of Leukocyte Biology</source><volume>105</volume><fpage>1143</fpage><lpage>1153</lpage><pub-id pub-id-type="doi">10.1002/JLB.MA0718-295RR</pub-id><pub-id pub-id-type="pmid">30835869</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhosle</surname><given-names>VK</given-names></name><name><surname>Mukherjee</surname><given-names>T</given-names></name><name><surname>Huang</surname><given-names>YW</given-names></name><name><surname>Patel</surname><given-names>S</given-names></name><name><surname>Pang</surname><given-names>BWF</given-names></name><name><surname>Liu</surname><given-names>GY</given-names></name><name><surname>Glogauer</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>JY</given-names></name><name><surname>Philpott</surname><given-names>DJ</given-names></name><name><surname>Grinstein</surname><given-names>S</given-names></name><name><surname>Robinson</surname><given-names>LA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>SLIT2/ROBO1-signaling inhibits macropinocytosis by opposing cortical cytoskeletal remodeling</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>4112</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-17651-1</pub-id><pub-id pub-id-type="pmid">32807784</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borbora</surname><given-names>SM</given-names></name><name><surname>Satish</surname><given-names>BA</given-names></name><name><surname>Sundar</surname><given-names>S</given-names></name><name><surname>Mahima</surname><given-names>B</given-names></name><name><surname>Bhatt</surname><given-names>S</given-names></name><name><surname>Balaji</surname><given-names>KN</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Mycobacterium tuberculosis elevates SLIT2 expression within the host and contributes to oxidative stress responses during infection</article-title><source>The Journal of Infectious Diseases</source><volume>228</volume><fpage>519</fpage><lpage>532</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiad126</pub-id><pub-id pub-id-type="pmid">37158474</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borregaard</surname><given-names>N</given-names></name><name><surname>Cowland</surname><given-names>JB</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Granules of the human neutrophilic polymorphonuclear leukocyte</article-title><source>Blood</source><volume>89</volume><fpage>3503</fpage><lpage>3521</lpage><pub-id pub-id-type="doi">10.1182/blood.V89.10.3503</pub-id><pub-id pub-id-type="pmid">9160655</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buvelot</surname><given-names>H</given-names></name><name><surname>Posfay-Barbe</surname><given-names>KM</given-names></name><name><surname>Linder</surname><given-names>P</given-names></name><name><surname>Schrenzel</surname><given-names>J</given-names></name><name><surname>Krause</surname><given-names>KH</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title><italic>Staphylococcus aureus</italic>, phagocyte NADPH oxidase and chronic granulomatous disease</article-title><source>FEMS Microbiology Reviews</source><volume>41</volume><fpage>139</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1093/femsre/fuw042</pub-id><pub-id pub-id-type="pmid">27965320</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>DS</given-names></name><name><surname>Okamoto</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Local caspase activation interacts with Slit-Robo signaling to restrict axonal arborization</article-title><source>The Journal of Cell Biology</source><volume>203</volume><fpage>657</fpage><lpage>672</lpage><pub-id pub-id-type="doi">10.1083/jcb.201303072</pub-id><pub-id pub-id-type="pmid">24385488</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chadwick</surname><given-names>JW</given-names></name><name><surname>Macdonald</surname><given-names>R</given-names></name><name><surname>Ali</surname><given-names>AA</given-names></name><name><surname>Glogauer</surname><given-names>M</given-names></name><name><surname>Magalhaes</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>TNFα Signaling Is Increased in Progressing Oral Potentially Malignant Disorders and Regulates Malignant Transformation in an Oral Carcinogenesis Model</article-title><source>Frontiers in Oncology</source><volume>11</volume><elocation-id>741013</elocation-id><pub-id pub-id-type="doi">10.3389/fonc.2021.741013</pub-id><pub-id pub-id-type="pmid">34650923</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chambers</surname><given-names>HF</given-names></name><name><surname>Deleo</surname><given-names>FR</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Waves of resistance: <italic>Staphylococcus aureus</italic> in the antibiotic era</article-title><source>Nature Reviews. Microbiology</source><volume>7</volume><fpage>629</fpage><lpage>641</lpage><pub-id pub-id-type="doi">10.1038/nrmicro2200</pub-id><pub-id pub-id-type="pmid">19680247</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaturvedi</surname><given-names>S</given-names></name><name><surname>Yuen</surname><given-names>DA</given-names></name><name><surname>Bajwa</surname><given-names>A</given-names></name><name><surname>Huang</surname><given-names>Y-W</given-names></name><name><surname>Sokollik</surname><given-names>C</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Lam</surname><given-names>GY</given-names></name><name><surname>Tole</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>G-Y</given-names></name><name><surname>Pan</surname><given-names>J</given-names></name><name><surname>Chan</surname><given-names>L</given-names></name><name><surname>Sokolskyy</surname><given-names>Y</given-names></name><name><surname>Puthia</surname><given-names>M</given-names></name><name><surname>Godaly</surname><given-names>G</given-names></name><name><surname>John</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Lee</surname><given-names>WL</given-names></name><name><surname>Brumell</surname><given-names>JH</given-names></name><name><surname>Okusa</surname><given-names>MD</given-names></name><name><surname>Robinson</surname><given-names>LA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Slit2 prevents neutrophil recruitment and renal ischemia-reperfusion injury</article-title><source>Journal of the American Society of Nephrology</source><volume>24</volume><fpage>1274</fpage><lpage>1287</lpage><pub-id pub-id-type="doi">10.1681/ASN.2012090890</pub-id><pub-id pub-id-type="pmid">23766538</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>FG</given-names></name><name><surname>Horswill</surname><given-names>AR</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Overcoming pH defenses on the skin to establish infections</article-title><source>PLOS Pathogens</source><volume>18</volume><elocation-id>e1010512</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1010512</pub-id><pub-id pub-id-type="pmid">35617212</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crainiciuc</surname><given-names>G</given-names></name><name><surname>Palomino-Segura</surname><given-names>M</given-names></name><name><surname>Molina-Moreno</surname><given-names>M</given-names></name><name><surname>Sicilia</surname><given-names>J</given-names></name><name><surname>Aragones</surname><given-names>DG</given-names></name><name><surname>Li</surname><given-names>JLY</given-names></name><name><surname>Madurga</surname><given-names>R</given-names></name><name><surname>Adrover</surname><given-names>JM</given-names></name><name><surname>Aroca-Crevillén</surname><given-names>A</given-names></name><name><surname>Martin-Salamanca</surname><given-names>S</given-names></name><name><surname>Del Valle</surname><given-names>AS</given-names></name><name><surname>Castillo</surname><given-names>SD</given-names></name><name><surname>Welch</surname><given-names>HCE</given-names></name><name><surname>Soehnlein</surname><given-names>O</given-names></name><name><surname>Graupera</surname><given-names>M</given-names></name><name><surname>Sánchez-Cabo</surname><given-names>F</given-names></name><name><surname>Zarbock</surname><given-names>A</given-names></name><name><surname>Smithgall</surname><given-names>TE</given-names></name><name><surname>Di Pilato</surname><given-names>M</given-names></name><name><surname>Mempel</surname><given-names>TR</given-names></name><name><surname>Tharaux</surname><given-names>PL</given-names></name><name><surname>González</surname><given-names>SF</given-names></name><name><surname>Ayuso-Sacido</surname><given-names>A</given-names></name><name><surname>Ng</surname><given-names>LG</given-names></name><name><surname>Calvo</surname><given-names>GF</given-names></name><name><surname>González-Díaz</surname><given-names>I</given-names></name><name><surname>Díaz-de-María</surname><given-names>F</given-names></name><name><surname>Hidalgo</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Behavioural immune landscapes of inflammation</article-title><source>Nature</source><volume>601</volume><fpage>415</fpage><lpage>421</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-04263-y</pub-id><pub-id pub-id-type="pmid">34987220</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dahlgren</surname><given-names>C</given-names></name><name><surname>Karlsson</surname><given-names>A</given-names></name><name><surname>Bylund</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Measurement of respiratory burst products generated by professional phagocytes</article-title><source>Methods in Molecular Biology</source><volume>412</volume><fpage>349</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1007/978-1-59745-467-4_23</pub-id><pub-id pub-id-type="pmid">18453123</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dang</surname><given-names>PMC</given-names></name><name><surname>Stensballe</surname><given-names>A</given-names></name><name><surname>Boussetta</surname><given-names>T</given-names></name><name><surname>Raad</surname><given-names>H</given-names></name><name><surname>Dewas</surname><given-names>C</given-names></name><name><surname>Kroviarski</surname><given-names>Y</given-names></name><name><surname>Hayem</surname><given-names>G</given-names></name><name><surname>Jensen</surname><given-names>ON</given-names></name><name><surname>Gougerot-Pocidalo</surname><given-names>MA</given-names></name><name><surname>El-Benna</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>A specific p47phox -serine phosphorylated by convergent MAPKs mediates neutrophil NADPH oxidase priming at inflammatory sites</article-title><source>The Journal of Clinical Investigation</source><volume>116</volume><fpage>2033</fpage><lpage>2043</lpage><pub-id pub-id-type="doi">10.1172/JCI27544</pub-id><pub-id pub-id-type="pmid">16778989</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diebold</surname><given-names>BA</given-names></name><name><surname>Bokoch</surname><given-names>GM</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Molecular basis for Rac2 regulation of phagocyte NADPH oxidase</article-title><source>Nature Immunology</source><volume>2</volume><fpage>211</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1038/85259</pub-id><pub-id pub-id-type="pmid">11224519</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donadieu</surname><given-names>J</given-names></name><name><surname>Fenneteau</surname><given-names>O</given-names></name><name><surname>Beaupain</surname><given-names>B</given-names></name><name><surname>Mahlaoui</surname><given-names>N</given-names></name><name><surname>Chantelot</surname><given-names>CB</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Congenital neutropenia: diagnosis, molecular bases and patient management</article-title><source>Orphanet Journal of Rare Diseases</source><volume>6</volume><elocation-id>26</elocation-id><pub-id pub-id-type="doi">10.1186/1750-1172-6-26</pub-id><pub-id pub-id-type="pmid">21595885</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Douda</surname><given-names>DN</given-names></name><name><surname>Khan</surname><given-names>MA</given-names></name><name><surname>Grasemann</surname><given-names>H</given-names></name><name><surname>Palaniyar</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>SK3 channel and mitochondrial ROS mediate NADPH oxidase-independent NETosis induced by calcium influx</article-title><source>PNAS</source><volume>112</volume><fpage>2817</fpage><lpage>2822</lpage><pub-id pub-id-type="doi">10.1073/pnas.1414055112</pub-id><pub-id pub-id-type="pmid">25730848</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ekpenyong</surname><given-names>AE</given-names></name><name><surname>Toepfner</surname><given-names>N</given-names></name><name><surname>Fiddler</surname><given-names>C</given-names></name><name><surname>Herbig</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Cojoc</surname><given-names>G</given-names></name><name><surname>Summers</surname><given-names>C</given-names></name><name><surname>Guck</surname><given-names>J</given-names></name><name><surname>Chilvers</surname><given-names>ER</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mechanical deformation induces depolarization of neutrophils</article-title><source>Science Advances</source><volume>3</volume><elocation-id>e1602536</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.1602536</pub-id><pub-id pub-id-type="pmid">28630905</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Benna</surname><given-names>J</given-names></name><name><surname>Dang</surname><given-names>PMC</given-names></name><name><surname>Gougerot-Pocidalo</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Priming of the neutrophil NADPH oxidase activation: role of p47phox phosphorylation and NOX2 mobilization to the plasma membrane</article-title><source>Seminars in Immunopathology</source><volume>30</volume><fpage>279</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.1007/s00281-008-0118-3</pub-id><pub-id pub-id-type="pmid">18536919</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Benna</surname><given-names>J</given-names></name><name><surname>Dang</surname><given-names>PMC</given-names></name><name><surname>Gougerot-Pocidalo</surname><given-names>MA</given-names></name><name><surname>Marie</surname><given-names>JC</given-names></name><name><surname>Braut-Boucher</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>p47phox, the phagocyte NADPH oxidase/NOX2 organizer: structure, phosphorylation and implication in diseases</article-title><source>Experimental &amp; Molecular Medicine</source><volume>41</volume><fpage>217</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.3858/emm.2009.41.4.058</pub-id><pub-id pub-id-type="pmid">19372727</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faul</surname><given-names>F</given-names></name><name><surname>Erdfelder</surname><given-names>E</given-names></name><name><surname>Lang</surname><given-names>AG</given-names></name><name><surname>Buchner</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences</article-title><source>Behavior Research Methods</source><volume>39</volume><fpage>175</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.3758/bf03193146</pub-id><pub-id pub-id-type="pmid">17695343</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrante</surname><given-names>A</given-names></name><name><surname>Harvey</surname><given-names>DP</given-names></name><name><surname>Bates</surname><given-names>EJ</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title><italic>Staphylococcus aureus</italic>-stimulated mononuclear leucocyte-conditioned medium increases the neutrophil bactericidal activity, and augments oxygen radical production and degranulation in response to the bacteria</article-title><source>Clinical and Experimental Immunology</source><volume>78</volume><fpage>366</fpage><lpage>371</lpage><pub-id pub-id-type="pmid">2558821</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fine</surname><given-names>N</given-names></name><name><surname>Hassanpour</surname><given-names>S</given-names></name><name><surname>Borenstein</surname><given-names>A</given-names></name><name><surname>Sima</surname><given-names>C</given-names></name><name><surname>Oveisi</surname><given-names>M</given-names></name><name><surname>Scholey</surname><given-names>J</given-names></name><name><surname>Cherney</surname><given-names>D</given-names></name><name><surname>Glogauer</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Distinct oral neutrophil subsets define health and periodontal disease states</article-title><source>Journal of Dental Research</source><volume>95</volume><fpage>931</fpage><lpage>938</lpage><pub-id pub-id-type="doi">10.1177/0022034516645564</pub-id><pub-id pub-id-type="pmid">27270666</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fine</surname><given-names>Noah</given-names></name><name><surname>Barzilay</surname><given-names>O</given-names></name><name><surname>Sun</surname><given-names>C</given-names></name><name><surname>Wellappuli</surname><given-names>N</given-names></name><name><surname>Tanwir</surname><given-names>F</given-names></name><name><surname>Chadwick</surname><given-names>JW</given-names></name><name><surname>Oveisi</surname><given-names>M</given-names></name><name><surname>Tasevski</surname><given-names>N</given-names></name><name><surname>Prescott</surname><given-names>D</given-names></name><name><surname>Gargan</surname><given-names>M</given-names></name><name><surname>Philpott</surname><given-names>DJ</given-names></name><name><surname>Dror</surname><given-names>Y</given-names></name><name><surname>Glogauer</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Primed PMNs in healthy mouse and human circulation are first responders during acute inflammation</article-title><source>Blood Advances</source><volume>3</volume><fpage>1622</fpage><lpage>1637</lpage><pub-id pub-id-type="doi">10.1182/bloodadvances.2018030585</pub-id><pub-id pub-id-type="pmid">31138591</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flannagan</surname><given-names>RS</given-names></name><name><surname>Heinrichs</surname><given-names>DE</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A fluorescence based-proliferation assay for the identification of replicating bacteria within host cells</article-title><source>Frontiers in Microbiology</source><volume>9</volume><elocation-id>3084</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2018.03084</pub-id><pub-id pub-id-type="pmid">30619165</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontayne</surname><given-names>A</given-names></name><name><surname>Dang</surname><given-names>PMC</given-names></name><name><surname>Gougerot-Pocidalo</surname><given-names>MA</given-names></name><name><surname>El-Benna</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Phosphorylation of p47phox sites by PKC alpha, beta II, delta, and zeta: effect on binding to p22phox and on NADPH oxidase activation</article-title><source>Biochemistry</source><volume>41</volume><fpage>7743</fpage><lpage>7750</lpage><pub-id pub-id-type="doi">10.1021/bi011953s</pub-id><pub-id pub-id-type="pmid">12056906</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freeley</surname><given-names>M</given-names></name><name><surname>Kelleher</surname><given-names>D</given-names></name><name><surname>Long</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Regulation of Protein Kinase C function by phosphorylation on conserved and non-conserved sites</article-title><source>Cellular Signalling</source><volume>23</volume><fpage>753</fpage><lpage>762</lpage><pub-id pub-id-type="doi">10.1016/j.cellsig.2010.10.013</pub-id><pub-id pub-id-type="pmid">20946954</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fyhrquist</surname><given-names>N</given-names></name><name><surname>Muirhead</surname><given-names>G</given-names></name><name><surname>Prast-Nielsen</surname><given-names>S</given-names></name><name><surname>Jeanmougin</surname><given-names>M</given-names></name><name><surname>Olah</surname><given-names>P</given-names></name><name><surname>Skoog</surname><given-names>T</given-names></name><name><surname>Jules-Clement</surname><given-names>G</given-names></name><name><surname>Feld</surname><given-names>M</given-names></name><name><surname>Barrientos-Somarribas</surname><given-names>M</given-names></name><name><surname>Sinkko</surname><given-names>H</given-names></name><name><surname>van den Bogaard</surname><given-names>EH</given-names></name><name><surname>Zeeuwen</surname><given-names>P</given-names></name><name><surname>Rikken</surname><given-names>G</given-names></name><name><surname>Schalkwijk</surname><given-names>J</given-names></name><name><surname>Niehues</surname><given-names>H</given-names></name><name><surname>Däubener</surname><given-names>W</given-names></name><name><surname>Eller</surname><given-names>SK</given-names></name><name><surname>Alexander</surname><given-names>H</given-names></name><name><surname>Pennino</surname><given-names>D</given-names></name><name><surname>Suomela</surname><given-names>S</given-names></name><name><surname>Tessas</surname><given-names>I</given-names></name><name><surname>Lybeck</surname><given-names>E</given-names></name><name><surname>Baran</surname><given-names>AM</given-names></name><name><surname>Darban</surname><given-names>H</given-names></name><name><surname>Gangwar</surname><given-names>RS</given-names></name><name><surname>Gerstel</surname><given-names>U</given-names></name><name><surname>Jahn</surname><given-names>K</given-names></name><name><surname>Karisola</surname><given-names>P</given-names></name><name><surname>Yan</surname><given-names>L</given-names></name><name><surname>Hansmann</surname><given-names>B</given-names></name><name><surname>Katayama</surname><given-names>S</given-names></name><name><surname>Meller</surname><given-names>S</given-names></name><name><surname>Bylesjö</surname><given-names>M</given-names></name><name><surname>Hupé</surname><given-names>P</given-names></name><name><surname>Levi-Schaffer</surname><given-names>F</given-names></name><name><surname>Greco</surname><given-names>D</given-names></name><name><surname>Ranki</surname><given-names>A</given-names></name><name><surname>Schröder</surname><given-names>JM</given-names></name><name><surname>Barker</surname><given-names>J</given-names></name><name><surname>Kere</surname><given-names>J</given-names></name><name><surname>Tsoka</surname><given-names>S</given-names></name><name><surname>Lauerma</surname><given-names>A</given-names></name><name><surname>Soumelis</surname><given-names>V</given-names></name><name><surname>Nestle</surname><given-names>FO</given-names></name><name><surname>Homey</surname><given-names>B</given-names></name><name><surname>Andersson</surname><given-names>B</given-names></name><name><surname>Alenius</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Microbe-host interplay in atopic dermatitis and psoriasis</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>4703</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-12253-y</pub-id><pub-id pub-id-type="pmid">31619666</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geraldo</surname><given-names>LH</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Jacob</surname><given-names>L</given-names></name><name><surname>Pibouin-Fragner</surname><given-names>L</given-names></name><name><surname>Rao</surname><given-names>R</given-names></name><name><surname>Maissa</surname><given-names>N</given-names></name><name><surname>Verreault</surname><given-names>M</given-names></name><name><surname>Lemaire</surname><given-names>N</given-names></name><name><surname>Knosp</surname><given-names>C</given-names></name><name><surname>Lesaffre</surname><given-names>C</given-names></name><name><surname>Daubon</surname><given-names>T</given-names></name><name><surname>Dejaegher</surname><given-names>J</given-names></name><name><surname>Solie</surname><given-names>L</given-names></name><name><surname>Rudewicz</surname><given-names>J</given-names></name><name><surname>Viel</surname><given-names>T</given-names></name><name><surname>Tavitian</surname><given-names>B</given-names></name><name><surname>De Vleeschouwer</surname><given-names>S</given-names></name><name><surname>Sanson</surname><given-names>M</given-names></name><name><surname>Bikfalvi</surname><given-names>A</given-names></name><name><surname>Idbaih</surname><given-names>A</given-names></name><name><surname>Lu</surname><given-names>QR</given-names></name><name><surname>Lima</surname><given-names>FR</given-names></name><name><surname>Thomas</surname><given-names>JL</given-names></name><name><surname>Eichmann</surname><given-names>A</given-names></name><name><surname>Mathivet</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>SLIT2/ROBO signaling in tumor-associated microglia and macrophages drives glioblastoma immunosuppression and vascular dysmorphia</article-title><source>The Journal of Clinical Investigation</source><volume>131</volume><elocation-id>e141083</elocation-id><pub-id pub-id-type="doi">10.1172/JCI141083</pub-id><pub-id pub-id-type="pmid">34181595</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guerra</surname><given-names>FE</given-names></name><name><surname>Borgogna</surname><given-names>TR</given-names></name><name><surname>Patel</surname><given-names>DM</given-names></name><name><surname>Sward</surname><given-names>EW</given-names></name><name><surname>Voyich</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Epic Immune Battles of History: Neutrophils vs. <italic>Staphylococcus aureus</italic></article-title><source>Frontiers in Cellular and Infection Microbiology</source><volume>7</volume><elocation-id>286</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2017.00286</pub-id><pub-id pub-id-type="pmid">28713774</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Günther</surname><given-names>J</given-names></name><name><surname>Petzl</surname><given-names>W</given-names></name><name><surname>Bauer</surname><given-names>I</given-names></name><name><surname>Ponsuksili</surname><given-names>S</given-names></name><name><surname>Zerbe</surname><given-names>H</given-names></name><name><surname>Schuberth</surname><given-names>HJ</given-names></name><name><surname>Brunner</surname><given-names>RM</given-names></name><name><surname>Seyfert</surname><given-names>HM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Differentiating Staphylococcus aureus from <italic>Escherichia coli</italic> mastitis: <italic>Staphylococcus aureus</italic> triggers unbalanced immune-dampening and host cell invasion immediately after udder infection</article-title><source>Scientific Reports</source><volume>7</volume><elocation-id>4811</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-017-05107-4</pub-id><pub-id pub-id-type="pmid">28684793</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gustafson</surname><given-names>D</given-names></name><name><surname>Ngai</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>R</given-names></name><name><surname>Hou</surname><given-names>H</given-names></name><name><surname>Schoffel</surname><given-names>AC</given-names></name><name><surname>Erice</surname><given-names>C</given-names></name><name><surname>Mandla</surname><given-names>S</given-names></name><name><surname>Billia</surname><given-names>F</given-names></name><name><surname>Wilson</surname><given-names>MD</given-names></name><name><surname>Radisic</surname><given-names>M</given-names></name><name><surname>Fan</surname><given-names>E</given-names></name><name><surname>Trahtemberg</surname><given-names>U</given-names></name><name><surname>Baker</surname><given-names>A</given-names></name><name><surname>McIntosh</surname><given-names>C</given-names></name><name><surname>Fan</surname><given-names>CPS</given-names></name><name><surname>Dos Santos</surname><given-names>CC</given-names></name><name><surname>Kain</surname><given-names>KC</given-names></name><name><surname>Hanneman</surname><given-names>K</given-names></name><name><surname>Thavendiranathan</surname><given-names>P</given-names></name><name><surname>Fish</surname><given-names>JE</given-names></name><name><surname>Howe</surname><given-names>KL</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Cardiovascular signatures of COVID-19 predict mortality and identify barrier stabilizing therapies</article-title><source>EBioMedicine</source><volume>78</volume><elocation-id>103982</elocation-id><pub-id pub-id-type="doi">10.1016/j.ebiom.2022.103982</pub-id><pub-id pub-id-type="pmid">35405523</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hordijk</surname><given-names>PL</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Regulation of NADPH oxidases: the role of Rac proteins</article-title><source>Circulation Research</source><volume>98</volume><fpage>453</fpage><lpage>462</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000204727.46710.5e</pub-id><pub-id pub-id-type="pmid">16514078</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jernigan</surname><given-names>JA</given-names></name><name><surname>Hatfield</surname><given-names>KM</given-names></name><name><surname>Wolford</surname><given-names>H</given-names></name><name><surname>Nelson</surname><given-names>RE</given-names></name><name><surname>Olubajo</surname><given-names>B</given-names></name><name><surname>Reddy</surname><given-names>SC</given-names></name><name><surname>McCarthy</surname><given-names>N</given-names></name><name><surname>Paul</surname><given-names>P</given-names></name><name><surname>McDonald</surname><given-names>LC</given-names></name><name><surname>Kallen</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Multidrug-Resistant Bacterial Infections in U.S</article-title><source>Hospitalized Patients</source><volume>382</volume><fpage>1309</fpage><lpage>1319</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1914433</pub-id><pub-id pub-id-type="pmid">32242356</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>T</given-names></name><name><surname>He</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Jia</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>RNA m6A reader IGF2BP3 promotes metastasis of triple-negative breast cancer via SLIT2 repression</article-title><source>FASEB Journal</source><volume>36</volume><elocation-id>e22618</elocation-id><pub-id pub-id-type="doi">10.1096/fj.202200751RR</pub-id><pub-id pub-id-type="pmid">36250924</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>B-J</given-names></name><name><surname>Lee</surname><given-names>Y-S</given-names></name><name><surname>Lee</surname><given-names>S-Y</given-names></name><name><surname>Baek</surname><given-names>W-Y</given-names></name><name><surname>Choi</surname><given-names>YJ</given-names></name><name><surname>Moon</surname><given-names>SA</given-names></name><name><surname>Lee</surname><given-names>SH</given-names></name><name><surname>Kim</surname><given-names>J-E</given-names></name><name><surname>Chang</surname><given-names>E-J</given-names></name><name><surname>Kim</surname><given-names>E-Y</given-names></name><name><surname>Yoon</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>S-W</given-names></name><name><surname>Ryu</surname><given-names>SH</given-names></name><name><surname>Lee</surname><given-names>S-K</given-names></name><name><surname>Lorenzo</surname><given-names>JA</given-names></name><name><surname>Ahn</surname><given-names>SH</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>K-U</given-names></name><name><surname>Kim</surname><given-names>GS</given-names></name><name><surname>Koh</surname><given-names>J-M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Osteoclast-secreted SLIT3 coordinates bone resorption and formation</article-title><source>Journal of Clinical Investigation</source><volume>128</volume><fpage>1429</fpage><lpage>1441</lpage><pub-id pub-id-type="doi">10.1172/JCI91086</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kondo</surname><given-names>A</given-names></name><name><surname>Osawa</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Establishment of an Extracellular Acidic pH Culture System</article-title><source>Journal of Visualized Experiments</source><volume>129</volume><elocation-id>56660</elocation-id><pub-id pub-id-type="doi">10.3791/56660</pub-id><pub-id pub-id-type="pmid">29286387</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>R</given-names></name><name><surname>Yi</surname><given-names>F</given-names></name><name><surname>Wen</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Ren</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Shang</surname><given-names>Y</given-names></name><name><surname>Nie</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>K</given-names></name><name><surname>Fan</surname><given-names>D</given-names></name><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Feng</surname><given-names>W</given-names></name><name><surname>Wu</surname><given-names>JY</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Myo9b is a key player in SLIT/ROBO-mediated lung tumor suppression</article-title><source>The Journal of Clinical Investigation</source><volume>125</volume><fpage>4407</fpage><lpage>4420</lpage><pub-id pub-id-type="doi">10.1172/JCI81673</pub-id><pub-id pub-id-type="pmid">26529257</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krismer</surname><given-names>B</given-names></name><name><surname>Weidenmaier</surname><given-names>C</given-names></name><name><surname>Zipperer</surname><given-names>A</given-names></name><name><surname>Peschel</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The commensal lifestyle of <italic>Staphylococcus aureus</italic> and its interactions with the nasal microbiota</article-title><source>Nature Reviews. Microbiology</source><volume>15</volume><fpage>675</fpage><lpage>687</lpage><pub-id pub-id-type="doi">10.1038/nrmicro.2017.104</pub-id><pub-id pub-id-type="pmid">29021598</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>XJ</given-names></name><name><surname>Marchal</surname><given-names>CC</given-names></name><name><surname>Stull</surname><given-names>ND</given-names></name><name><surname>Stahelin</surname><given-names>RV</given-names></name><name><surname>Dinauer</surname><given-names>MC</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>p47phox Phox homology domain regulates plasma membrane but not phagosome neutrophil NADPH oxidase activation</article-title><source>The Journal of Biological Chemistry</source><volume>285</volume><fpage>35169</fpage><lpage>35179</lpage><pub-id pub-id-type="doi">10.1074/jbc.M110.164475</pub-id><pub-id pub-id-type="pmid">20817944</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Gao</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>B</given-names></name><name><surname>Zha</surname><given-names>Q</given-names></name><name><surname>Yang</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2023">2023a</year><article-title>Hif-1α/Slit2 Mediates Vascular Smooth Muscle Cell Phenotypic Changes in Restenosis of Bypass Grafts</article-title><source>Journal of Cardiovascular Translational Research</source><pub-id pub-id-type="doi">10.1007/s12265-023-10384-8</pub-id><pub-id pub-id-type="pmid">37097589</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>X-X</given-names></name><name><surname>Hu</surname><given-names>L-P</given-names></name><name><surname>Ni</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>D-X</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Jiang</surname><given-names>S-H</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>M-W</given-names></name><name><surname>Jiang</surname><given-names>Y-S</given-names></name><name><surname>Xu</surname><given-names>C-J</given-names></name><name><surname>Zhang</surname><given-names>X-L</given-names></name><name><surname>Zhang</surname><given-names>Y-L</given-names></name><name><surname>Huang</surname><given-names>P-Q</given-names></name><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Gu</surname><given-names>J-R</given-names></name><name><surname>Xiao</surname><given-names>GG-S</given-names></name><name><surname>Sun</surname><given-names>Y-W</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Z-G</given-names></name></person-group><year iso-8601-date="2023">2023b</year><article-title>Coadaptation fostered by the SLIT2-ROBO1 axis facilitates liver metastasis of pancreatic ductal adenocarcinoma</article-title><source>Nature Communications</source><volume>14</volume><elocation-id>861</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-023-36521-0</pub-id><pub-id pub-id-type="pmid">36792623</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>London</surname><given-names>NR</given-names></name><name><surname>Zhu</surname><given-names>W</given-names></name><name><surname>Bozza</surname><given-names>FA</given-names></name><name><surname>Smith</surname><given-names>MCP</given-names></name><name><surname>Greif</surname><given-names>DM</given-names></name><name><surname>Sorensen</surname><given-names>LK</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Kaminoh</surname><given-names>Y</given-names></name><name><surname>Chan</surname><given-names>AC</given-names></name><name><surname>Passi</surname><given-names>SF</given-names></name><name><surname>Day</surname><given-names>CW</given-names></name><name><surname>Barnard</surname><given-names>DL</given-names></name><name><surname>Zimmerman</surname><given-names>GA</given-names></name><name><surname>Krasnow</surname><given-names>MA</given-names></name><name><surname>Li</surname><given-names>DY</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Targeting Robo4-dependent Slit signaling to survive the cytokine storm in sepsis and influenza</article-title><source>Science Translational Medicine</source><volume>2</volume><elocation-id>23ra19</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.3000678</pub-id><pub-id pub-id-type="pmid">20375003</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lowy</surname><given-names>FD</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title><italic>Staphylococcus aureus</italic> infections</article-title><source>The New England Journal of Medicine</source><volume>339</volume><fpage>520</fpage><lpage>532</lpage><pub-id pub-id-type="doi">10.1056/NEJM199808203390806</pub-id><pub-id pub-id-type="pmid">9709046</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>T</given-names></name><name><surname>Porter</surname><given-names>AR</given-names></name><name><surname>Kennedy</surname><given-names>AD</given-names></name><name><surname>Kobayashi</surname><given-names>SD</given-names></name><name><surname>DeLeo</surname><given-names>FR</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Phagocytosis and killing of <italic>Staphylococcus aureus</italic> by human neutrophils</article-title><source>Journal of Innate Immunity</source><volume>6</volume><fpage>639</fpage><lpage>649</lpage><pub-id pub-id-type="doi">10.1159/000360478</pub-id><pub-id pub-id-type="pmid">24713863</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>S</given-names></name><name><surname>Tong</surname><given-names>C</given-names></name><name><surname>Ibeagha-Awemu</surname><given-names>EM</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Identification and characterization of differentially expressed exosomal microRNAs in bovine milk infected with <italic>Staphylococcus aureus</italic></article-title><source>BMC Genomics</source><volume>20</volume><elocation-id>934</elocation-id><pub-id pub-id-type="doi">10.1186/s12864-019-6338-1</pub-id><pub-id pub-id-type="pmid">31805863</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magon</surname><given-names>NJ</given-names></name><name><surname>Parker</surname><given-names>HA</given-names></name><name><surname>Ashby</surname><given-names>LV</given-names></name><name><surname>Springer</surname><given-names>RJ</given-names></name><name><surname>Hampton</surname><given-names>MB</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Analysis of neutrophil bactericidal activity</article-title><source>Methods in Molecular Biology</source><volume>2087</volume><fpage>149</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.1007/978-1-0716-0154-9_12</pub-id><pub-id pub-id-type="pmid">31728990</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattsson</surname><given-names>E</given-names></name><name><surname>Persson</surname><given-names>T</given-names></name><name><surname>Andersson</surname><given-names>P</given-names></name><name><surname>Rollof</surname><given-names>J</given-names></name><name><surname>Egesten</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Peptidoglycan induces mobilization of the surface marker for activation marker CD66b in human neutrophils but not in eosinophils</article-title><source>Clinical and Diagnostic Laboratory Immunology</source><volume>10</volume><fpage>485</fpage><lpage>488</lpage><pub-id pub-id-type="doi">10.1128/cdli.10.3.485-488.2003</pub-id><pub-id pub-id-type="pmid">12738656</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meijles</surname><given-names>DN</given-names></name><name><surname>Fan</surname><given-names>LM</given-names></name><name><surname>Howlin</surname><given-names>BJ</given-names></name><name><surname>Li</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Molecular insights of p47phox phosphorylation dynamics in the regulation of NADPH oxidase activation and superoxide production</article-title><source>The Journal of Biological Chemistry</source><volume>289</volume><fpage>22759</fpage><lpage>22770</lpage><pub-id pub-id-type="doi">10.1074/jbc.M114.561159</pub-id><pub-id pub-id-type="pmid">24970888</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mollinedo</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Neutrophil degranulation, plasticity, and cancer metastasis</article-title><source>Trends in Immunology</source><volume>40</volume><fpage>228</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1016/j.it.2019.01.006</pub-id><pub-id pub-id-type="pmid">30777721</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Müller</surname><given-names>P</given-names></name><name><surname>Hartmann</surname><given-names>B</given-names></name><name><surname>O’Connell</surname><given-names>E</given-names></name><name><surname>Schlögel</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>Shape-out version 2.0.1. Graphical user interface for analysis and visualization of RT-DC data sets</data-title><source>ShapeOut2</source><ext-link ext-link-type="uri" xlink:href="https://github.com/ZELLMECHANIK-DRESDEN/ShapeOut2">https://github.com/ZELLMECHANIK-DRESDEN/ShapeOut2</ext-link></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neehus</surname><given-names>AL</given-names></name><name><surname>Moriya</surname><given-names>K</given-names></name><name><surname>Nieto-Patlán</surname><given-names>A</given-names></name><name><surname>Le Voyer</surname><given-names>T</given-names></name><name><surname>Lévy</surname><given-names>R</given-names></name><name><surname>Özen</surname><given-names>A</given-names></name><name><surname>Karakoc-Aydiner</surname><given-names>E</given-names></name><name><surname>Baris</surname><given-names>S</given-names></name><name><surname>Yildiran</surname><given-names>A</given-names></name><name><surname>Altundag</surname><given-names>E</given-names></name><name><surname>Roynard</surname><given-names>M</given-names></name><name><surname>Haake</surname><given-names>K</given-names></name><name><surname>Migaud</surname><given-names>M</given-names></name><name><surname>Dorgham</surname><given-names>K</given-names></name><name><surname>Gorochov</surname><given-names>G</given-names></name><name><surname>Abel</surname><given-names>L</given-names></name><name><surname>Lachmann</surname><given-names>N</given-names></name><name><surname>Dogu</surname><given-names>F</given-names></name><name><surname>Haskologlu</surname><given-names>S</given-names></name><name><surname>İnce</surname><given-names>E</given-names></name><name><surname>El-Benna</surname><given-names>J</given-names></name><name><surname>Uzel</surname><given-names>G</given-names></name><name><surname>Kiykim</surname><given-names>A</given-names></name><name><surname>Boztug</surname><given-names>K</given-names></name><name><surname>Roderick</surname><given-names>MR</given-names></name><name><surname>Shahrooei</surname><given-names>M</given-names></name><name><surname>Brogan</surname><given-names>PA</given-names></name><name><surname>Abolhassani</surname><given-names>H</given-names></name><name><surname>Hancioglu</surname><given-names>G</given-names></name><name><surname>Parvaneh</surname><given-names>N</given-names></name><name><surname>Belot</surname><given-names>A</given-names></name><name><surname>Ikinciogullari</surname><given-names>A</given-names></name><name><surname>Casanova</surname><given-names>JL</given-names></name><name><surname>Puel</surname><given-names>A</given-names></name><name><surname>Bustamante</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Impaired respiratory burst contributes to infections in PKCδ-deficient patients</article-title><source>The Journal of Experimental Medicine</source><volume>218</volume><elocation-id>e20210501</elocation-id><pub-id pub-id-type="doi">10.1084/jem.20210501</pub-id><pub-id pub-id-type="pmid">34264265</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noore</surname><given-names>J</given-names></name><name><surname>Noore</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Cationic antimicrobial peptide LL-37 is effective against both extra- and intracellular <italic>Staphylococcus aureus</italic></article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>57</volume><fpage>1283</fpage><lpage>1290</lpage><pub-id pub-id-type="doi">10.1128/AAC.01650-12</pub-id><pub-id pub-id-type="pmid">23274662</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ostrowski</surname><given-names>PP</given-names></name><name><surname>Roth</surname><given-names>Z</given-names></name><name><surname>Grinstein</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Labeling acidic compartments of neutrophils with cresyl violet</article-title><source>Methods in Molecular Biology</source><volume>2087</volume><fpage>207</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1007/978-1-0716-0154-9_15</pub-id><pub-id pub-id-type="pmid">31728993</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otto</surname><given-names>O</given-names></name><name><surname>Rosendahl</surname><given-names>P</given-names></name><name><surname>Mietke</surname><given-names>A</given-names></name><name><surname>Golfier</surname><given-names>S</given-names></name><name><surname>Herold</surname><given-names>C</given-names></name><name><surname>Klaue</surname><given-names>D</given-names></name><name><surname>Girardo</surname><given-names>S</given-names></name><name><surname>Pagliara</surname><given-names>S</given-names></name><name><surname>Ekpenyong</surname><given-names>A</given-names></name><name><surname>Jacobi</surname><given-names>A</given-names></name><name><surname>Wobus</surname><given-names>M</given-names></name><name><surname>Töpfner</surname><given-names>N</given-names></name><name><surname>Keyser</surname><given-names>UF</given-names></name><name><surname>Mansfeld</surname><given-names>J</given-names></name><name><surname>Fischer-Friedrich</surname><given-names>E</given-names></name><name><surname>Guck</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Real-time deformability cytometry: on-the-fly cell mechanical phenotyping</article-title><source>Nature Methods</source><volume>12</volume><fpage>199</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1038/nmeth.3281</pub-id><pub-id pub-id-type="pmid">25643151</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parker</surname><given-names>H</given-names></name><name><surname>Dragunow</surname><given-names>M</given-names></name><name><surname>Hampton</surname><given-names>MB</given-names></name><name><surname>Kettle</surname><given-names>AJ</given-names></name><name><surname>Winterbourn</surname><given-names>CC</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Requirements for NADPH oxidase and myeloperoxidase in neutrophil extracellular trap formation differ depending on the stimulus</article-title><source>Journal of Leukocyte Biology</source><volume>92</volume><fpage>841</fpage><lpage>849</lpage><pub-id pub-id-type="doi">10.1189/jlb.1211601</pub-id><pub-id pub-id-type="pmid">22802447</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>YW</given-names></name><name><surname>Reheman</surname><given-names>A</given-names></name><name><surname>Pluthero</surname><given-names>FG</given-names></name><name><surname>Chaturvedi</surname><given-names>S</given-names></name><name><surname>Mukovozov</surname><given-names>IM</given-names></name><name><surname>Tole</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>GY</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Durocher</surname><given-names>Y</given-names></name><name><surname>Ni</surname><given-names>H</given-names></name><name><surname>Kahr</surname><given-names>WHA</given-names></name><name><surname>Robinson</surname><given-names>LA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The cell motility modulator Slit2 is a potent inhibitor of platelet function</article-title><source>Circulation</source><volume>126</volume><fpage>1385</fpage><lpage>1395</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.112.105452</pub-id><pub-id pub-id-type="pmid">22865890</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pilling</surname><given-names>D</given-names></name><name><surname>Zheng</surname><given-names>Z</given-names></name><name><surname>Vakil</surname><given-names>V</given-names></name><name><surname>Gomer</surname><given-names>RH</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Fibroblasts secrete Slit2 to inhibit fibrocyte differentiation and fibrosis</article-title><source>PNAS</source><volume>111</volume><fpage>18291</fpage><lpage>18296</lpage><pub-id pub-id-type="doi">10.1073/pnas.1417426112</pub-id><pub-id pub-id-type="pmid">25489114</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pilsczek</surname><given-names>FH</given-names></name><name><surname>Salina</surname><given-names>D</given-names></name><name><surname>Poon</surname><given-names>KKH</given-names></name><name><surname>Fahey</surname><given-names>C</given-names></name><name><surname>Yipp</surname><given-names>BG</given-names></name><name><surname>Sibley</surname><given-names>CD</given-names></name><name><surname>Robbins</surname><given-names>SM</given-names></name><name><surname>Green</surname><given-names>FHY</given-names></name><name><surname>Surette</surname><given-names>MG</given-names></name><name><surname>Sugai</surname><given-names>M</given-names></name><name><surname>Bowden</surname><given-names>MG</given-names></name><name><surname>Hussain</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Kubes</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A novel mechanism of rapid nuclear neutrophil extracellular trap formation in response to <italic>Staphylococcus aureus</italic></article-title><source>Journal of Immunology</source><volume>185</volume><fpage>7413</fpage><lpage>7425</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1000675</pub-id><pub-id pub-id-type="pmid">21098229</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piper</surname><given-names>M</given-names></name><name><surname>Anderson</surname><given-names>R</given-names></name><name><surname>Dwivedy</surname><given-names>A</given-names></name><name><surname>Weinl</surname><given-names>C</given-names></name><name><surname>van Horck</surname><given-names>F</given-names></name><name><surname>Leung</surname><given-names>KM</given-names></name><name><surname>Cogill</surname><given-names>E</given-names></name><name><surname>Holt</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Signaling mechanisms underlying Slit2-induced collapse of <italic>Xenopus</italic> retinal growth cones</article-title><source>Neuron</source><volume>49</volume><fpage>215</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2005.12.008</pub-id><pub-id pub-id-type="pmid">16423696</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poli</surname><given-names>V</given-names></name><name><surname>Zanoni</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Neutrophil intrinsic and extrinsic regulation of NETosis in health and disease</article-title><source>Trends in Microbiology</source><volume>31</volume><fpage>280</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2022.10.002</pub-id><pub-id pub-id-type="pmid">36344311</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potera</surname><given-names>RM</given-names></name><name><surname>Jensen</surname><given-names>MJ</given-names></name><name><surname>Hilkin</surname><given-names>BM</given-names></name><name><surname>South</surname><given-names>GK</given-names></name><name><surname>Hook</surname><given-names>JS</given-names></name><name><surname>Gross</surname><given-names>EA</given-names></name><name><surname>Moreland</surname><given-names>JG</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Neutrophil azurophilic granule exocytosis is primed by TNF-α and partially regulated by NADPH oxidase</article-title><source>Innate Immunity</source><volume>22</volume><fpage>635</fpage><lpage>646</lpage><pub-id pub-id-type="doi">10.1177/1753425916668980</pub-id><pub-id pub-id-type="pmid">27655046</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prabhakara</surname><given-names>R</given-names></name><name><surname>Foreman</surname><given-names>O</given-names></name><name><surname>De Pascalis</surname><given-names>R</given-names></name><name><surname>Lee</surname><given-names>GM</given-names></name><name><surname>Plaut</surname><given-names>RD</given-names></name><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Stibitz</surname><given-names>S</given-names></name><name><surname>Elkins</surname><given-names>KL</given-names></name><name><surname>Merkel</surname><given-names>TJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Epicutaneous model of community-acquired <italic>Staphylococcus aureus</italic> skin infections</article-title><source>Infection and Immunity</source><volume>81</volume><fpage>1306</fpage><lpage>1315</lpage><pub-id pub-id-type="doi">10.1128/IAI.01304-12</pub-id><pub-id pub-id-type="pmid">23381997</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rincón</surname><given-names>E</given-names></name><name><surname>Rocha-Gregg</surname><given-names>BL</given-names></name><name><surname>Collins</surname><given-names>SR</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A map of gene expression in neutrophil-like cell lines</article-title><source>BMC Genomics</source><volume>19</volume><elocation-id>573</elocation-id><pub-id pub-id-type="doi">10.1186/s12864-018-4957-6</pub-id><pub-id pub-id-type="pmid">30068296</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rollin</surname><given-names>G</given-names></name><name><surname>Tan</surname><given-names>X</given-names></name><name><surname>Tros</surname><given-names>F</given-names></name><name><surname>Dupuis</surname><given-names>M</given-names></name><name><surname>Nassif</surname><given-names>X</given-names></name><name><surname>Charbit</surname><given-names>A</given-names></name><name><surname>Coureuil</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Intracellular Survival of <italic>Staphylococcus aureus</italic> in Endothelial Cells: A Matter of Growth or Persistence</article-title><source>Frontiers in Microbiology</source><volume>8</volume><elocation-id>1354</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2017.01354</pub-id><pub-id pub-id-type="pmid">28769913</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romano</surname><given-names>E</given-names></name><name><surname>Manetti</surname><given-names>M</given-names></name><name><surname>Rosa</surname><given-names>I</given-names></name><name><surname>Fioretto</surname><given-names>BS</given-names></name><name><surname>Ibba-Manneschi</surname><given-names>L</given-names></name><name><surname>Matucci-Cerinic</surname><given-names>M</given-names></name><name><surname>Guiducci</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Slit2/Robo4 axis may contribute to endothelial cell dysfunction and angiogenesis disturbance in systemic sclerosis</article-title><source>Annals of the Rheumatic Diseases</source><volume>77</volume><fpage>1665</fpage><lpage>1674</lpage><pub-id pub-id-type="doi">10.1136/annrheumdis-2018-213239</pub-id><pub-id pub-id-type="pmid">30021803</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sagiv</surname><given-names>JY</given-names></name><name><surname>Michaeli</surname><given-names>J</given-names></name><name><surname>Assi</surname><given-names>S</given-names></name><name><surname>Mishalian</surname><given-names>I</given-names></name><name><surname>Kisos</surname><given-names>H</given-names></name><name><surname>Levy</surname><given-names>L</given-names></name><name><surname>Damti</surname><given-names>P</given-names></name><name><surname>Lumbroso</surname><given-names>D</given-names></name><name><surname>Polyansky</surname><given-names>L</given-names></name><name><surname>Sionov</surname><given-names>RV</given-names></name><name><surname>Ariel</surname><given-names>A</given-names></name><name><surname>Hovav</surname><given-names>AH</given-names></name><name><surname>Henke</surname><given-names>E</given-names></name><name><surname>Fridlender</surname><given-names>ZG</given-names></name><name><surname>Granot</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer</article-title><source>Cell Reports</source><volume>10</volume><fpage>562</fpage><lpage>573</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2014.12.039</pub-id><pub-id pub-id-type="pmid">25620698</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samelson</surname><given-names>BK</given-names></name><name><surname>Gore</surname><given-names>BB</given-names></name><name><surname>Whiting</surname><given-names>JL</given-names></name><name><surname>Nygren</surname><given-names>PJ</given-names></name><name><surname>Purkey</surname><given-names>AM</given-names></name><name><surname>Colledge</surname><given-names>M</given-names></name><name><surname>Langeberg</surname><given-names>LK</given-names></name><name><surname>Dell’Acqua</surname><given-names>ML</given-names></name><name><surname>Zweifel</surname><given-names>LS</given-names></name><name><surname>Scott</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A-kinase Anchoring Protein 79/150 Recruits Protein Kinase C to Phosphorylate Roundabout Receptors</article-title><source>The Journal of Biological Chemistry</source><volume>290</volume><fpage>14107</fpage><lpage>14119</lpage><pub-id pub-id-type="doi">10.1074/jbc.M115.637470</pub-id><pub-id pub-id-type="pmid">25882844</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schindelin</surname><given-names>J</given-names></name><name><surname>Arganda-Carreras</surname><given-names>I</given-names></name><name><surname>Frise</surname><given-names>E</given-names></name><name><surname>Kaynig</surname><given-names>V</given-names></name><name><surname>Longair</surname><given-names>M</given-names></name><name><surname>Pietzsch</surname><given-names>T</given-names></name><name><surname>Preibisch</surname><given-names>S</given-names></name><name><surname>Rueden</surname><given-names>C</given-names></name><name><surname>Saalfeld</surname><given-names>S</given-names></name><name><surname>Schmid</surname><given-names>B</given-names></name><name><surname>Tinevez</surname><given-names>JY</given-names></name><name><surname>White</surname><given-names>DJ</given-names></name><name><surname>Hartenstein</surname><given-names>V</given-names></name><name><surname>Eliceiri</surname><given-names>K</given-names></name><name><surname>Tomancak</surname><given-names>P</given-names></name><name><surname>Cardona</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fiji: an open-source platform for biological-image analysis</article-title><source>Nature Methods</source><volume>9</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id><pub-id pub-id-type="pmid">22743772</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>T</given-names></name><name><surname>Zündorf</surname><given-names>J</given-names></name><name><surname>Grüger</surname><given-names>T</given-names></name><name><surname>Brandenburg</surname><given-names>K</given-names></name><name><surname>Reiners</surname><given-names>AL</given-names></name><name><surname>Zinserling</surname><given-names>J</given-names></name><name><surname>Schnitzler</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>CD66b overexpression and homotypic aggregation of human peripheral blood neutrophils after activation by a gram-positive stimulus</article-title><source>Journal of Leukocyte Biology</source><volume>91</volume><fpage>791</fpage><lpage>802</lpage><pub-id pub-id-type="doi">10.1189/jlb.0911483</pub-id><pub-id pub-id-type="pmid">22319104</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sima</surname><given-names>C</given-names></name><name><surname>Aboodi</surname><given-names>GM</given-names></name><name><surname>Lakschevitz</surname><given-names>FS</given-names></name><name><surname>Sun</surname><given-names>C</given-names></name><name><surname>Goldberg</surname><given-names>MB</given-names></name><name><surname>Glogauer</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Nuclear factor Erythroid 2-Related factor 2 down-regulation in Oral Neutrophils is associated with Periodontal Oxidative Damage and Severe Chronic Periodontitis</article-title><source>The American Journal of Pathology</source><volume>186</volume><fpage>1417</fpage><lpage>1426</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2016.01.013</pub-id><pub-id pub-id-type="pmid">27070823</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Small</surname><given-names>EM</given-names></name><name><surname>Sutherland</surname><given-names>LB</given-names></name><name><surname>Rajagopalan</surname><given-names>KN</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Olson</surname><given-names>EN</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>MicroRNA-218 regulates vascular patterning by modulation of Slit-Robo signaling</article-title><source>Circulation Research</source><volume>107</volume><fpage>1336</fpage><lpage>1344</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.110.227926</pub-id><pub-id pub-id-type="pmid">20947829</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sørensen</surname><given-names>O</given-names></name><name><surname>Arnljots</surname><given-names>K</given-names></name><name><surname>Cowland</surname><given-names>JB</given-names></name><name><surname>Bainton</surname><given-names>DF</given-names></name><name><surname>Borregaard</surname><given-names>N</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils</article-title><source>Blood</source><volume>90</volume><fpage>2796</fpage><lpage>2803</lpage><pub-id pub-id-type="pmid">9326247</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tavora</surname><given-names>B</given-names></name><name><surname>Mederer</surname><given-names>T</given-names></name><name><surname>Wessel</surname><given-names>KJ</given-names></name><name><surname>Ruffing</surname><given-names>S</given-names></name><name><surname>Sadjadi</surname><given-names>M</given-names></name><name><surname>Missmahl</surname><given-names>M</given-names></name><name><surname>Ostendorf</surname><given-names>BN</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Kim</surname><given-names>JY</given-names></name><name><surname>Olsen</surname><given-names>O</given-names></name><name><surname>Welm</surname><given-names>AL</given-names></name><name><surname>Goodarzi</surname><given-names>H</given-names></name><name><surname>Tavazoie</surname><given-names>SF</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Tumoural activation of TLR3-SLIT2 axis in endothelium drives metastasis</article-title><source>Nature</source><volume>586</volume><fpage>299</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2774-y</pub-id><pub-id pub-id-type="pmid">32999457</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terzi</surname><given-names>A</given-names></name><name><surname>Roeder</surname><given-names>H</given-names></name><name><surname>Weaver</surname><given-names>CJ</given-names></name><name><surname>Suter</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Neuronal NADPH oxidase 2 regulates growth cone guidance downstream of slit2/robo2</article-title><source>Developmental Neurobiology</source><volume>81</volume><fpage>3</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1002/dneu.22791</pub-id><pub-id pub-id-type="pmid">33191581</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thammavongsa</surname><given-names>V</given-names></name><name><surname>Missiakas</surname><given-names>DM</given-names></name><name><surname>Schneewind</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title><italic>Staphylococcus aureus</italic> degrades neutrophil extracellular traps to promote immune cell death</article-title><source>Science</source><volume>342</volume><fpage>863</fpage><lpage>866</lpage><pub-id pub-id-type="doi">10.1126/science.1242255</pub-id><pub-id pub-id-type="pmid">24233725</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toepfner</surname><given-names>N</given-names></name><name><surname>Herold</surname><given-names>C</given-names></name><name><surname>Otto</surname><given-names>O</given-names></name><name><surname>Rosendahl</surname><given-names>P</given-names></name><name><surname>Jacobi</surname><given-names>A</given-names></name><name><surname>Kräter</surname><given-names>M</given-names></name><name><surname>Stächele</surname><given-names>J</given-names></name><name><surname>Menschner</surname><given-names>L</given-names></name><name><surname>Herbig</surname><given-names>M</given-names></name><name><surname>Ciuffreda</surname><given-names>L</given-names></name><name><surname>Ranford-Cartwright</surname><given-names>L</given-names></name><name><surname>Grzybek</surname><given-names>M</given-names></name><name><surname>Coskun</surname><given-names>Ü</given-names></name><name><surname>Reithuber</surname><given-names>E</given-names></name><name><surname>Garriss</surname><given-names>G</given-names></name><name><surname>Mellroth</surname><given-names>P</given-names></name><name><surname>Henriques-Normark</surname><given-names>B</given-names></name><name><surname>Tregay</surname><given-names>N</given-names></name><name><surname>Suttorp</surname><given-names>M</given-names></name><name><surname>Bornhäuser</surname><given-names>M</given-names></name><name><surname>Chilvers</surname><given-names>ER</given-names></name><name><surname>Berner</surname><given-names>R</given-names></name><name><surname>Guck</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Detection of human disease conditions by single-cell morpho-rheological phenotyping of blood</article-title><source>eLife</source><volume>7</volume><elocation-id>e29213</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.29213</pub-id><pub-id pub-id-type="pmid">29331015</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tole</surname><given-names>S</given-names></name><name><surname>Mukovozov</surname><given-names>IM</given-names></name><name><surname>Huang</surname><given-names>YW</given-names></name><name><surname>Magalhaes</surname><given-names>MAO</given-names></name><name><surname>Yan</surname><given-names>M</given-names></name><name><surname>Crow</surname><given-names>MR</given-names></name><name><surname>Liu</surname><given-names>GY</given-names></name><name><surname>Sun</surname><given-names>CX</given-names></name><name><surname>Durocher</surname><given-names>Y</given-names></name><name><surname>Glogauer</surname><given-names>M</given-names></name><name><surname>Robinson</surname><given-names>LA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The axonal repellent, Slit2, inhibits directional migration of circulating neutrophils</article-title><source>Journal of Leukocyte Biology</source><volume>86</volume><fpage>1403</fpage><lpage>1415</lpage><pub-id pub-id-type="doi">10.1189/jlb.0609391</pub-id><pub-id pub-id-type="pmid">19759280</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Ziffle</surname><given-names>JA</given-names></name><name><surname>Lowell</surname><given-names>CA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Neutrophil-specific deletion of Syk kinase results in reduced host defense to bacterial infection</article-title><source>Blood</source><volume>114</volume><fpage>4871</fpage><lpage>4882</lpage><pub-id pub-id-type="doi">10.1182/blood-2009-05-220806</pub-id><pub-id pub-id-type="pmid">19797524</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>Pathak</surname><given-names>JL</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Liang</surname><given-names>D</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Zhong</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Deng</surname><given-names>S</given-names></name><name><surname>Zheng</surname><given-names>L</given-names></name><name><surname>Yan</surname><given-names>Y</given-names></name><name><surname>Hou</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Ge</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>SLIT2 Overexpression in Periodontitis intensifies inflammation and Alveolar Bone Loss, possibly via the activation of MAPK pathway</article-title><source>Frontiers in Cell and Developmental Biology</source><volume>8</volume><elocation-id>593</elocation-id><pub-id pub-id-type="doi">10.3389/fcell.2020.00593</pub-id><pub-id pub-id-type="pmid">32760720</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ward</surname><given-names>RA</given-names></name><name><surname>Nakamura</surname><given-names>M</given-names></name><name><surname>McLeish</surname><given-names>KR</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Priming of the neutrophil respiratory burst involves p38 mitogen-activated protein kinase-dependent exocytosis of flavocytochrome b558-containing granules</article-title><source>The Journal of Biological Chemistry</source><volume>275</volume><fpage>36713</fpage><lpage>36719</lpage><pub-id pub-id-type="doi">10.1074/jbc.M003017200</pub-id><pub-id pub-id-type="pmid">10976103</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warnatsch</surname><given-names>A</given-names></name><name><surname>Tsourouktsoglou</surname><given-names>TD</given-names></name><name><surname>Branzk</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Reincke</surname><given-names>S</given-names></name><name><surname>Herbst</surname><given-names>S</given-names></name><name><surname>Gutierrez</surname><given-names>M</given-names></name><name><surname>Papayannopoulos</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Reactive oxygen species localization programs inflammation to clear microbes of different size</article-title><source>Immunity</source><volume>46</volume><fpage>421</fpage><lpage>432</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2017.02.013</pub-id><pub-id pub-id-type="pmid">28314592</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Werth</surname><given-names>N</given-names></name><name><surname>Beerlage</surname><given-names>C</given-names></name><name><surname>Rosenberger</surname><given-names>C</given-names></name><name><surname>Yazdi</surname><given-names>AS</given-names></name><name><surname>Edelmann</surname><given-names>M</given-names></name><name><surname>Amr</surname><given-names>A</given-names></name><name><surname>Bernhardt</surname><given-names>W</given-names></name><name><surname>von Eiff</surname><given-names>C</given-names></name><name><surname>Becker</surname><given-names>K</given-names></name><name><surname>Schäfer</surname><given-names>A</given-names></name><name><surname>Peschel</surname><given-names>A</given-names></name><name><surname>Kempf</surname><given-names>VAJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Activation of hypoxia inducible factor 1 is a general phenomenon in infections with human pathogens</article-title><source>PLOS ONE</source><volume>5</volume><elocation-id>e11576</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0011576</pub-id><pub-id pub-id-type="pmid">20644645</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Westman</surname><given-names>J</given-names></name><name><surname>Walpole</surname><given-names>GFW</given-names></name><name><surname>Kasper</surname><given-names>L</given-names></name><name><surname>Xue</surname><given-names>BY</given-names></name><name><surname>Elshafee</surname><given-names>O</given-names></name><name><surname>Hube</surname><given-names>B</given-names></name><name><surname>Grinstein</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Lysosome fusion maintains phagosome integrity during fungal infection</article-title><source>Cell Host &amp; Microbe</source><volume>28</volume><fpage>798</fpage><lpage>812</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2020.09.004</pub-id><pub-id pub-id-type="pmid">33022213</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>JY</given-names></name><name><surname>Feng</surname><given-names>L</given-names></name><name><surname>Park</surname><given-names>HT</given-names></name><name><surname>Havlioglu</surname><given-names>N</given-names></name><name><surname>Wen</surname><given-names>L</given-names></name><name><surname>Tang</surname><given-names>H</given-names></name><name><surname>Bacon</surname><given-names>KB</given-names></name><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Rao</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>The neuronal repellent Slit inhibits leukocyte chemotaxis induced by chemotactic factors</article-title><source>Nature</source><volume>410</volume><fpage>948</fpage><lpage>952</lpage><pub-id pub-id-type="doi">10.1038/35073616</pub-id><pub-id pub-id-type="pmid">11309622</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>BQ</given-names></name><name><surname>Geng</surname><given-names>ZH</given-names></name><name><surname>Ma</surname><given-names>L</given-names></name><name><surname>Geng</surname><given-names>JG</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Slit2 regulates attractive eosinophil and repulsive neutrophil chemotaxis through differential srGAP1 expression during lung inflammation</article-title><source>Journal of Immunology</source><volume>185</volume><fpage>6294</fpage><lpage>6305</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1001648</pub-id><pub-id pub-id-type="pmid">20944010</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Zong</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Jiang</surname><given-names>C</given-names></name><name><surname>Shan</surname><given-names>H</given-names></name><name><surname>Xia</surname><given-names>W</given-names></name><name><surname>Yin</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>N</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Yu</surname><given-names>X</given-names></name><name><surname>Chia</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title><italic>Staphylococcus aureus</italic> infection initiates Hypoxia-Mediated Transforming Growth Factor-β1 upregulation to Trigger Osteomyelitis</article-title><source>mSystems</source><volume>7</volume><elocation-id>e0038022</elocation-id><pub-id pub-id-type="doi">10.1128/msystems.00380-22</pub-id><pub-id pub-id-type="pmid">35852344</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>SL</given-names></name><name><surname>Luo</surname><given-names>CB</given-names></name><name><surname>Song</surname><given-names>CL</given-names></name><name><surname>Zhou</surname><given-names>ZJ</given-names></name><name><surname>Xin</surname><given-names>HY</given-names></name><name><surname>Hu</surname><given-names>ZQ</given-names></name><name><surname>Sun</surname><given-names>RQ</given-names></name><name><surname>Fan</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Genomic evolution and the impact of SLIT2 mutation in relapsed intrahepatic cholangiocarcinoma</article-title><source>Hepatology</source><volume>75</volume><fpage>831</fpage><lpage>846</lpage><pub-id pub-id-type="doi">10.1002/hep.32164</pub-id><pub-id pub-id-type="pmid">34543483</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><table-wrap id="app1keyresource" position="anchor"><label>Appendix 1—key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-β-Actin<break/>(Mouse monoclonal)<break/>Clone AC-15</td><td align="left" valign="bottom">Sigma-Aldrich, Oakville, ON, Canada</td><td align="left" valign="bottom">Cat# A5441<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_476744">AB_476744</ext-link></td><td align="left" valign="bottom">Western blot (WB)- 1:2000 1 hr @ Room temperature</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-phospho-p38 MAPK (Thr180/Tyr182)<break/>(Rabbit polyclonal)</td><td align="left" valign="bottom">Cell Signaling Technology, Danvers, MA, USA</td><td align="left" valign="bottom">Cat# 9211<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_331641">AB_331641</ext-link></td><td align="left" valign="bottom">WB- 1:2000<break/>1 hr @ Room temperature</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Total p38 MAPK<break/>(Rabbit polyclonal)</td><td align="left" valign="bottom">Cell Signaling Technology, Danvers, MA, USA</td><td align="left" valign="bottom">Cat# 9212<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_330713">AB_330713</ext-link></td><td align="left" valign="bottom">WB- 1:2000<break/>Overnight (O/N) @ 4 °C</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-phospho-p47phox (NCF1) (Ser345)<break/>(Rabbit polyclonal)</td><td align="left" valign="bottom">Thermo Fisher Scientific, Mississauga, ON, Canada</td><td align="left" valign="bottom">Cat# PA5-37806<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2554414">AB_2554414</ext-link></td><td align="left" valign="bottom">WB- 1:1000<break/>O/N @ 4 °C</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-p47phox (NCF1)<break/>(Rabbit monoclonal)<break/>Clone G.207.2</td><td align="left" valign="bottom">Thermo Fisher Scientific, Mississauga, ON, Canada</td><td align="left" valign="bottom">Cat# MA5-14778<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10989232">AB_10989232</ext-link></td><td align="left" valign="bottom">WB- 1:1000<break/>O/N @ 4 °C</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-phospho-PKC Pan (Thr497) (Rabbit polyclonal)</td><td align="left" valign="bottom">Thermo Fisher Scientific, Mississauga, ON, Canada</td><td align="left" valign="bottom">Cat# PA5-38418<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2555019">AB_2555019</ext-link></td><td align="left" valign="bottom">WB- 1:1000<break/>1 hr @ Room temperature</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-phospho-PKCδ (Tyr311) (Rabbit polyclonal)</td><td align="left" valign="bottom">Cell Signaling Technology, Danvers, MA, USA</td><td align="left" valign="bottom">Cat# 2055<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_330876">AB_330876</ext-link></td><td align="left" valign="bottom">WB- 1:2000<break/>1 hr @ Room temperature</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-PKCδ (Rabbit polyclonal)</td><td align="left" valign="bottom">Cell Signaling Technology, Danvers, MA, USA</td><td align="left" valign="bottom">Cat# 2058<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10694655">AB_10694655</ext-link></td><td align="left" valign="bottom">WB- 1:2000<break/>O/N @ 4 °C</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-His tag<break/>(Mouse monoclonal)<break/>Clone AD1.1.10<break/>HRP-conjugated</td><td align="left" valign="bottom">R&amp;D Systems, Inc.<break/>Minneapolis, MN, USA</td><td align="left" valign="bottom">Cat# MAB050H<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_357354">AB_357354</ext-link></td><td align="left" valign="bottom">WB- 1:2000<break/>1 hr @ Room temperature</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-human IgG-Cy3 (Donkey polyclonal)</td><td align="left" valign="bottom">Jackson ImmunoResearch Labs, West Grove, PA, USA</td><td align="left" valign="bottom">Cat# 709-165-149<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2340535">AB_2340535</ext-link></td><td align="left" valign="bottom">Phagocytosis- 1:1000 in block buffer, 30 min @ Room temperature</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-8-OHdG (Rabbit polyclonal)</td><td align="left" valign="bottom">Bioss Antibodies, Woburn, MA, USA</td><td align="left" valign="bottom">Cat# bs-1278R<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10856120">AB_10856120</ext-link></td><td align="left" valign="bottom">IHC- 1:500 for 1 hr @ Room temperature</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-mouse Ly6g (Rabbit monoclonal)<break/>Clone: EPR22909-135</td><td align="left" valign="bottom">Abcam Inc, Toronto, ON, Canada</td><td align="left" valign="bottom">Cat# ab238132<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2923218">AB_2923218</ext-link></td><td align="left" valign="bottom">IHC- 1:500 O/N @ 4 °C</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-mouse F4/80 (Rat monoclonal)<break/>Clone: CI:A3-1</td><td align="left" valign="bottom">Abcam Inc, Toronto, ON, Canada</td><td align="left" valign="bottom">Cat# ab6640<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1140040">AB_1140040</ext-link></td><td align="left" valign="bottom">IHC- 1:100 O/N @ 4 °C</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Mouse IgG (H+L) (Goat polyclonal) Peroxidase-conjugated AffiniPure</td><td align="left" valign="bottom">Jackson ImmunoResearch Labs, West Grove, PA, USA</td><td align="left" valign="bottom">Cat# 115-035-003<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10015289">AB_10015289</ext-link></td><td align="left" valign="bottom">WB- 1:10000<break/>1 hr @ Room temperature</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Rabbit IgG (H+L) (Goat polyclonal) Peroxidase-conjugated AffiniPure</td><td align="left" valign="bottom">Jackson ImmunoResearch, West Grove, PA, USA</td><td align="left" valign="bottom">Cat# 111-035-144<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2307391">AB_2307391</ext-link></td><td align="left" valign="bottom">WB- 1:10000<break/>1 hr @ Room temperature</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Rabbit IgG (H+L) (Goat polyclonal) Cross-Adsorbed 2° Antibody, Alexa Fluor (AF-)555</td><td align="left" valign="bottom">Thermo Fisher Scientific, Mississauga, ON, Canada</td><td align="left" valign="bottom">Cat# A-21428<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_141784">AB_141784</ext-link></td><td align="left" valign="bottom">IHC- 1:200 1 hr @ Room temperature</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Rat IgG (H+L) (Goat polyclonal) Cross-Adsorbed 2° Antibody, Alexa Fluor 488</td><td align="left" valign="bottom">Thermo Fisher Scientific, Mississauga, ON, Canada</td><td align="left" valign="bottom">Cat# A-11006<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_141373">AB_141373</ext-link></td><td align="left" valign="bottom">IHC- 1:200 1 hr @ Room temperature</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">PE Anti-Human CD16 (Mouse monoclonal)<break/>Clone 3G8</td><td align="left" valign="bottom">BioLegend, San Diego, CA, USA</td><td align="left" valign="bottom">Cat# 980102<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2616616">AB_2616616</ext-link></td><td align="left" valign="bottom">FC- 1 µl per 50 µl final volume, 30 min @ 4 °C in the dark</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">APC/Cyanine7 Anti-Human CD11b (Mouse monoclonal)<break/>Clone ICRF44</td><td align="left" valign="bottom">BioLegend, San Diego, CA, USA</td><td align="left" valign="bottom">Cat# 301342<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2563395">AB_2563395</ext-link></td><td align="left" valign="bottom">FC- 1.25 µl per 50 µl final volume, 30 min @ 4 °C in the dark</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">BV421 Anti-Human CD18 (Mouse monoclonal)<break/>Clone 6.7</td><td align="left" valign="bottom">BD Biosciences, Mississauga, ON, Canada</td><td align="left" valign="bottom">Cat# 743370<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2871511">AB_2871511</ext-link></td><td align="left" valign="bottom">FC- 1.25 µl per 50 µl final volume, 30 min @ 4 °C in the dark</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">PerCP/Cyanine5.5 Anti-Human CD63 (Mouse monoclonal)<break/>Clone H5C6</td><td align="left" valign="bottom">BioLegend, San Diego, CA, USA</td><td align="left" valign="bottom">Cat# 353020<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2561685">AB_2561685</ext-link></td><td align="left" valign="bottom">FC- 1.25 µl per 50 µl final volume, 30 min @ 4 °C in the dark</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Pacific Blue Anti-Human CD14 (Mouse monoclonal)<break/>Clone HCD14</td><td align="left" valign="bottom">BioLegend, San Diego, CA, USA</td><td align="left" valign="bottom">Cat# 325616<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_830689">AB_830689</ext-link></td><td align="left" valign="bottom">FC- 2.5 µl per 50 µl final volume, 30 min @ 4 °C in the dark</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">APC anti-human CD66b, eBioscience (Mouse monoclonal)<break/>Clone G10F5</td><td align="left" valign="bottom">Thermo Fisher Scientific, Mississauga, ON, Canada</td><td align="left" valign="bottom">Cat# 17-0666-42<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2573152">AB_2573152</ext-link></td><td align="left" valign="bottom">FC- 1.25 µl per 50 µl final volume, 30 min @ 4 °C in the dark</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Normal Mouse IgG (Mouse polyclonal)</td><td align="left" valign="bottom">Sigma-Aldrich, Oakville, ON, Canada</td><td align="left" valign="bottom">Cat# 12–371<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_145840">AB_145840</ext-link></td><td align="left" valign="bottom">Flow cytometry (FC)- 2 µg, block 20 min @ 4 °C</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Human IgG control (Human polyclonal)</td><td align="left" valign="bottom">Sigma-Aldrich, Oakville, ON, Canada</td><td align="left" valign="bottom">Cat# I4506<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1163606">AB_1163606</ext-link></td><td align="left" valign="bottom">Phagocytosis- 1:1000 in block buffer, 30 min @ Room temperature</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">InVivoMAb human IgG<sub>1</sub> (Human polyclonal) Isotype Control</td><td align="left" valign="bottom">Bio X Cell, Lebanon, NH, USA</td><td align="left" valign="bottom">Cat# BE0297<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2687817">AB_2687817</ext-link></td><td align="left" valign="bottom">In vivo- 7 µg per injection per mouse</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">SLIT2_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom"><named-content content-type="sequence">TCCTCCTCGCACCTTTGATGGATT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">SLIT2_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom"><named-content content-type="sequence">AGAGGGTTGGCTCCAATTGCTAGA</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">GAPDH_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom"><named-content content-type="sequence">GGTGTGAACCATGAGAAGTATGA</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">GAPDH_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom"><named-content content-type="sequence">GAGTCCTTCCACGATACCAAAG</named-content></td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Acti-stain-AF670</td><td align="left" valign="bottom">Universal Biologicals, Cambridge, UK</td><td align="left" valign="bottom">Cat# PHDN1-A</td><td align="left" valign="bottom">Phagocytosis</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">BOND Epitope Retrieval Solution 1</td><td align="left" valign="bottom">Leica Biosystems, Concord, ON, Canada</td><td align="left" valign="bottom">Cat# AR9961</td><td align="left" valign="bottom">IHC Antigen Retrieval</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Concanavalin A-AF647</td><td align="left" valign="bottom">Thermo Fisher Scientific, Mississauga, ON, Canada</td><td align="left" valign="bottom">Cat# C21421</td><td align="left" valign="bottom">Phagocytosis</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Ethylenediaminetetraacetic acid (EDTA), 0.5 M, pH 8.0, Sterile</td><td align="left" valign="bottom">Bio-World, Dublin, OH, USA</td><td align="left" valign="bottom">Cat# 40520000<break/>CAS# 60-00-4</td><td align="left" valign="bottom">Flow Cytometry buffer ingredient</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Detoxi-Gel Endotoxin Removing Gel</td><td align="left" valign="bottom">Thermo Fisher Scientific, Mississauga, ON, Canada</td><td align="left" valign="bottom">Cat# 20339</td><td align="left" valign="bottom">Endotoxin removal</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Detoxi-Gel Endotoxin Removing Gel Columns</td><td align="left" valign="bottom">Thermo Fisher Scientific, Mississauga, ON, Canada</td><td align="left" valign="bottom">Cat# 20344</td><td align="left" valign="bottom">Endotoxin removal</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Gentamicin (10 mg/mL)</td><td align="left" valign="bottom">Thermo Fisher Scientific, Mississauga, ON, Canada</td><td align="left" valign="bottom">Cat# 15710064</td><td align="left" valign="bottom">HMEC-1 culture to selectively kill extracellular <italic>S. aureu</italic>s bacteria</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Isoluminol<break/>(4-Aminophthalhydrazide)</td><td align="left" valign="bottom">Sigma-Aldrich, Oakville, ON, Canada</td><td align="left" valign="bottom">Cat# A8264<break/>CAS# 3682-14-2</td><td align="left" valign="bottom">Extracellular ROS measurement</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">p38 MAPK Inhibitor IV</td><td align="left" valign="bottom">Cayman Chemical, Ann Arbor, MI, USA</td><td align="left" valign="bottom">Cat# 22219<break/>CAS# 1638-41-1</td><td align="left" valign="bottom">p38 MAPK inhibitor</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Paraformaldehyde 16% solution</td><td align="left" valign="bottom">Electron Microscopy Sciences, Hatfield, PA, USA</td><td align="left" valign="bottom">Cat# 15710<break/>CAS# 50-00-0</td><td align="left" valign="bottom">Fixative</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">PD 184161</td><td align="left" valign="bottom">Cayman Chemical,<break/>Ann Arbor, MI, USA</td><td align="left" valign="bottom">Cat# 10012431<break/>CAS# 212631-67-9</td><td align="left" valign="bottom">MEK1/2 inhibitor</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Percoll</td><td align="left" valign="bottom">Sigma-Aldrich, Oakville, ON, Canada</td><td align="left" valign="bottom">Cat# P1644</td><td align="left" valign="bottom">Murine neutrophil isolation</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">PolymorphPrep</td><td align="left" valign="bottom">Progen, Wayne, PA, USA</td><td align="left" valign="bottom">Cat# 1895</td><td align="left" valign="bottom">Human neutrophil isolation</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Power SYBR Green PCR Master Mix</td><td align="left" valign="bottom">Thermo Fisher Scientific, Mississauga, ON, Canada</td><td align="left" valign="bottom">Cat# 4367659</td><td align="left" valign="bottom">Quantitative PCR</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Phorbol 12-myristate 13-acetate (PMA)</td><td align="left" valign="bottom">Sigma-Aldrich, Oakville, ON, Canada</td><td align="left" valign="bottom">Cat# P8139<break/>CAS #16561-29-8</td><td align="left" valign="bottom">Neutrophil activation</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">Recombinant Human N-SLIT2</td><td align="left" valign="bottom">PeproTech, Cranbury, NJ, USA</td><td align="left" valign="bottom">Cat# 150–11</td><td align="left" valign="bottom">Neutrophil treatments</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">Recombinant Human ROBO1 Fc Chimera (N-ROBO1)</td><td align="left" valign="bottom">R&amp;D Systems, Minneapolis, MN, USA</td><td align="left" valign="bottom">Cat# 8975-RB</td><td align="left" valign="bottom">Neutrophil treatment</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">SB 203580</td><td align="left" valign="bottom">Sigma-Aldrich, Oakville, ON, Canada</td><td align="left" valign="bottom">Cat# S8307<break/>CAS #152121-47-6</td><td align="left" valign="bottom">p38 MAPK inhibitor</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Superscript VILO MasterMix</td><td align="left" valign="bottom">Thermo Fisher Scientific, Mississauga, ON, Canada</td><td align="left" valign="bottom">Cat# 11755</td><td align="left" valign="bottom">Reverse Transcription</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">SYTOX Green Nucleic Acid Stain</td><td align="left" valign="bottom">Thermo Fisher Scientific, Mississauga, ON, Canada</td><td align="left" valign="bottom">Cat# S7020</td><td align="left" valign="bottom">NETosis assay</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Y-27632, ROCK inhibitor</td><td align="left" valign="bottom">Sigma-Aldrich, Oakville, Canada</td><td align="left" valign="bottom">Cat# SCM075 CAS# 331752-47-7</td><td align="left" valign="bottom">Neutrophil treatment</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Bond Polymer Refine Detection kit</td><td align="left" valign="bottom">Leica Biosystems, Concord, ON, Canada</td><td align="left" valign="bottom">Cat# DS9800</td><td align="left" valign="bottom">8-OHdG (DAB) staining</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">G-LISA Rac Activation Assay</td><td align="left" valign="bottom">Cytoskeleton, Inc, Denver, CO, USA</td><td align="left" valign="bottom">Cat# BK125</td><td align="left" valign="bottom">Rac1/2/3 activation assay</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Human LL-37 ELISA kit</td><td align="left" valign="bottom">Hycult Biotech, Uden, Netherlands</td><td align="left" valign="bottom">Cat# HK321</td><td align="left" valign="bottom">ELISA</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Human SLIT2 ELISA kit</td><td align="left" valign="bottom">Cusabio, Wuhan, P.R. China</td><td align="left" valign="bottom">Cat# CSB-E11038h</td><td align="left" valign="bottom">ELISA</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Mouse SLIT2 ELISA Kit</td><td align="left" valign="bottom">Cusabio, Wuhan, P.R. China</td><td align="left" valign="bottom">Cat# CSB-E11039m</td><td align="left" valign="bottom">ELISA</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Mouse SLIT3 ELISA kit</td><td align="left" valign="bottom">Lifespan Biosciences<break/>Seattle, WA, USA</td><td align="left" valign="bottom">Cat# LS-F7173</td><td align="left" valign="bottom">ELISA</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">RNeasy Plus Mini Kit</td><td align="left" valign="bottom">Qiagen, Toronto, ON, Canada</td><td align="left" valign="bottom">Cat# 74136</td><td align="left" valign="bottom">RNA isolation</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">FreeStyle 293-F Cells (HEK293F)</td><td align="left" valign="bottom">Thermo Fisher Scientific, Mississauga, ON, Canada</td><td align="left" valign="bottom">R79007<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:CVCL_D603">CVCL_D603</ext-link></td><td align="left" valign="bottom">N-SLIT2ΔD2 production</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">HMEC-1</td><td align="left" valign="bottom">American Type Culture Collection (ATCC), Manassas, VA, USA</td><td align="left" valign="bottom">CRL-3243<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:CVCL_0307">CVCL_0307</ext-link></td><td align="left" valign="bottom">Immortalized human dermal microvascular endothelial cells</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">RAW264.7</td><td align="left" valign="bottom">American Type Culture Collection (ATCC), Manassas, VA, USA</td><td align="left" valign="bottom">TIB-71<break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:CVCL_0493">CVCL_0493</ext-link></td><td align="left" valign="bottom">Murine macrophage cell line</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Staphylococcus aureus</italic>)</td><td align="left" valign="bottom"><italic>Staphylococcus aureus</italic> GFP<break/>USA300 LAC strain</td><td align="left" valign="bottom">Dr. Ronald S. Flannagan (University of Western Ontario, London, ON, Canada)<break/>PMID: 30619165</td><td align="left" valign="bottom"><italic>Staphylococcus aureus</italic> GFP</td><td align="left" valign="bottom">Phagocytosis</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Staphylococcus aureus</italic>)</td><td align="left" valign="bottom"><italic>Staphylococcus aureus subsp. Aureus Rosenbach</italic></td><td align="left" valign="bottom">American Type Culture Collection (ATCC), Manassas, VA, USA</td><td align="left" valign="bottom">ATCC 25923</td><td align="left" valign="bottom"><italic>S. aureus</italic> (all experiments except phagocytosis)</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ShapeOut2</td><td align="left" valign="bottom">PMID: 29331015</td><td align="left" valign="bottom">ShapeOut2; <xref ref-type="bibr" rid="bib51">Müller et al., 2019</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://github.com/ZELLMECHANIK-DRESDEN/ShapeOut2">https://github.com/ZELLMECHANIK-DRESDEN/ShapeOut2</ext-link></td></tr></tbody></table></table-wrap></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.87392.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Rothlin</surname><given-names>Carla V</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03v76x132</institution-id><institution>Yale University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><p>Bhosle and colleagues present valuable findings on the function of the N-terminal fragment of SLIT2 in the amplification of reactive oxygen species production and exocytosis of secretory granules by neutrophils. The authors present solid in vitro and in vivo data supporting this unexpected role for SLIT2. This work advances our knowledge of innate immunity to pathogens.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.87392.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Rothlin</surname><given-names>Carla V</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03v76x132</institution-id><institution>Yale University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p>[Editors' note: this paper was reviewed by <ext-link ext-link-type="uri" xlink:href="https://www.reviewcommons.org/">Review Commons</ext-link>.]</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.87392.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>General Statements</p></disp-quote><p>We sincerely thank the reviewers for their comprehensive and constructive feedback. Below, we submit our revision plan addressing the points raised by the reviewers.</p><disp-quote content-type="editor-comment"><p>Description of the planned revisions</p><p>Reviewer #1 (Evidence, reproducibility and clarity (Required)):</p></disp-quote><p>The study analyzes the role of SLIT2 in clearance of S. aureus via neutrophils. It suggests that N-SLIT2 play a key role as an amplifier of the ROS response and release of antimicrobial peptides. The manuscript is well written and is technologically sound. However, a few issues need to be addressed that preclude publication of the manuscript:</p><p>We thank the reviewer for the positive feedback.</p><disp-quote content-type="editor-comment"><p>Major comments:</p><p>1. The study analyzes different parameters of neutrophil function. One major effect of neutrophil activation is NETosis. This has not been addressed in the study albeit it is deemed to act in concert with the other immune mechanisms described.</p></disp-quote><p>We thank the reviewer for the suggestion. To investigate whether N-SLIT2 modulates <italic>S. aureus</italic>-induced Neutrophil Extracellular Trap formation (NETosis), we used Sytox Green, a membrane-impermeable nucleic acid label and calculated the NETotic index, as previously described (Douda et al., 2015). Exposure of neutrophils to N-SLIT2 in the absence of bacteria did not induce NETosis. In line with previously published results (Monteith et al., 2021; Wan et al., 2017), incubation of neutrophils with <italic>S. aureus</italic> (MOI 10) for 2 hours resulted in significant NETosis (p = 0.0004). Incubation of neutrophils with N-SLIT2 and <italic>S. aureus</italic> showed a trend towards higher NETosis compared to incubation with <italic>S. aureus</italic> alone, but this did not reach statistical significance (p = 0.0883). <italic>S. aureus</italic> is known to induce NETosis in both NADPH oxidase (NOX)–dependent and –independent manners (Douda et al., 2015; Parker et al., 2012; Pilsczek et al., 2010). Additionally, <italic>S. aureus</italic> is known to promote the degradation of neutrophil-derived NETs (Thammavongsa et al., 2013). Our results demonstrate that N-SLIT2-ROBO1 signaling primes p47phox, a component of neutrophil NOX2 complex, in a p38-dependent manner but the contribution of NOX-independent NETosis as well as degradation of NETs by <italic>S. aureus</italic> cannot be presently ruled out. New studies are warranted to investigate the effects of SLIT-ROBO signaling on pathogen-induced NETosis. In the revised manuscript, we included the new results and discussed these important points in revised Figure 3—figure supplement 1H-J and on pages 7 and 10 of the revised manuscript.</p><fig id="sa2fig1" position="float"><label>Author response image 1.</label><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87392-sa2-fig1-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>2. Furthermore, the authors discuss a role of SLIT2 in the regulation of neutrophil migration. However, the current data set does not provide sufficient evidence for this. The reviewer suggests that the authors provide migration/chemotaxis assays and/or in vivo data to prove their hypothesis or revise their argumentation.</p></disp-quote><p>We thank the reviewer for this important suggestion. Several groups, including ours, have previously demonstrated that SLIT2-ROBO1 signaling potently inhibits neutrophil chemotaxis in vitro and in vivo (Chaturvedi et al., 2013; Tole et al., 2009; Ye et al., 2010; Zhou et al., 2022). Additionally, a recent study showed that shRNA-mediated knockdown of SLIT2 resulted in increased neutrophil infiltration into murine tumors further supporting the negative regulatory effect of SLIT2 on neutrophil migration (Geraldo et al., 2021). In our current study, in an effort to selectively examine the effects of SLIT2 on neutrophil function rather than on neutrophil migration, we intentionally administered N-ROBO1 to block endogenous SLIT2 signaling at 48 and 72 hours after inducing skin and soft tissue infection (SSTI) with <italic>S. aureus</italic>. In this model, the majority of neutrophil influx occurs early on, namely within 24 hours (Prabhakara et al., 2013). We observed that blocking endogenous SLIT2 signaling in a murine model of SSTI resulted in enhanced localized infection and injury. We have now performed immunohistochemistry (IHC) to evaluate within the tissue levels of 8-hydroxydeoxyguanosine (8-OHdG), an indicator of oxidative tissue damage which has previously been shown to be associated with neutrophil activity (Sima et al., 2016). Congruent with the H&amp;E results, neutralizing endogenous SLIT2 signaling using N-ROBO1 resulted in decreased oxidative damage in SSTI (Figure 4—figure supplement 1F-G). Next, we used IHC staining to directly measure neutrophil (Ly6G<sup>+</sup>F4/80<sup>-</sup>) numbers in SSTI (Chadwick et al., 2021). In line with aforementioned studies demonstrating the potent ability of exogenously administered SLIT2 to inhibit neutrophil chemotaxis in murine models of non-infectious diseases, we found that neutralization of endogenous SLIT2, using N-ROBO1, augmented neutrophil infiltration in SSTI.</p><p>Interestingly, a small but significant increase in neutrophil infiltration was also observed in animals treated with N-ROBO1 alone in the absence of SSTI (Figure 4—figure supplement 1D-E). We now discuss these important points on pages 7 and 11 of the revised manuscript.</p><disp-quote content-type="editor-comment"><p>3. The timeline of SLIT2 expression indicates that environmental conditions could influence the expression of SLIT2. Have the authors analyzed whether SLIT2 expression is affected by low pH or hypoxia? Is there any data indicating what factors regulate SLIT2 expression? In the same line, it would be interesting to know whether SLIT2 immune effects (specifically ROS and LL37 release) are similarly triggered under hypoxic conditions often found in an abscess.</p></disp-quote><p>We thank the reviewer for raising this important point and for the suggestions. The regulation of SLIT2 levels in tissues is an active area of research. Hypoxia has been reported to increase SLIT2 expression in placental tissue (Liao et al., 2012), but this has not been investigated in the context of bacterial infection. In different physiologic and pathophysiologic settings, vascular endothelial cells, including dermal microvascular endothelial cells, have been shown to be an important source of SLIT2 (Romano et al., 2018; Tavora et al., 2020). We performed additional experiments using HMEC-1, a human dermal microvascular endothelial cell line (Ades et al., 1992) to investigate effects of hypoxia and low pH, conditions found within bacterial abscesses, on production of SLIT2. In line with tissue levels of SLIT2 protein in <italic>S. aureus</italic>-induced SSTI (Figure 4A), SLIT2 production by HMEC-1 cells was significantly attenuated at 12 hours, but then increased at 48 hours after infection with <italic>S. aureus</italic> both at mRNA and protein levels (Figure 5 A-B). Lowering the pH of the cell culture media to pH 7.0 and 6.6 did not significantly alter SLIT2 production by HMEC-1 cells (Figure 5—figure supplement 1A). To test the effects of hypoxia on SLIT2 production we exposed dermal microvascular endothelial cells to 1% O<sub>2</sub> and observed significant reduction in SLIT2 levels at 12 hours and an increase at 48 hours (Figure 5 C-D). While our manuscript was in revision, Li <italic>et al.</italic> reported that cellular levels of Hypoxia-inducible factor 1-α (HIF-1α) negatively regulate SLIT2 production in vascular smooth muscle cells, with higher HIF-1α levels suppressing SLIT2 production and vice versa (Li et al., 2023b). Intriguingly, <italic>S. aureus</italic> infection is also known to activate HIF-1α signaling in vitro and in vivo (Thompson et al., 2017; Werth et al., 2010; Zhang et al., 2022). Taken together, these results suggest that temporal regulation of local HIF-1α signaling could regulate endogenous SLIT2 levels in SSTI. We have included the results of our new experiments and also discuss the important points above in the Discussion section of the revised manuscript (Figure 5 and page 11).</p><p>Finally, we investigated the effects of SLIT2, produced by HMEC-1 cells, on LL-37 production by treating neutrophils with conditioned media from HMEC-1 cells. The conditioned medium from <italic>S. aureus</italic>-infected HMEC-1 cells (48 h) stimulated LL-37 from neutrophils but this effect was blocked by treatment of conditioned medium with N-ROBO1, which contains the N-SLIT2-binding Ig1 motif (Morlot et al., 2007) and blocks the action of bioactive N-SLIT2 (p = 0.0362) (Figure 5—figure supplement 1B). Similarly, conditioned medium from HMEC-1 cells subjected to hypoxia (48 h) stimulated LL-37 release but this was significantly attenuated by N-ROBO1 treatment (p = 0.0190) (Figure 5—figure supplement 1B). We discuss these new results on page 8 of the revised manuscript.</p><disp-quote content-type="editor-comment"><p>4. Lastly, it is unclear whether SLIT2 binds to a defined target on the neutrophil. This needs to be highlighted in the discussion in respect to future work and ideally resolved experimentally.</p></disp-quote><p>We apologize for the confusion. We and others have previously demonstrated that human and murine neutrophils express ROBO1 but not ROBO2, and that ROBO1 is the primary Roundabout receptor which binds N-SLIT2 in neutrophils (Rincon et al., 2018; Tole et al., 2009). We have now included this information in the Introduction section (please see page 4 of the revised manuscript). In our manuscript we showed experimentally that incubation of N-SLIT2 with the soluble N-terminal fragment of ROBO1 (N-ROBO1) blocked the effect of N-SLIT2 on ROS production, thereby confirming that the observed actions of SLIT2 occurred through ROBO1 (Figure 1G). In the revised version of the manuscript, we clarify this point in the Results section (page 5).</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Significance (Required)):</p><p>The manuscript provides insight into a new mechanism regulating neutrophil function in the presence of S. aureus. The study provides evidence that the N-terminus of SLIT2 is involved in these effects and highlights p38-mediated signaling events as molecular targets increasing antibacterial effects in neutrophils. However, some contradictory findings imply that timing of the response is crucial.</p><p>Nevertheless, with the molecular mechanisms not fully understood many questions remain and the study adds to the complexity of the anti-staphylococcal immune response. Therefore, the audience for this manuscript requires knowledge on S. aureus-specific host-pathogen interaction and is not suitable for a broad audience as it does not provide information on a generally new mechanism of neutrophil activation or defense.</p></disp-quote><p>We thank the reviewer for highlighting the point that the temporal control of endogenous SLIT2 levels is crucial for modulating innate immune responses. We complete agree and clarify and expand upon this important point in the revised manuscript (page 11).</p><p>To more fully elucidate the molecular and cellular mechanisms responsible for our observations, we performed a series of new experiments. We recently reported that exposure to N-SLIT2 increases cell rounding and decreases spreading in macrophages and this effect is mediated by inactivation of the endogenous RhoGAP, MYO9B (Bhosle et al., 2020). Using novel methodology, neutrophil priming was recently shown to be associated with characteristic cytoskeletal changes (Bashant et al., 2019). We, therefore, collaborated with Dr. Nicole Toepfner (Technische Universität Dresden, Dresden) to investigate SLIT2-induced cytoskeletal changes in neutrophils isolated from whole blood using Real-time deformability cytometry (RT-DC), a technique that has recently been utilized to investigate priming-associated cytoskeletal changes in neutrophils in situ (Bashant et al., 2019; Toepfner et al., 2018). In line with aforementioned findings in macrophages, exposure to bioactive N-SLIT2, but not bio-inactive N-SLIT2ΔD2 resulted in approximately 10% reduction in average cell area for neutrophils although the difference did not reach statistical significance (vehicle vs N-SLIT2, p = 0.0676) (Figure 3—figure supplement 1B). Additionally, N-SLIT2-exposed neutrophils were less deformed as compared to the N-SLIT2ΔD2 (vehicle vs N-SLIT2, p = 0.0955) (Figure 3—figure supplement 1A). This could be due to the dilution of the sample with RT-DC buffer thereby reducing the magnitude of NSLIT-2-induced cellular effects. N-SLIT2 can also interact with other proteins present in whole blood, thereby modulating activity of the protein. We discuss these points on page 10 of the revised manuscript.</p><p>Congruent with our results in innate immune cells (neutrophils and macrophages), Li et al. very recently reported that SLIT2-ROBO1 signaling similarly stimulates p38 MAPK activity in human cancer cells, but the underlying mechanism has remained elusive so far (Li et al., 2023a). Rho-associated kinase (ROCK) signaling is known to augment p38 MAPK activity in epithelial cells (Wagstaff et al., 2016). Since we and others have shown that SLIT2-ROBO1 signaling enhances RhoA activation in immune and cancer cells (Bhosle et al., 2020; Kong et al., 2015), we tested the effect of ROCK inhibition on SLIT2-induced p38 activation in neutrophils. In the presence of the specific ROCK inhibitor, Y-27632, N-SLIT2 failed to activate p38 MAPK in neutrophils (p = 0.0007) (Figure 2G-H). We discuss these results on page 10 of the revised manuscript.</p><p>We also thank the reviewer for pointing out the complexity of host-pathogen interactions involving neutrophils and <italic>S. aureus</italic>. SLIT2 is well-known for its anti-inflammatory properties via its effects on immune cell chemotaxis in vivo (Anand et al., 2013; Chaturvedi et al., 2013; Geraldo et al., 2021). We demonstrated that SLIT2-ROBO1 signaling inhibits macropinocytosis in macrophages, and consequently, attenuates NOD2-induced inflammasome activation in mice (Bhosle et al., 2020). Based on these earlier observations, SLIT2 would be anticipated to impair innate immune responses to infection. Unexpectedly, we found that SLIT2 does not impair, but instead enhances the ability of neutrophils to kill <italic>S. aureus</italic>. Indeed, through different mechanisms SLIT2 has been shown to have widespread immunomodulatory properties against not only <italic>S. aureus</italic> but against diverse pathogens, including <italic>M. tuberculosis,</italic> intestinal pathogens<italic>,</italic> H5N1 influenza, and most recently, COVID-19 (Borbora et al., 2023; Gustafson et al., 2022; London et al., 2010). Together, these studies highlight the importance of spatiotemporal regulation of SLIT2 levels in tissues during bacterial and viral infections and the direct effects of SLIT2 on modulating host-pathogen interactions. In the revised manuscript, we now discuss these important points (page 11) in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Evidence, reproducibility and clarity (Required)):</p><p>Summary:</p><p>The manuscript deals with the role of the neurorepellent SLIT2 in killing of the bacterial pathogen Staphylococcus aureus. The authors show that neutrophils incubated with the N-terminal region of SLIT2 kill S. aureus more efficiently than neutrophils without pre-exposure to N-SLIT2. This effect was due to an increased production of reactive oxygen species by NADPH oxidase complex activation and stimulating exocytosis of antibacterial peptide containing granules. The concept was proven in an animal model of skin and soft tissue infection in mice in which neutralization of endogenous SLIT2 reduced CFU numbers in ear skin and decreased tissue destruction in response to S. aureus infection.</p><p>Major comments:</p><p>1. In general the findings and key conclusions are convincingly covered by the results presented in the manuscript. The methods are adequate to allow the conclusions drawn. Data are clearly presented and easy to follow. Statistical methods are appropriate.</p></disp-quote><p>We thank the reviewer for the positive feedback.</p><disp-quote content-type="editor-comment"><p>Minor comments:</p><p>1. In the Materials and methods section line 340 a GFP-expressing S. aureus USA300 strain is indicated. What was the exact strain designation, e.g. LAC or JE2, as USA300 is not a strain name (different strains belong to this pulsed-field electrophoresis based classification).</p></disp-quote><p>We thank the reviewer for this comment. The strain designation of the GFP-expressing <italic>S. aureus</italic> we used is USA300 LAC (Flannagan et al., 2018). In the revised version of the manuscript we have now included the correct information (please see page 13).</p><disp-quote content-type="editor-comment"><p>2. In the legend of figure 3 the inhibitors are mentioned for part B and E but not C and D.</p></disp-quote><p>We apologize for the error. The legend of Figure 3 has now been corrected and is now included in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>3. Figure S4 would be nice to have in the main manuscript.</p></disp-quote><p>We thank the reviewer for the suggestion. In the revised manuscript we moved the original Supplementary Figure S4B to main Figure 4B. The schematic from main Figure 4B has been moved to the new Supplementary Figure 4B (Figure 4—figure supplement 1B). The graphical summary is now presented as the new main Figure 6.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Significance (Required)):</p><p>The manuscript deals with a novel mechanism of neutrophil activation by SLIT-2, a protein which was originally thought to act in the nervous system but is also expressed in many peripheral tissues. Importantly SLIT-2 may be involved in tumor suppression but also chemotaxis of immune cells. In this manuscript a novel, rather unexpected role of the N-terminal region of SLIT-2 in activation of antibacterial mechanisms of neutrophils was shown. This could be interesting for a broader readership interested in innate immune mechanisms and bacterial infections. Since little is known on the role of SLIT-2 in response to bacterial infections the paper could initiate a number of new studies in this field. This reviewer has experience with S. aureus virulence and resistance mechanisms and animal infection models.</p></disp-quote><p>We thank the reviewer for the very positive feedback regarding the appeal of our manuscript to a broad readership. As noted in our response to Reviewer #1 Significance, recent studies suggest that SLIT2 could not only serve as a therapeutic to combat <italic>S. aureus</italic>, but could have broad anti-microbial activity against a number of pathogens including <italic>Mycobacterium tuberculosis,</italic> intestinal pathogens<italic>,</italic> H5N1 influenza, and COVID-19 (Borbora et al., 2023; Gustafson et al., 2022; London et al., 2010). We believe that the ability of SLIT2 to combat diverse bacterial and viral infections will even further enhance the appeal of our manuscript to a broad audience. In the revised manuscript we expand the discussion (page 11) to include these very important points.</p><p>References:</p><p>Ades, E.W., Candal, F.J., Swerlick, R.A., George, V.G., Summers, S., Bosse, D.C., and Lawley, T.J. (1992). HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol <italic>99</italic>, 683-690.</p><p>Anand, A.R., Zhao, H., Nagaraja, T., Robinson, L.A., and Ganju, R.K. (2013). N-terminal Slit2 inhibits HIV-1 replication by regulating the actin cytoskeleton. Retrovirology <italic>10</italic>, 2.</p><p>Bashant, K.R., Vassallo, A., Herold, C., Berner, R., Menschner, L., Subburayalu, J., Kaplan, M.J., Summers, C., Guck, J., Chilvers, E.R.<italic>, et al.</italic> (2019). Real-time deformability cytometry reveals sequential contraction and expansion during neutrophil priming. J Leukoc Biol <italic>105</italic>, 1143-1153.</p><p>Bhosle, V.K., Mukherjee, T., Huang, Y.W., Patel, S., Pang, B.W.F., Liu, G.Y., Glogauer, M., Wu, J.Y., Philpott, D.J., Grinstein, S.<italic>, et al.</italic> (2020). SLIT2/ROBO1-signaling inhibits macropinocytosis by opposing cortical cytoskeletal remodeling. Nat Commun <italic>11</italic>, 4112.</p><p>Borbora, S.M., Satish, B.A., Sundar, S., B, M., Bhatt, S., and Balaji, K.N. (2023). <italic>Mycobacterium tuberculosis</italic> elevates SLIT2 expression within the host and contributes to oxidative stress responses during infection. J Infect Dis.</p><p>Chadwick, J.W., Macdonald, R., Ali, A.A., Glogauer, M., and Magalhaes, M.A. (2021). TNFalpha Signaling Is Increased in Progressing Oral Potentially Malignant Disorders and Regulates Malignant Transformation in an Oral Carcinogenesis Model. Front Oncol <italic>11</italic>, 741013.</p><p>Chaturvedi, S., Yuen, D.A., Bajwa, A., Huang, Y.W., Sokollik, C., Huang, L., Lam, G.Y., Tole, S., Liu, G.Y., Pan, J.<italic>, et al.</italic> (2013). Slit2 prevents neutrophil recruitment and renal ischemia-reperfusion injury. J Am Soc Nephrol <italic>24</italic>, 1274-1287.</p><p>Douda, D.N., Khan, M.A., Grasemann, H., and Palaniyar, N. (2015). SK3 channel and mitochondrial ROS mediate NADPH oxidase-independent NETosis induced by calcium influx. Proc Natl Acad Sci U S A <italic>112</italic>, 2817-2822.</p><p>Flannagan, R.S., Kuiack, R.C., McGavin, M.J., and Heinrichs, D.E. (2018). Staphylococcus aureus Uses the GraXRS Regulatory System To Sense and Adapt to the Acidified Phagolysosome in Macrophages. mBio <italic>9</italic>.</p><p>Geraldo, L.H., Xu, Y., Jacob, L., Pibouin-Fragner, L., Rao, R., Maissa, N., Verreault, M., Lemaire, N., Knosp, C., Lesaffre, C.<italic>, et al.</italic> (2021). SLIT2/ROBO signaling in tumor-associated microglia and macrophages drives glioblastoma immunosuppression and vascular dysmorphia. J Clin Invest <italic>131</italic>.</p><p>Gustafson, D., Ngai, M., Wu, R., Hou, H., Schoffel, A.C., Erice, C., Mandla, S., Billia, F., Wilson, M.D., Radisic, M.<italic>, et al.</italic> (2022). Cardiovascular signatures of COVID-19 predict mortality and identify barrier stabilizing therapies. EBioMedicine <italic>78</italic>, 103982.</p><p>Kong, R., Yi, F., Wen, P., Liu, J., Chen, X., Ren, J., Li, X., Shang, Y., Nie, Y., Wu, K.<italic>, et al.</italic> (2015). Myo9b is a key player in SLIT/ROBO-mediated lung tumor suppression. J Clin Invest <italic>125</italic>, 4407-4420.</p><p>Li, Q., Zhang, X.X., Hu, L.P., Ni, B., Li, D.X., Wang, X., Jiang, S.H., Li, H., Yang, M.W., Jiang, Y.S.<italic>, et al.</italic> (2023a). Coadaptation fostered by the SLIT2-ROBO1 axis facilitates liver metastasis of pancreatic ductal adenocarcinoma. Nat Commun <italic>14</italic>, 861.</p><p>Li, S., Gao, Z., Li, H., Xu, C., Chen, B., Zha, Q., Yang, K., and Wang, W. (2023b). Hif-1alpha/Slit2 Mediates Vascular Smooth Muscle Cell Phenotypic Changes in Restenosis of Bypass Grafts. J Cardiovasc Transl Res.</p><p>Liao, W.X., Laurent, L.C., Agent, S., Hodges, J., and Chen, D.B. (2012). Human placental expression of SLIT/ROBO signaling cues: effects of preeclampsia and hypoxia. Biol Reprod <italic>86</italic>, 111.</p><p>London, N.R., Zhu, W., Bozza, F.A., Smith, M.C., Greif, D.M., Sorensen, L.K., Chen, L., Kaminoh, Y., Chan, A.C., Passi, S.F.<italic>, et al.</italic> (2010). Targeting Robo4-dependent Slit signaling to survive the cytokine storm in sepsis and influenza. Sci Transl Med <italic>2</italic>, 23ra19.</p><p>Monteith, A.J., Miller, J.M., Maxwell, C.N., Chazin, W.J., and Skaar, E.P. (2021). Neutrophil extracellular traps enhance macrophage killing of bacterial pathogens. Sci Adv <italic>7</italic>, eabj2101.</p><p>Morlot, C., Thielens, N.M., Ravelli, R.B., Hemrika, W., Romijn, R.A., Gros, P., Cusack, S., and McCarthy, A.A. (2007). Structural insights into the Slit-Robo complex. Proc Natl Acad Sci U S A <italic>104</italic>, 14923-14928.</p><p>Parker, H., Dragunow, M., Hampton, M.B., Kettle, A.J., and Winterbourn, C.C. (2012). Requirements for NADPH oxidase and myeloperoxidase in neutrophil extracellular trap formation differ depending on the stimulus. J Leukoc Biol <italic>92</italic>, 841-849.</p><p>Pilsczek, F.H., Salina, D., Poon, K.K., Fahey, C., Yipp, B.G., Sibley, C.D., Robbins, S.M., Green, F.H., Surette, M.G., Sugai, M.<italic>, et al.</italic> (2010). A novel mechanism of rapid nuclear neutrophil extracellular trap formation in response to Staphylococcus aureus. J Immunol <italic>185</italic>, 7413-7425.</p><p>Prabhakara, R., Foreman, O., De Pascalis, R., Lee, G.M., Plaut, R.D., Kim, S.Y., Stibitz, S., Elkins, K.L., and Merkel, T.J. (2013). Epicutaneous model of community-acquired Staphylococcus aureus skin infections. Infect Immun <italic>81</italic>, 1306-1315.</p><p>Rincon, E., Rocha-Gregg, B.L., and Collins, S.R. (2018). A map of gene expression in neutrophil-like cell lines. BMC Genomics <italic>19</italic>, 573.</p><p>Romano, E., Manetti, M., Rosa, I., Fioretto, B.S., Ibba-Manneschi, L., Matucci-Cerinic, M., and Guiducci, S. (2018). Slit2/Robo4 axis may contribute to endothelial cell dysfunction and angiogenesis disturbance in systemic sclerosis. Ann Rheum Dis <italic>77</italic>, 1665-1674.</p><p>Sima, C., Aboodi, G.M., Lakschevitz, F.S., Sun, C., Goldberg, M.B., and Glogauer, M. (2016). Nuclear Factor Erythroid 2-Related Factor 2 Down-Regulation in Oral Neutrophils Is Associated with Periodontal Oxidative Damage and Severe Chronic Periodontitis. Am J Pathol <italic>186</italic>, 1417-1426.</p><p>Tavora, B., Mederer, T., Wessel, K.J., Ruffing, S., Sadjadi, M., Missmahl, M., Ostendorf, B.N., Liu, X., Kim, J.Y., Olsen, O.<italic>, et al.</italic> (2020). Tumoural activation of TLR3-SLIT2 axis in endothelium drives metastasis. Nature <italic>586</italic>, 299-304.</p><p>Thammavongsa, V., Missiakas, D.M., and Schneewind, O. (2013). Staphylococcus aureus degrades neutrophil extracellular traps to promote immune cell death. Science <italic>342</italic>, 863-866.</p><p>Thompson, A.A., Dickinson, R.S., Murphy, F., Thomson, J.P., Marriott, H.M., Tavares, A., Willson, J., Williams, L., Lewis, A., Mirchandani, A.<italic>, et al.</italic> (2017). Hypoxia determines survival outcomes of bacterial infection through HIF-1alpha dependent re-programming of leukocyte metabolism. Sci Immunol <italic>2</italic>.</p><p>Toepfner, N., Herold, C., Otto, O., Rosendahl, P., Jacobi, A., Krater, M., Stachele, J., Menschner, L., Herbig, M., Ciuffreda, L.<italic>, et al.</italic> (2018). Detection of human disease conditions by single-cell morpho-rheological phenotyping of blood. <italic>ELife 7</italic>.</p><p>Tole, S., Mukovozov, I.M., Huang, Y.W., Magalhaes, M.A., Yan, M., Crow, M.R., Liu, G.Y., Sun, C.X., Durocher, Y., Glogauer, M.<italic>, et al.</italic> (2009). The axonal repellent, Slit2, inhibits directional migration of circulating neutrophils. J Leukoc Biol <italic>86</italic>, 1403-1415.</p><p>Wagstaff, L., Goschorska, M., Kozyrska, K., Duclos, G., Kucinski, I., Chessel, A., Hampton-O'Neil, L., Bradshaw, C.R., Allen, G.E., Rawlins, E.L.<italic>, et al.</italic> (2016). Mechanical cell competition kills cells via induction of lethal p53 levels. Nat Commun <italic>7</italic>, 11373.</p><p>Wan, T., Zhao, Y., Fan, F., Hu, R., and Jin, X. (2017). Dexamethasone Inhibits S. aureus-Induced Neutrophil Extracellular Pathogen-Killing Mechanism, Possibly through Toll-Like Receptor Regulation. Front Immunol <italic>8</italic>, 60.</p><p>Werth, N., Beerlage, C., Rosenberger, C., Yazdi, A.S., Edelmann, M., Amr, A., Bernhardt, W., von Eiff, C., Becker, K., Schafer, A.<italic>, et al.</italic> (2010). Activation of hypoxia inducible factor 1 is a general phenomenon in infections with human pathogens. PLoS One <italic>5</italic>, e11576.</p><p>Ye, B.Q., Geng, Z.H., Ma, L., and Geng, J.G. (2010). Slit2 regulates attractive eosinophil and repulsive neutrophil chemotaxis through differential srGAP1 expression during lung inflammation. J Immunol <italic>185</italic>, 6294-6305.</p><p>Zhang, W., Lin, Y., Zong, Y., Ma, X., Jiang, C., Shan, H., Xia, W., Yin, L., Wang, N., Zhou, L.<italic>, et al.</italic> (2022). Staphylococcus aureus Infection Initiates Hypoxia-Mediated Transforming Growth Factor-beta1 Upregulation to Trigger Osteomyelitis. mSystems <italic>7</italic>, e0038022.</p><p>Zhou, S.L., Luo, C.B., Song, C.L., Zhou, Z.J., Xin, H.Y., Hu, Z.Q., Sun, R.Q., Fan, J., and Zhou, J. (2022). Genomic evolution and the impact of SLIT2 mutation in relapsed intrahepatic cholangiocarcinoma. Hepatology <italic>75</italic>, 831-846.</p></body></sub-article></article>